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Abstract 
Gram-negative bacteria possess tripartite pumps, composed of a membrane fusion 
protein (MFP), an inner membrane protein (IMP) and an outer membrane protein 
(OMP), to transport drugs across the inner and outer membranes. The plasmid 
encoding MacA, MacB and TolC confers resistance to the macrolide erythromycin in 
the host E. coli cell Kam3, indicating the three proteins are assembled and actively 
functional. MFPs are believed to have an important role in the stabilizing the pump 
complex; intriguingly, we found that the MFP MacA not only interacts directly with 
the IMP MacB and the OMP TolC, but regulates the function of MacB, apparently 
increasing its affinity for both ATP and erythromycin. As MacB hydrolyzes ATP there 
is a burst in phosphate production that is symptomatic of the reaction being rate-
limited by product release; but the burst disappeared in the presence of MacA. Since 
MacA caused only a marginal increase in the k c a t , but a significant decrease in the K m , 
for the steady-state ATPase activity, this suggests that the disappearance of the 
phosphate burst is due to a decrease in the rate of hydrolysis, rather than an increase in 
the rate of product release. This kinetic behaviour indicates that MacA promotes and 
stabilizes the ATP-binding form of the transporter. MacA regulates the activity of 
MacB via its 0-strand domain since S. aureus MacA, which lacks the coiled coil 
structure that is present in E. coli MacA and believed to be involved in the interaction 
with TolC, was able to abolish the Pi burst catalysed by MacB, in direct analogy with 
the effect of E. coli MacA on MacB. Analytical ultracentrifugation, mass spectrometry 
and atomic force microscopy indicated that MacB forms dimers, in analogy to ABC-
transporters that require a pair of NBDs to bind ATP. Our data suggests a direct role 
for MacA in facilitating the delivery of drugs by MacB to TolC: by enhancing the 
binding of drugs to MacB and stabilizing the reorientation of MacB to the outward-
facing conformation. 
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the effect of E. coli MacA on MacB. Analytical ultracentrifugation, mass spectrometry 
and atomic force microscopy indicated that MacB forms dimers, in analogy to ABC-
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Chapter one: Introduction 
Membrane transporters are involved in the translocation of drugs and 
antibiotics, uptake of nutrients, protein secretion, toxin production, photosynthesis and 
many other vital functions in all organisms (Henderson, 1998). Such membrane 
proteins are notoriously difficult to study due to their hydrophobicity and low 
expression levels. These difficulties can explain that whilst membranes proteins 
account for 30% of all cells proteins, only around 160 membrane proteins structures 
have been solved, whereas the structures of over 8,000 soluble proteins have been 
solved (Michel, 2006; White, 2008). 
Multidrug transporters, as implied by the name, confer resistance to multiple 
drugs by pumping them out of cells, decreasing the intracellular concentration of the 
drug to subtoxic levels (Borges-Walmsley, 2003). It therefore not only leads to 
prolonged and more complicated treatments but also an increase in the cost of 
diagnoses and cures. Recent progress in sequencing of microbial genomes and protein 
crystallography provide opportunities to identify novel antibacterial targets for the new 
development of drugs. To prevent and control infectious diseases caused by the 
multidrug-resistant bacteria, more research into multidrug transporters, which are 
recognized as a major contributor to multidrug resistance, are urgently required. 
The MacB protein, an ATP binding casstte (ABC) macrolide antibiotic 
resistance transporter from E. coli (Kobayashi et al., 2001), was studied in order to 
determine its biochemical and structural properties. Our interest was in determining the 
mechanism of regulation of the ATPase activity of MacB by MacA and the function of 
the tripartite complex pump: MacA/MacB/TolC. The ABC transporter MacB was 
easier to investigate than other pumps, such as those belonging to the RND family in 
terms of its interaction with MacA due its ATPase characteristic. Importantly, an 
understanding of the MacA/MacB/TolC system may give us more understanding of 
type I secretion systems in bacteria, such as the HlyB/HlyD/TolC system, where HlyB 
is an ABC transporter (Thanabalu et al., 1998). 
In the Type I secretion system, a continuous channel is formed by the assembly 
of multiple proteins into a complex that spans the inner, outer membranes and 
periplasmic region. The mechanisms of the type II and type V secretion systems are 
2 
characterized by a two-step process that involves periplasmic intermediates. The type 
III secretion system was mediated by approximately 20 proteins and it is sec-
independent. The type IV secretion system is involved in genetic exchange, transfer of 
DNA (Gerlach and Hensel, 2007). 
3 
1.1 Antibiotics 
Antibiotics, which literally means "against life", were originally produced by 
bacteria or fungi. They are used to attack the specific agent causing the infection, 
hence helping the infected host to eliminate the infection. However, extensive use of 
antibiotics has raised a serious public health problem due to multidrug resistance, in 
which bacteria become resistant to multi-antibiotics.A common clinical problem in 
patients with infectious diseases as well as in patients with cancer, multidrug resistance, 
a phenomenon which enable a disease-causing prokaryotic or eukaryotic 
microorganisms to resist distinct drugs of a wide variety of structure and function 
targeted at eliminating the organism. The efflux of drugs by the multidrug transporter 
p-glycoprotein is one of the principal ways for multidrug resistance. 
To combat diseases caused by multidrug resistant bacteria, we need to learn more 
about the physiology of pathogens to aid in designing new drugs and extend the life of 
antibiotics (Alanis et al., 2005). 
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1.1.1 Target of antibiotics 
Antibiotics are usually classified on the basis of their chemical structures and 
modes of action. The main classes of antibiotics inhibit four classical targets: (a) cell 
wall biosynthesis, (b) protein biosynthesis, (c) DNA and RNA biosynthesis, and (d) 
other targets, such as cytoplasmic membrane biosynthesis. 
Inhibition of bacterial cell wall biosynthesis 
p-lactam antibiotics, such as penicillin, penicillin G and amoxicillin, can inhibit 
the formation of peptidoglycan crosslinkings in the bacterial cell wall. The P-lactam 
(Figure 1.1) moiety of penicillin binds to the transpeptidase that links the 
peptidoglycan molecules in bacteria, weakening the cell wall of the bacteria, that can 
lead to cell cytolysis (Spratt and Cromie, 1988). 
The p-lactam ring 
Y 
Figure 1.1 Penicillin core structure; with the P-lactam ring indicated. 
Inhibition of protein biosynthesis 
There are a large number of steps involved in protein synthesis, and many kinds of 
antibiotics are used to bind to bacteria ribosome and block protein synthesis. This 
action is mainly bacteriostatic, but can also be bactericidal at higher concentrations. 
Bacteriostatic antiobiotics interfere with bacterial growth, while bactericidal 
antiobiotics kill bacteria. These two actions are accomplished by different mechanisms. 
Bactericidal actions can disrupt bacterial cell wall or plasma membrane, and 
bacteriostatic actions can interfere with protein synthesis, nucleic acid synthesis, or 
other vital metabolic processes, which may become bactericidal when the bacteria 
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deplete some essential materials, such as ATP, a main energy source for the majority 
of cellular functions. 
For example, aminoglycosides and tetracyclines can interact with the 30S 
subunit of the bacterial ribosome; macrolides (Figure 1.2) and chloramphenicol can 
bind to the 50S subunit of the bacterial ribosome, therefore inhibiting translocation of 
tRNA (Brodersen et al., 2000; Katz and Ashley, 2005). 
macrolide ring 
OH 
\ 
H / 
OH 
Figure 1.2 Core structure of erythromycin. A first generation macrolide, with 
the macrolide ring indicated upper left. 
Inhibition ofDNA and RNA biosynthesis 
DNA replication is an essential process for all organisms. On the premise that 
eukaryotic cells do not contain DNA gyrase or topoisomerase IV, quinolone and 
fluoroquinolones antibiotics such as norfloxacin are used to inhibit the DNA gyrase or 
the topoisomerase IV enzyme to stop DNA replication and transcription, therefore 
actively killing bacteria (Li, 2005). Rifampicin inhibits RNA polymerase by binding to 
the P subunit of RNA polymerase, thus preventing transcription of mRNA and its 
subsequent translation into proteins (Campbell et al., 2001). 
Other targets 
The current generation sulfa drug sulfamethoxazole is used in combination 
with trimethoprim and each drug inhibits distinct steps in folic acid metabolism 
(Huovinen, 2001). 
Antimicrobial peptides, secreted from both gram-positive and gram-negative 
bacterial, have been classified within the bacteriocins. Most antimicrobial peptides 
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such as nisin can attack cytoplasmic membranes, permeabilize target membranes, 
eventually leading to cell death (Hancock and Chappie, 1999). 
1.1.2 Antibiotic resistance 
Antimicrobial resistance is a growing problem in the world. For instance, the 
first case of antimicrobial resistance occurred in the late 1930s and 1940s, soon after 
the introduction of the first antibiotic classes, sulfonamides and penicillins (Alekshun 
and Levy, 2007). Common bacteria, such as strains of S. aureus, became resistant to 
these classes of antibiotics. In 2002, a report indicated that strains of Group A 
Streptococcus are becoming resistant to macrolides and spreading outside the hospital, 
causing community-acquired infections (Martin et al., 2002). 
The major mechanisms of antibiotic resistance are as follows: 
Avoiding accumulation of antibiotics 
The prevention of antibiotic action is by either increasing the efflux or 
decreasing the influx of antibiotics across biological membranes. Cells having mutant 
TolC, R367H or R390C, show hypersensitivity to drugs, which is presumably caused 
by having TolC tunnel open, which allow more antibiotics entered the cell than were 
expelled (Augustus et al., 2004). 
Drugs are pumped out by multidrug transporters faster than they can diffuse 
across membranes, so the drug level inside can be kept low, at levels that are much less 
effective. Multidrug transporters present in both gram-positive and gram-negative 
bacteria confer resistance to a wide variety of drugs and this is now recognized as a 
major mechanism for multidrug resistance in bacteria (Alekshun and Levy, 2007). 
Destruction of antibiotics by either modification or hydrolysis 
Enzymatic inactivation of antibiotics is a major mechanism of resistance in 
pathogenic bacteria to natural antibiotics such as p-lactams, aminoglycosides and 
chloramphenicol (Walsh, 2000). The classic case is the hydrolysis of the four-
7 
membered P-lactam ring in penicillins by P-lactamases from resistant bacteria, 
resulting in the inactivation of the antibiotics. 
Modification of the drug target 
The antibiotic mechanism of target alternation is by modification of the normal 
target so that it does not bind the antibiotics. As previously stated, erythromycin can 
bind to the 50S subunit of the bacterial ribosome to inhibit the translocation of tRNA. 
The methyl transferase enzyme Erm can methylate a specific adenine residue of the 
23S RNA component of the ribosome without the interference of protein biosynthesis 
and lower the affinity of the macrolides for the RNA (Walsh, 2000). 
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1.2 Multidrug transporters 
ATP ADP ATP ADP 
H +/Na + 
Drug 
Drug 
ABC transporter Secondary active transporter 
Figure 1.3 ABC and secondary active transporters 
The efflux of cytotoxic compounds out of cells by transmembrane proteins is 
one of the most important mechanisms for drug resistance in prokaryotes and 
eukaryotes (Borges-Walmsley et al, 2003). Most multidrug transporters have been 
divided into two groups by their energy requirements: those membrane transporters 
belonging to ATP binding Cassette (ABC) transporters which can couple transport to 
the hydrolysis of ATP; and secondary active transporter, which can use the potential 
energy of the electrochemical gradients of H + or Na + across the membrane (Figure 1.3). 
1.2.1 Powerful multidrug transporters: What are they? 
Secondary active transporters have been categorized into several families by 
their sequence similarities: these include the Resistance-Nodulation-cell Division 
(RND) family, the Major Facilitator (MF) superfamily, the Small Multidrug Resistance 
(SMR) family, the Multi and Toxic Compound Extrusion (MATE) family and the 
Drug-Metabolite Efflux (DME) family; while the DME family has only recently been 
described and are not well characterized, they are believed to have some similarity to 
the SMR family (Jack et al., 2001). 
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1.2.1 Secondary active transporters 
MF family 
The MF transporters form the largest family of the secondary active 
transporters (Figure 1.4) (Saidijam et al, 2006), and these MF family proteins 
transport drugs, ions, sugars sugar-phosphates, nucleosides, amino acids, and peptides. 
In 1998, transport proteins from eukarya, archaea and bacteria were categorized 
on the basis of their molecular phylogeny (Saijijam et al., 2006) and transport 
proteins for each organism are classified on the basis of their energy coupling 
mechanism, protein phylogenic family and substrate specificity. Drug efflux proteins 
fall into five classes, where MF and ABC superfamily are the the largest families 
among them. 
MF transporters are typically 400 to 600 amino acids long and arranged into 12 
trans-membrane a-helices (Figure 1.5), with a large cytoplasmic loop between helices 
six and seven (Saier et al., 1999). A smaller number of these transporters have 14 
trans-membrane a-helices, such as the 5*. aureus tetracycline and divalent cation 
transporters TetA(K) (Ginn et al., 1997) and QacA, respectively (Paulsen et al., 
1996). 
Distribution of Drug Efflux Systsms 
mw.tr i w f i . 
M 3 
•a; 
•3 
1 • - > 
iiLJiiiiiiiL m k 
Figure 1.4 Distribution of putative drug efflux systems in different 
microorganisms. The colors signify as follows from the bottom: light 
blue, ABC; red, MFS; green, RND; dark blue, MATE; and orange, 
SMR. See ref. Saidijam et al., 2006 for more formation. 
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MdfA 
MdfA, a 410 residue protein arranged into 12 transmembrane helices (Figure 
1.5) (Adler et al. 2004; Adler and Bibi, 2002), confers resistance to a remarkably 
diverse group of cytotoxic compounds, including cationic, zwitterionic and uncharged 
substrates (Edgar and Bibi, 1997; Nishino and Yamaguchi, 2001; Lewinson et al., 
2006). 
Figure 1.5 Secondary structure model of M d f A (Adler et al., 2004) 
Early studies revealed that the charged residue located in the transmemembrane 
domain, Glu 2 6 in helices 1, is important in substrate recognition (Edgar and Bibi, 1999). 
Oft 
Replacement of Glu with the positively charged residue lysine eliminated the 
resistance against the positively charged drug ethidium bromide, but retained the 
resistance to chloramphenicol. Interestingly, when Glu 2 was replaced by the 
negatively charged residue aspartate, chloramphenicol recognition and transport 
greatly decreased; however, resistance against lipophilic cations remained. In addition, 
mutagenesis studies revealed many second site mutations that restored the function of 
inactive E26 mutants in chloramphenicol. Several of them were differentially affected 
by different substrates, suggesting different drugs may interact with different regions 
of the pocket (Adler and Bibi, 2004). A similar observation was made using direct 
binding studies, which showed positively charged drugs competed with the cationic 
compound tetraphenylphosphonium (TPP+) in binding to MdfA, whereas some 
zwitterionic drugs did not. Besides, the neutral drug chloramphenicol stimulated the 
binding of TPP+ by increasing its affinity for MdfA, implying that the two drugs could 
simultaneously bind to two distinct sites (Lewinson and Bibi, 2001). 
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EmrD 
The MF family transporter EmrD structure was reported and the transport 
mechanism was proposed in 2006 (Yin et al., 2006). EmrD was first identified as an 
efflux pump transporting uncouplers of oxidative phosphorylation such as cyanide-M-
chlorophenyl hydrazone (CCCP) (Naroditskaya et al., 1993), but subsequently 
reported to be able to export a broad spectrum of hydrophobic compounds (Nishino 
and Yamaguchi, 2001). The topology of EmrD is shown in figure 1.6a; EmrD has 12 
transmembrane a helices and its N - and C- termini are located in the cytoplasm. As 
illustrated in figure 1.6b H3, H6, H9 and H12 face away from the interior and are not 
involved in the pore formation; on other hand, the four central helices H I , H4, H7, 
H10 and the four lateral helices H2, H5, H8, H l l surround a central cavity, which 
consists mostly of hydrophobic residues, allowing transportation of lipophilic 
compounds. Among them are the two pairs of stacked aromatic groups, Tyr /Tyr and 
Trp 3 0 0/Phe 2 4 9, which could be involved in substrate binding. In Bmr, a close homolog 
of EmrD, two phenylalanines have been implicated in substrate recognition. Yin et al 
in 2006 proposed that two long helical regions, (H4/L4-5/H5 and H10/L10-11/ H I 1), 
and H I , located on the cytoplasmic side, could serve as a selectivity filter. A potential 
mechanism for drug transport is that CCCP can enter the central cavity, either through 
the membrane leaflet or cytoplasm, and is recognized by the long helical filter region, 
and is subsequently bound by hydrophobic residues in the cavity (Figure 1.6c). 
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Figure 1.6 The structure of EmrD by ribbon presentation, (a) Side view of the 
EmrD. (b) Top view of the EmrD. (c) The proposed mechanism of the 
EmrD transporter (Yin et al., 2006). 
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SMR family 
The smallest multidrug transporters belong to the SMR family, which are 
around 100 amino acids long. The SMR family transporters extrude various drugs in 
exchange for protons, conferring bacteria resistance to these compounds (Yerushalmi 
et al., 1995; Schuldiner et al., 2001). 
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Figure 1.7 Secondary structure model of EmrE-His. Putative transmembrane 
domains are shown in boxes connected by hydrophilic segements. 
Charged residues are highlighted and the ones conserved in EmrE 
homologs are shown with black circles (Yerushalmi and Schuldiner, 
2000). 
The best studied SMR transporter EmrE from E. coli, which confers resistance 
to ethidium bromide and methyl viologen, is putatively arranged into four 
transmembrane a helices (Figure 1.7) (Yerushalmi et al., 1995; Yerushalmi and 
Schuldiner, 2000; Ninio et al., 2004). Cysteine scanning mutagenesis and FTIR 
experiments indicated that EmrE is composed of a tightly packed bundle of a-helices 
without any continuous aqueous domains, implying substrates are transported through 
a hydrophobic pathway in the protein (Mordoch et al., 1999; Arkin et al., 1996). 
Further study on the identity of amino acid residues in the substrate binding and 
transportation pathway have been provided by site-directed mutagenesis and 
biochemical experiments. Seven of the eight charged amino acids located in putative 
loops of EmrE can be replaced with either cysteine or other amino acids bearing the 
same charge without significant change on transport activity. The other charged amino 
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acid Glu , a carboxylic residue conserved in all EmrE homologs, located in the first 
putative transmembrane domain is essential for substrate binding and efflux of the 
drug TPP+ (Yerushalmi and Schuldiner, 2000). In addition, further data exploring the 
drug binding domain indicated that some aromatic residues from transmembrane 
domain 2 and 3 form part of the binding site (Sharoni et al., 2005). 
Although the oligomeric state in vivo is still under dispute, the minimal 
functional unit for substrate binding is a dimer (Butler et al., 2004; Ubarretxena-
Belandia et al., 2003). The EmrE-detergent complex was extracted from membranes in 
a form that retains the ability to bind the drug TPP+ in a 3 to 1 molar ratio (Muth et al., 
2000), which may be due to some inactive monomer. A projection structure of EmrE at 
7.0 A resolution 2D crystals showed the repetitive unit in the crystal comprised of 
eight a-helices arranged in an asymmetric manner, indicating the minimal functional 
unit for EmrE was a dimer (Figure 1.8a) (Tate et al., 2001). When TPP+ binds to EmrE 
in the 2D crystals, a small conformational change occurs that is shown to be mainly 
due to the movement of a single a-helix (Tate et al., 2003). The recent X-ray EmrE-
TPP+ strucuture revealed another characteristic in the EmrE structure, dual topology 
(Chen et al., 2007). In this structure, the SeMet sites are related by a pseudo-twofold 
rotational axis running along the dimmer interface parallel with the membrane plane. 
Conserved Glu 1 4 point toward the binding chamber and appear well placed to form 
ionic contacts with the positively charged TPP molecular (Figure 1.8b). As illustrated 
in 1.8c, it shows the Se sites in the first transmembrane helices (residues 21 and 21*) 
are located pseudo-symmetrically on opposite sides of the bilayer. This feature 
indicates that the X-ray structure of the EmrE-TPP+ is an antiparallel dimer. 
This EmrE structure is consistent with some biochemical data; for example, the 
membrane-embedded glutamate (E 1 4 ) is involved in substrate binding and 
translocation; the conserved Trp 6 3 in the third transmembrane helix has been identified 
as an essential residue that is involved with binding of the substrate and protein 
activity (Elbaz et al., 2005); in the same helix, Tyr 6 0 is also essential for activity; Tyr 4 0 
is conserved in the EmrE branch of the SMR family, and its replacement has an effect 
on the specificity of the transporter to substrates (Soskine et al., 2004; Sharoni et al., 
2005). Tryptophan residues may play several roles in intergral membrane proteins. For 
example, tryptophan residues can maintain interactions between a protein and its 
substrate using hydrophobic stacking interactions (Vazquez-Ibar et al., 2003); they 
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may also participate in cation/n interactions between protein and their ligands 
(Zacharias and Dougherty, 2002); moreover, the locations of tryptophan resides of 
membrane proteins tend to be at the ends of transmemrbane a-helices (Arkin and 
Brunger, 1998), reflecting the amphipathic nature of a tryptophan residue that has the 
ability to form hydrogen bonds, as well as to exhibit hydrophobic character. 
The proposed mechanism of transport involves the binding of TPP+ by the two 
membrane-embedded Glu 1 4 residues located in transmembrane domain 1 (Figure 1.8d). 
The substrate enters EmrE either from the inner leaflet of the cytoplasmic membrane 
or directly from the cytoplasm. The binding site, occupied by the substrate, triggers a 
conformational change so that it becomes accessible to the other face of the membrane. 
The direct binding of protons to both Glu 1 4 residues induces the release of substrate at 
the periplasmic surface. The chamber where TPP+ binds is sealed at the top by helix H; 
the creation of an opening on the opposite side of the membrane from the chamber 
entrance would require the move of this helix, whilst the proximity of helices G and F 
could mean they move as a group. 
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Figure 1.8 Structure of EmrE. (a) Projection map of EmrE at 7.0 A resolution. 
The interpretation of each mark are as follows: P, an a-helix nearly 
perpendicular to the membrane plane; T, probably a single a-helix tilted 
with respect to the membrane normal; A, an arc of probably for tilted a 
helices (Tate et al., 2001). (b) Top view of the EmrE-TPP+ structure, 
with transmembrane helices labeled. Red spheres represent the residues 
that have been implicated in substrate binding and transport by 
biochemical and mutagenesis studies (Chen et al., 2007). (c) Front view 
of the EmrE-TPP+ structure, with two SeMet markers, (d) The proposed 
mechanism of transport by EmrE (Ubarretxena-Belandia et al., 2003). 
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RND family 
RND transporters can be found in all three kingdoms of life, Eukarya, Acrhaea 
and Eubacteria. RND transporters are composed typically of 1000 amino acid residues 
and are much larger than other secondary active transporters (Borges-Walmsley et al., 
2003). A characteristic feature of the topology of RND transporters is the presence of 2 
large periplasmic loops between transmembrane helices 1 and 2 and 7 and 8. Since the 
N-terminal halves of RND transporters are homologous to the C-terminal halves, this 
suggests that these transporters have arisen by gene duplication. 
AcrB 
AcrB, the best studied member of the RND family, is a multidrug transporter 
that confers resistance to a wide range of antibiotics; including tetracycline, 
chloramphenicol, P-lactams, novobiocin, fusidic acid, nalidixic acid, and 
fluoroquinolones; the detergent SDS and Triton X-100; various cationic dyes, 
disinfectants, and even solvents (Poole, 2001). 
The first crystal structure of AcrB was obtained at 3.5 A resolution. The three 
protomers are fixed symmetrically by the crystal packing force (Murakami et al., 
2002). The appearance of the AcrB trimer is like a jellyfish with a three-fold symmetry 
axis perpendicular to the membrane plane. It comprises a periplasmic headpiece and a 
transmembrane region with approximate dimensions of 70 A by 50 A, respectively. 
The AcrB structure contains three domains: the transmembrane (TM) domain, the 
porter domain and the TolC docking domain (Figure 1.9a). The porter domain is 
composed of four subdomains, PN1, PN2, PCI and PC2 for each protomer. PN1 and 
PN2 locate between TM1 and TM2 and PCI and PC2 locate between TM7 and TM8. 
Each subdomain contains two characteristic P-strand-a-helix-P-strand motifs. These 
four subdomains are packed with their P-sheets surrounding a substrate binding pocket 
(Figure 1.9b). 
More recently, the structure of new crystal forms of AcrB have been 
determined in which each protomer adopts a different conformation (Murakami et al., 
2006; Seeger M. et al., 2006), leading to a rotating pump mechanism. 
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Figure 1.9 AcrB structure, (a) The side view of the AcrB structure in ribbon 
representation, (b) The topology diagram of the protomer (Murakami et 
al, 2002). 
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Bound minocycline was observed in one of the three protomers at the distal end of the 
pocket, between the p-sheets of PN2 and PC 1 (Figure 1.1 Oa). The substrate binding 
pocket is rich in aromatic amino acid residues which may interact with the drug 
molecule by hydrophobic or aromatic-aromatic interactions. It has been shown that 
two different sets of amino acid can interact with different drugs, indicating different 
sets of residues are used for binding of different kinds of substrates. 
I f we compare the protomer involved in extrusion to the one involved in 
binding drugs, an asymmetric difference can be recognized (Sennhauser et al., 2007; 
Das et al., 2007; Seeger et al., 2008). PN2 and PCI are moved back towards PN1 and 
PC2 in the extrusion protomers, making the pocket too small to bind substrates. The 
inclined central helix (Figure 1.10a) from the extrusion protomer fills the possible 
"exit gap" between PN1 and PN2 in the binding protomer and creates a space between 
PN1 and PN2 in the extrusion protomer opening to the top funnel. Based on the 
different conformations of the three protomers of AcrB, a three step, (access, binding 
and extrusion), mechanism was proposed (Figure 1.11). In the access state, the 
vestibule is open to the periplasm, but the binding pocket is shrunken, making it 
impossible for substrates to have access to the vestibule. In the binding state, the 
vestibule is kept open and the binding pocket is expanded for substrate binding. At this 
stage, exit from the binding site is blocked by the inclined central helix from the 
extrusion protomer. Final, in the extrusion state, the squeezing of the binding pocket 
pushes the bound drugs out via the top funnel. Theses protomer conformation can be 
expected to be coupled with proton translocation across the membrane. Asp 4 0 7 , Asp 4 0 8 
and Lys 9 4 0 in transmembrane helices have been identified as essential amino acid 
residues for AcrB function and are probably involved in proton translocation. In the 
access and binding protomers, Lys 9 4 0 of TM10 is coordinated by salt bridges with 
Asp 4 0 7 and Asp 4 0 8 of TM4. In contrast, Lys 9 4 0 in the extrusion protomer is turned 
towards Thr 9 7 8 of TM11 and this causes movement of TM4 and TM10 (Figure 1.10b). 
Site mutagenesis and drug susceptibility studies have also shown that Thr 9 7 8 is 
essential for drug transport (Takatsuka and Nikaido, 2006). Unfortunately, how the 
twisting of these transmembrane helices causes the movement of the subdomains and 
the central a-helix inclination is still unclear. 
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Figure 1.10 The asymmetric crystal structure of AcrB-minocycline complex, (a) 
Cut view of the porter domain from the distal side of the cell. The 
bound minocycline molecule is colored in orange, (b) The bottom view 
of the AcrB transmembrane domain structure from the periplasmic side 
(Murakami et al., 2006). 
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Figure 1.11 Schematic illustration of the proposed transporter mechanism. A, B 
and E represents the Access, Binding and Extrusion conformation 
respectively, (a) Side view of the proposed tripartite efflux pump AcrA-
AcrB-TolC. (b) The proposed conformational change mechanism of 
three protomers of AcrB in a transport cycle (Schuldiner, 2006). 
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MATE family 
MATE transporters can be found in all three kingdoms of life, Eukarya, 
Archaea and Eubacteria. In bacteria, these transporters are around 450 amino acids 
long and putatively arranged into 12 transmembrane ot-helices (Figure 1.12) (Singh et 
al., 2006). Based on the similar size and topology, MATE transporters were once 
suggested to be members of the MF family; however, they have no similarity in 
protein sequence with MF transporters (Brown et al., 1999), such as the five-residue 
motif (RXGRR), located between TM2 and TM3. (Pao et al., 1998) 
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Figure 1.12 Putative topology of NorM, with the 12 transmembrane helices boxed 
(Singh et al., 2006). 
NorM 
Of all multidrug transporters, our knowledge of the MATE transporters is most 
rudimentary because they have had little study. NorM, a Na+/multidrug anti-porter, 
first found in V. parahaemolyticus, confers resistance to hydrophilic fluoroquinolone 
such as norfloxacin, ciprofloxacin and ethidium bromide, is the best characterized 
MATE transporter (Morita et al., 1998). The topology of NorM from V. cholerae 
originally predicted by the algorithm HMMTOP was validated by fusing C-terminal 
truncations of NorM to either the TEM p-lactamase or chloramphenicol 
acetyltransferase (CAT) reporter (Figure 1.12). These studies indicated that NorM has 
12 transmembrane domains and both the N - and C-terminal ends are located in the 
cytoplasm. In addition, some residues located on the hydrophilic loops are suggested to 
be involved in norfloxacin efflux (Singh et al., 2006). Mutagenesis experiments 
indicated that the acidic amino acid residues Asp , Glu , and Asp , highly 
conserved in cluster 1 MATE transporters, located on the putative transmembrane 
domains 1, 7 and 10 of NorM, are involved in Na+-dependent drug transport process 
(Otsuka et al., 2005). 
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1.2.2 ABC transporters 
1.2.2.1 What are they? 
ATP binding Cassette (ABC) transporters can couple ATP (Adenosine 5'-
triphosphate) hydrolysis to transport of a tremendous variety of substrates including 
drugs, vitamins, peptides, polysaccharides, ions, sugars, lipids and even proteins across 
cellular membranes in all organisms (Higgins, 1992; Hollenstein et al., 2007). 
ABC transporters have been conserved across the three kingdoms of Archaea, 
Eubacteria and Eukarya. Their ubiquitous distribution and primordial origin reflect the 
fundamental requirement of cellular homeostasis to import and concentrate essential 
nutrients, expel toxins acquired from the environment, and produce metabolic by-
products. The report of the complete genome sequence of E. coli K-12 identified 80 
ABC proteins, equals to 5% of the genome. In humans, ABC transporters can be 
grouped into seven different subfamilies (A, B, C, D, E, F, G) (Tatusov et al, 1997). 
In humans, P-glycoprotein (p-gp) in the plasma membrane is probably the best 
studied ABC drug efflux transporter. It can transport a wide of substrates; including a 
number of drugs, such as the anti-cancer drugs doxorubicin and daunorubicin that are 
applied in therapeutic applications. MRP1, which localizes to the basolateral 
membrane of epithelial cells, was first identified in a cell line and shown to confer 
resistance to a range of anti-cancer drugs, such as anthracyclines (Cole et al, 1994; 
Evers et al, 1996). 
ABC importers mediate the uptake of essential nutrients, whereas ABC 
exporters expel diverse substrates (Figure 1.13). The ABC exporter is formed by the 
transmembrane domains (TMD) and the nucleotide binding domains (NBD). In most 
cases, P-gp for example (Figure 1.13a), a single polypeptide includes the four domains, 
forming a TMD-NBD-TMD-NBD structure. On the other hand, the LmrA, a multidrug 
efflux pump, needs two polypeptides to form the functional unit. 
Unlike ABC exporters, the ABC importers require the additional soluble 
protein substrate-binding-protein (SBP) to bind the substrate and deliver it to the 
translocator in the membrane. In many cases, each domain of ABC importers is 
present as a separate polypeptide, giving a total of five unique proteins (Figure 1.13b), 
such as the maltose importer MalEFGK2 and vitamin B12 importer BtuC2D2F. 
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The membrane-bound complex importer MalFGK 2 from E. coli, with the help 
from MalE, a soluble periplasmic receptor, can mediate the uptake of the nutrient 
maltose from the periplasm across the membrane into the cytoplasm (Diederichs et al., 
2000). Some ABC transporters in bacteria are around 35% identical to the P-gp and the 
region of homology extends from the nucleotide binding domains to the 
transmembrane domains, thus suggesting these ABC transporters not only have similar 
sequences but may transport similar substrates. LmrA, a multidrug efflux pump, from 
L. lactis, confers resistance to drugs and antibiotics and has been found to functionally 
substitute for human P-gp when expressed in lung fibroblast cells (van Veen et al., 
1998). In addition, the ABC pump Savl866 from 5". aureus also shows significant 
sequence similarity to P-gp. The structure of the Savl866-ADP complex has been 
determined and can be helpful in understanding the substrate recognition and 
transportation process (Dawson and Locher, 2006). 
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Figure 1.13 The topology of different ABC transporters. TMDs are represented 
by squares, NBDs are represented by circles, and substrate binding 
proteins with ABC importers are represented by pac-men. 
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1.2.2.2 Human diseases associated with ABC transporter 
Drugs are pumped out by ABC transporters faster than they can diffuse across 
membranes, so the drug level inside is kept low and is much less effective, causing 
problems with chemotherapeutic treatments. Besides, there are approximately 50 
known ABC transporters in humans and there are currently 13 genetic diseases 
associated with defects in 14 of these transporters. A few human diseases related to 
ABC transporters are described as follows (Gottesman and Ambudkar, 2001). 
Cancer 
Multidrug resistance (MDR) means cells have a cross-resistance phenotype against 
several unrelated drugs which differ in structure and target specificities. Resistance to 
chemotherapy is a common clinical problem in patients with cancer, and cellular 
resistance to drugs is a major reason for treatment failure. The MDR phenotype was 
first described as P-gp mediated for cancer cell, but cancer cells can be MDR without 
the involvement of P-gp (Lage, 2003). The Alterations in the signal-transduction 
pathways can abolish the function of drugs that accelerate programmed cell death. For 
example, a mutated, inactive p53 that is no longer able to trigger apoptosis after the 
detection of DNA damage caused by drugs (Hannun, 1997; Lowe et al., 1993). 
AIDS 
Human immunodeficiency virus (HIV), which causes acquired immune 
deficiency syndrome (AIDS), has been studied for more than a decade. However, it 
can not be eradicated from infected patients partially due to multidrug resistance 
(Huisman et al., 2000). The ABC transporter P-gp is known to efflux a number of 
drugs that includes the human immunodeficiency virus protease inhibitor. A report 
indicated that overexpression of p-gp can protect cell lines from the cytotoxic effects 
of high concentrations of phosphatidylinositol (PI) (Choo et al., 2000). In vivo, 
pharmacological inhibition of the accumulation of Pis in brain and testes of mice 
(Choo et al., 2000) and p-gp knockout mice also demonstrated an increased 
antiretroviral drug saquinavir accumulation in the brain (Washington et al., 2000). 
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Surprisingly, growing evidence suggests that p-gp may also affect replication 
of enveloped viruses (Owen et al., 2005). A report showed that p-gp overexpression 
can block insertion of the influenza virus fusion protein into the plasma membrane, 
inhibiting the membrane fusion and infectivity of the influenza virus (Raviv et al., 
2000). 
Cystic fibrosis 
Malfunctional ABC transporters can also cause diseases. The cystic fibrosis 
transmembrane conductance regulator (CFTR) is a cAMP-activated chloride channel, 
which creates sweat, digestive juices, and mucus, is expressed in the epithelia of the 
lung, intestine, pancreas and other tissues (Verkman et al., 2006). Mutations, such as 
the most common mutation AF508, in CFTR can cause cystic fibrosis (CF), a 
hereditary disease, where defective epithelial cell fluid transport produces chromic 
lung infection and deterioration of lung function, pancreatic insufficiency and male 
infertility. 
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1.3 The structure and mechanism of ATP-binding cassette transporters 
1.3.1 Conserved domains and motifs 
So far, each ABC transporter has been discovered to consist of four domains: 
two nucleotide binding domains (NBD) that serve as engines, where ATP can be 
hydrolyzed, coupling hydrolysis to active transport; and two transmembrane domains 
(TMD) that are believed to constitute the transport pathway. 
NBD in ABC transporters 
Many crystals of isolated NBDs are available, yielding detailed information 
about the overall structures of the nucleotide-binding sites (Davidson and Chen, 2004). 
Generally, the NBDs can be divided into two sub-domains: a RecA-like sub-domain 
and a helical sub-domain, the latter being specific for ABC transporters. The RecA-
like fold is characterized by a central P-sheet flanked by a-helices and can be found in 
a broad subclass of topologically homologues including RecA, DNA and RNA 
helicases, Fl-ATP synthase, DNA repair enzymes and ABC transporters (Ye et al., 
2004). 
Many conserved motifs, involved in ATP binding and hydrolysis or facilitating 
crucial interfaces in the assembled transporter (Higgins et al., 2004), can be recognized 
in the NBDs of ABC transporters (Figure 1.14) and will be described as follows: 
Walker A and Walker B 
The Walker A (Walker et al., 1982), also known as the P-loop, and Walker B 
motifs, present in many ATP-binding proteins and are not specific to ABC transporters. 
The highly conserved Walker A motif (G-X-X-G-X-G-K-S/T, where X represents any 
amino acid) is located after P-strand 3 and before the a-helix, and is involved in the 
coordination of the phosphates of ATP during the hydrolysis reaction. The less 
conserved Walker B motif (O-O-O-O-D-E, where O represents a hydrophobic amino 
acid) located on p-strand 7 provides a conserved aspartate that coordinates the M g 2 + 
ion in the nucleotide-binding site through H2O. The last residue, a glutamate, in the 
Walker B motif arranges the nucleophilic attack on ATP via a water molecule and 
mutation of this residue leads to loss of ATPase activity (Moody el al., 2002; Smith et 
al., 2002). Zaitseva et al. suggested that residue H662 may interact with the 7-
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phosphate moiety of ATP and water molecule 90, which forms hydrogen bonds to 
H662, E631, and via water molecule 109 to Q550, could serve as the catalytic water 
since a slight movement would be sufficient to put it in a proper orientation for attack 
of the scissile bond. 
Signature sequence 
The signature sequence, also known as the LSGGQ motif and C-loop, located 
at the joint point between the helical domain and the Walker B motif, binds to ATP, 
and is the motif that distinguishes ABC proteins from other nucleotide-binding 
proteins (Davidson, 2002). Mutations in the signature sequence inhibit ATPase activity 
(Schmees et al., 1999; Bakos et al., 1997) and structural studies indicated the motif 
contacts the nucleotide in the ATP-bound state (Smith et al., 2002; Chen et al., 2003; 
Dawson and Locher, 2006; Dawson and Locher, 2007). 
Q-loop 
The Q-loop, also known as the y-phosphate linker, following p-strand 6, 
contains a glutamine that can form hydrogen bonds with the M g 2 + and the attacking 
H2O. Verdon and co-workers (Verdon et al., 2003), on the basis of the strucutre of the 
ABC-ATPase GlcV, proposed that the role of the conserved Q-loop glutamine residue, 
and its interaction with Mg 2 + , is to keep the two ABC subdomains in close contact to 
each other. For example, mutations in the conserved glutamine in the Q-loop of MalK 
had only marginally reduced the ATPase activity but led to defective transporters when 
they interated in the membrane protein complex. 
H motif 
A conserved histidine in the H motif, located before a-helix 7, is believed to 
serve as a linchpin in ATP hydrolysis (Zaitseva et al., 2005). Chen and co-workers 
found that the H motif residue (His 1 9 2 ) not only forms a hydrogen bond with the y-
phosphate but is also involved in direct protein-protein interactions across the dimer 
interface in the ATP-bound MalK dimer (Chen el al., 2003). Mutations of the 
conserved histidine in HisP (His 2 1 1 ) (Shyamala et al., 1991), MalK (His 1 9 2 ) (Davidson 
and Sharma, 1997) and HlyB (H 6 6 2 ) (Zaitseva et al., 2004) resulted in a substantive 
decrease in the steady-state ATPase activities of these proteins. 
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D-loop 
The D-loop is located between the Walker B motif and a-helix 5 and 
contributes in the contact interface between the two NBDs. In the closed form of Malk, 
the conserved Asp 1 6 5 in the D-loop was found to form a hydrogen bond with Ser38 in 
the Walker A motif of the other subunit (Chen et al., 2003) 
A-loop 
The A-loop, a highly conserved aromatic residue approxmately 25 amino acids 
upstream of the Walker A motif, is essential for ATP-binding (Ambudkar et al., 2006). 
The structure of GlcV indicated that a phenylalanine residue is involved in the 
recognition of the adenine base (Verdon et al, 2003). Similarly, it was shown that a 
tyrosine reside interacts with the adenine ring of ATP in the HlyB-NBD structure 
(Zaitseva et al., 2005). Mutagenesis studies also indicated that ATP hydrolysis was 
abolished when Tyr 1 6 was mutated to cysteine in the histidine permease (Shyamala et 
al., 1991). 
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Figure 1.14 The conserved motifs in NBDs of ABC transporters. Crystal 
structure of the Hlyb-NBD dimer with bound ATP/Mg + (Zaitseva et al., 
2005). ATP (stick representation) and M g 2 + (green spheres) are 
sandwiched at the interface of the two monomers. 
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TMD in ABC transporters 
The TMDs create the channel that substrates pass through during translocation. 
Unlike the NBDs, the TMDs are poorly conserved. The TMDs of ABC transporters are 
diverse in primary sequence, length, and the number of transmembrane helices, 
reflecting the large diversity of substrates transported. Characteristically, ABC 
importers have between 10 and 20 transmembrane helices; while ABC exporters tend 
to form the two-times-six a-helix structure, making a total of 12 transmembrane 
helices per functional unit (Figure 1.15). However, this is not always the case. For 
example, P-gp and CFTR are functional as a single polypeptide that includes all four 
domains (Sheppard and Welsh, 1999; Loo and Clarke, 1995); whilst the ABC 
transporter MacB from E. coli is predicted to have a topology consisting of four 
transmembrane helices; which wil l be described further below (Kabayashi et al., 2003). 
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Figure 1.15 Illustration of the TMDs topology of ABC transporters. Savl866 is 
shown in green, ModB is shown in yellow and BtuC, HI 1471 are in red 
(Hollenstein et al., 2007). 
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1.3.2 Structures of ABC transporters 
So far there are five complete ABC transporter structures that have been 
determined: the importers BtuCD, from E. coli, HI1470/1, from H. influenzae and 
ModB2C2A from A. fulgidus, and the exporter Savl866, from S. aureus and MsbA. 
The four domains of the importers are on separate polypeptides and form a complex of 
homodimeric NBDs and TMDs (the structure of the periplasmic binding protein ModA 
is also shown in the ModB2C2A structure) whereas Savl866 is a half transporter with 
one NBD and one TMD on each polypeptide (Locher et al., 2002; Pinkett et al., 2007; 
Hollenstein et al., 2007; Dawson and Locher, 2006; Ward et al., 2007). 
Savl866 
Savl866 is a multidrug ABC transporter from S. aureus. When reconstituted 
into liposomes, Savl866 ATPase activity can be stimulated by the anti-cancer drugs 
doxorubicin, vinblastine and the fluorescent dye Hoechst 33342 (Dawson and Locher, 
2006), indicative of communication between the substrate binding site, in the TMD, 
and the cytoplasmic NBDs. 
The Savl866 structure is the first determined for an ABC exporter (Dawson 
and Locher, 2006). The Savl866 transporter (Figure 1.16) is a 120 A long, 65 A wide 
and 55 A deep homodimer and each polypeptide is composed of two domains: an N -
terminal TMD (amino acid residues 1-320) and a C-terminal NBD (residues 337-578). 
Conserved ATP-binding and hydrolysis motifs, which are exposed at the interface, can 
be observed in the structure, revealing a "head-to-tail" arrangement. The electron 
density map indicated that the two bound ADP molecules were sandwiched at the 
NBD-NBD interface, in contact with the Walker A motif of one NBD and the ABC 
signature motif of the other. 
Each Savl866 subunit has 6 transmembrane helices, making a full transporter 
with 12 transmembrane helices. Bundles of transmembrane helices are divided into 
two wings that point away from one another towards the cell exterior, providing an 
outward-facing conformation in the crystal (Figure 1.16). Interestingly, each wing is 
composed of helices 1 and 2 from one subunit and helices 3 to 6 from the other. A 
large cavity was observed in the interface of the two TMDs, which is exposed to the 
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extracellular space. The cavity features a hydrophilic surface, lined primarily with 
polar and charged amino-acid side chains from helices 2 to 5, in the inner leaflet. 
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Figure 1.16 Savl866 structure by ribbon representation, (a) Side view of the 
Savl866 structure with subunits colored in yellow and green, (b) Stereo 
view rotated with respect to "(a)" by 90° around the vertical axis, (c) 
Close-up view of the interfaces between NBDs and TMDs of Savl866. 
One subunit is colored in green ribbon representation and other is in 
yellow coil representation (Dawson and Locher, 2006). 
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The transmembrane helices are extended beyond the lipid bilayer by short 
extracellular loops (ECLs) and long cytoplasmic loops (ICLs), which protrude 25 A 
into the cytoplasm. ICLs 1 and 2, which connected helix 2 and 3, and 4 and 5, 
respectively, both contain short helices, known as "coupling helices", and are 
orientated approximately parallel to the membrane of the shared interface formed by 
the TMDs (figure 1.16c). Surprisingly, coupling helix 1 contacts both subunits whereas 
coupling helix 2 contacts only the other, indicating that the ICLs of Savl866 primarily 
contact the NBD of the opposite unit. In contrast, the TMDs of the ABC importer 
BtuCD contact only on NBD, resulting in a large gap at the center of the four protein 
domains (Locher et al., 2002). Residues around the conserved Q loops from the NBDs 
participate in the NBD-TMD contact interface and those residues can also be observed 
in the ABC importer BtuCD. In the BtuCD structure, residues around the Q loop 
dominate the interface between BtuC and BtuD. Side chains making specific contacts 
to the L loop of BtuC are located in helices H2, H3 of BtuD. Elements involved in 
ATP-binding and hydrolysis may be coupled to the conformation of the L loop from 
the membrane-spanning subunit and vice versa. 
In the Savl866, two prominent exceptions which wer not observed in the 
BtuCD include the conserved residues Tyr 3 9 1 and Glu 4 7 3 . The residue Glu 4 7 3 contacts 
both ICLs and is found to be part of a previously unrecognized sequence motif 
(EVGERG), only conserved in ABC exporters. This newly-discovered specific 
sequence motif, called the X-loop, may indicate that ABC importers and exporters 
have diverse coupling mechanisms (Dawson and Locher, 2006). 
Nucleotide-bound structures of MsbA provide another example of the outward-
facing conformation of an ABC transporter (Figure 1.17). The electron-density maps 
of the MsbA-AMPPNP complex showed a conformation similar to the homologous 
Savl866-ADP complex (Ward et al., 2007). Each monomer of MsbA has six 
transmembrane helices, forming a full transporter of 12 transmembrane helices. 
Similar to the Savl866 strucutre, each wing of the MsbA full transporter is composed 
of helices 1 and 2 from one subunit and helices 3 to 6 from the other. In this study, the 
structural evidence arising from three MsbA structures, the nucleotide boud, open apo 
and closed apo forms, indicated that MsbA can undergo a large range of motions 
between the apo and nucleotide-bound states. This proposal will be described in the 
following sections. 
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Figure 1.17 The stereoview of the nucleotide-bound MsbA structure. One 
monomer is colored with a rainbow gradient (N to C terminus, blue to 
red), and the other is white. The AMP-PNP molecule is displayed as 
blue sticks. 
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ModB2C2A 
The ModB2C2A is an archaeal molybdate ABC importer from A. fulgidus. This 
full-size transporter is composed of two NBDs (ModC) and two TMDs (ModB) that 
interact with a periplasmic binding protein (ModA). The structure of the complex has 
been determined to a resolution of 3.1 A using X-ray crystallography (Hollenstein et 
al., 2007) (Figure 1.18a). In the crystal, a single binding protein ModA, with bound 
tungstate, is attached to the external side of ModB2. Each ModB subunit has 6 
transmembrane helices, making a full tranporter of 12 transmembrane helices. The 
twelve helices provide an inward-facing conformation, which is wide open to the 
cytoplasm. The nucleotide free ModC subunits reveal an open conformation, which 
contrasts with the "closed conformation" for the NBDs of Savl866-ADP. 
The ModB subunits form a large cavity, possibly representing the translocation 
pathway, shielded from the lipid bilayer and only accessible form the cytoplasm. The 
cavity opens to the cytoplasmic space, narrows down towards the external membrane 
boundary and is separated from the extracytoplasmic space by a closed gate below the 
interface with the binding protein ModA (Figure 1.18b). The gate is formed by the 
joining of four protein stretches (gate regions), two from each ModB subunit. Gate 
region 1 and 2 are located in transmembrane helices 3 and 5 respectively. In addition, 
the phenyl rings of the conserved Phe2 0 0, in transmembrane helix 5, from the two 
ModB subunits are within van der Waals distance, implying their involvement in 
gating (Figure 1.18c). 
An "head-to-tail" arrangement between the P loops and the ABC signature motifs 
was observed in the two ModC subunits. Not surprisingly, a gap was observed 
between the ATP-binding motifs of the nucleotide-free NBDs, indicating a so called 
"open conformation" of NBDs. The observation of the spacing between the Walker A 
motif and the ABC signature sequence is consistent with the biochemical studies of 
Mai ABC importers in which the solvent accessibility to the fluorescently labelled 
ATP binding sites is increased in the absence of ATP (Mannering et al., 2001). In this 
study, Cys 4 0, in the Walker A motif of MalK, was labelled with 2-(4'-
maleimidoanilino) naphthalene-6-sulfonic acid (MIANS) in order to observe the 
conformational changes in the Malk subunit. 
The ModB-ModC interface is believed to transmit conformational changes, 
coupling ATP binding and hydrolysis to substrate transport. Similar to the Savl866 
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structure, the residues around the Q-loop of ModC are involved in the ModB-ModC 
interfac. The ModB residues involved in the ModB-ModC interface are located on the 
short cytoplasmic helices 4a and 4b, with 4a providing the bulk of the contacts. Similar 
coupling helices have been found in the structures of the exporter Savl866 and 
importers BtuCD and HI 1470/71. However, the sequence similarities between the 
coupling helices are limited, although their position suggests a role in coupling ATP 
binding and hydrolysis to transport. 
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Figure 1.18 The structure of the ABC transporter ModB 2C 2A. (a) The ModB 
subunits are in yellow and blue, the ModC subunits are in green and 
pink, the substrate binding protein ModA is in red, and with bound 
tungstate in van der Waals representation (yellow and blue spheres). 
The grey box indicates the possible location of the lipid bilayer on the 
basis of the hydrophobicity of the protein surface, (b) Topology of the 
ModB subunit. The conserved gated regions are colored in green and 
red. (c) Top view of transmembrane ModB subunits, with one subunit 
in yellow ribbon representation and the other in blue backbone trace 
(Hollenstein et al., 2007). 
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1.3.3 Conformational changes in NBDs 
The SavI866 and ModB2C2A structures are indicative of the "closed 
conformation" and "open conformation" of the NBDs respectively. The idea is drawn 
from comparison of the nucleotide-free-MalK and ATP-bound-MalK structures, in 
which it was possible to observe major conformational changes in the NBDs as ATP 
was bound, which has been likened to the action of a pair of tweezers (Figure 1.19). 
on 
The distance between the two His on the Q-Ioop moved from the closed form to the 
semi-open or open conformations by 9 or 25 A respectively (Chen et al., 2003; 
Oldham et al., 2007). 
In addition to the movement of the whole NBDs, a hinge rotation of the helical 
subdomain relative to the RecA-like subdomain can be observed in the MalK 
structures. The difference can be found not only in different NBD structures but in the 
same protein crystallized in different crystal lattices and even between molecules in the 
same lattice (Chen et al., 2003). Interesting, the orientation of the helical subdomains 
are the same among the three ATP-bound structures: HisP, MalK and MJ0796, 
suggesting the helical subdomain has unique orientation in the presence of y-phosphate. 
The flexibility of the helical subdomain was only observed in the NBD structures in 
the absence of the y-phosphate of ATP, suggesting an important mechanistic role for 
this movement. When the helical subdomain is tilted away from the RecA-like 
subdomain, as in the nucleotide-free conformation, the two NBDs are unable to come 
into close enough contact to form the ATP-bound dimer. This rotation of the helical 
subdomain could also be coupled with ATP binding and hydrolysis and the 
characteristic flexibility may be important in adjusting the size of the opening of the 
translocation pathway for various sizes of substrates. This can also be found in full size 
ABC transporters by comparing the NBD structures from Savl866 (closed form) and 
ModB2C2A (open form). A difference can be observed in the ModC2 dimer in the 
withdrawal of the helical subdomain from the interface with the opposite NBD, 
combined with a slight outward tilt. Also, several lines of biochemical evidence 
indicated that the association and dissociation of NBDs plays an important role in 
transport. The El71Q mutant of MJ0796 eliminated hydrolysis and stabilized the ATP-
bound dimer (Smith el al., 2002). Addition of ATP enhanced disulfide-crosslinking 
between cysteines introduced at position 85 in the Q-loops of the MalK subunits 
(Hunke et al., 2000). 
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Figure 1.19 Comparison of two MalK structures, where closed form MalK with 
bound ATP is in yellow and semi-open form MalK without bound ATP 
is in blue (Chen et al, 2003). 
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1.3.4 Mechanisms for coupling of hydrolysis to transport 
That the binding of ATP triggers the NBDs to dimerize has been described in 
the previous section. Two models for the transport mechanism, based on the Savl866 
and ModB2C2A structures, and MsbA structures, wil l be described below. 
A transport mechanism based on the Savl866 and Modl$2C2A structures 
4 <w \ 
r 
AMP-PNP 
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Figure 1.20 Conformational changes triggered by ATP. The structure of 
ModB2C2A indicates an inward-facing conformation and the Savl866 
structure indicates an outward-facing conformation The black helices 
are the coupling helices from the TMDs (Hollenstein et al., 2007). 
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A mechanism for ABC transporters has been proposed on the basis of the 
structures of the two full size ABC transporters, Sav 1866 and ModB2C2A (Hollenstein 
et at., 2007) (Figure 1.20), where Sav 1866 represents the "closed form" of the NBDs 
and the "outward-facing" conformation of the TMDs whilst ModB2C2A represents the 
"open form" of the NBDs and the "inward-facing" conformation of the TMDs. In the 
Sav 1866 structure, the distance between the coupling helices is decreased by 10-15 A 
when compared with the nucleotide-free structure for ModB2C2A. ABC importers may 
now accept substrates from their cognate binding proteins and ABC exporters may 
extrude bound drugs to the environment by presenting a cavity of low affinity to the 
extracellular medium (Loo and Clarke, 2005). The hydrolysis of ATP, and the 
subsequent release of ADP and inorganic phosphate, may return the transporter to an 
inward-facing conformation. ABC importers may now release their substrates into the 
cytoplasm, whereas ABC exporters may recruit new substrates into their high-affinity 
binding sites. 
A transport mechanism based on the structures of three conformations of MsbA 
Ward and co-workers (Ward et al, 2007) provided structural evidence, arising 
from different conformational states for MsbA, showing that MsbA can undergo a 
large range of motions between the apo and nucleotide-bound states (Figure 1.22a). 
The conformational changes between difference MsbA structures are most 
noticeable when monomers from each state are aligned using transmembrane helices 1, 
2, 3, and 6 (Figure 1.21). Comparison of the apo structures reveals that TM4/TM5/IH2 
can pivot around 30° about a hinge formed by EL2/EL3 in a rigid-body motion with 
nearly conserved NBD alignment. In apo structures, this hinge creates an inward-
facing conformation between TM3/TM6 and TM4/TM5 (Figure 1.21). Interestingly, 
although the NBDs were closed in the apo state, an ATP sandwich structure was not 
observed (Figure 1.22). In addition, the P-loops of opposing monomers are positioned 
next to one another (Figure 1.22c). 
The transition from the closed apo conformation to the nucleotide-bound 
conformation can be accounted for by two motions. Firstly, there is a 10° pivot about 
the hinge, EL2/EL3 (Figure 1.21), bringing the NBDs closer together. Secondly, the 
NBDs form an ATP sandwich by tilting the TM4/TM5 pair around 20° out of plane 
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(relative to the first motion) about that pivot point centered along its length. Since 
TM3/TM6 are connected to TM4/TM5 via EL2 and EL3, the formation of the NBD 
sandwich pulls TM3/TM away from TM1/TM2 (Figure 1.22ab). An outward opening 
is created between TM3/TM6 and TM1/TM2, which is different from the inward 
opening created between TM3/TM6 and TM4/TM5. The conformational changes 
(Figure 1.21 and 1.22) in the NBDs cause a rearrangement of the packing of TMDs, 
switching access to the internal chamber from the inner to the outer leaflet of the 
bilayer. The large inward-facing opening may serve an important role in transport 
because the open and closed apo structures can accommodate substrates from the inner 
leaflet or the cytoplasm. Substrate binding to the inward-facing conformation may lead 
to the closure the TMDs and then rearrangement of the NBD, allowing the formation 
of an ATP sandwich conformation. 
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Figure 1.21 Comparison of the MsbA monomers. The stereoview of the 
conformational changes within the MsbA monomer illustrates the 
mobility of the TM4/TM5/IL2. Monomers are aligned on 
transmembrane helices 1, 2, 3 and 6. Two apo open MsbA monomers 
that differ in the relative positioning of TM4/TM5/IH2 are shown in 
blue and cyan. The apo closed MsbA is colored in green and the 
nucleotide-bound MsbA is in yellow (Ward et al., 2007). 
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Figure 1.22 Conformational changes in MsbA. (a) Conformational changes in the 
open apo, closed apo and nucleotide-bound MsbA. (b) Model of the 
conformations changes. The arrows illustrate the motions required to go 
to the next state, (c) Top view of the NBDs. One monomer is colored in 
white and the other in gray (Ward et ah, 2007). 
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1.4 Tripartite multidrug efflux pumps in gram-negative bacteria 
Antibiotic resistance due to multidrug transporters is a growing problem in the 
world; to combat them, more research into the transport mechanism and structures of 
efflux pumps is necessary. Gram-negative bacteria possesse tripartite complex pumps 
which are composed of an inner membrane protein, a periplasmic protein and an outer 
membrane protein, which work together to confer multidrug resistance. Recent studies 
have brought a better understanding of tripartite drug efflux pumps, particularity, 
AcrA/AcrB/TolC in E. coli and MexA/MexB/OprM in P. aeruginosa. The 
determination of the structures of the three components, AcrA, AcrB and TolC, 
provide us with clues to the function and mechanism of these tripartite efflux 
complexes (Koronakis et al., 2000; Mikolosko et al, 2006; Murakami et al, 2002). 
TolC structure 
TolC, a multifunctional outer membrane protein, is involved in type I secretion 
of toxins and proteases and plays an important role in antibiotic efflux. It can export 
haemolysin by a substrate-induced transient interaction with the ABC transporter HlyB 
and the membrane fusion protein HlyD (Thanabalu et al., 1998). On the other hand, 
the in vivo disulfide cross-linking between AcrB and TolC may suggest that the 
AcrA/AcrB/TolC efflux complex appears to be independent for the drug substrates and 
is assembled constitutively (Touze et al., 2004). 
The TolC structure has been solved by X-ray crystallography (Koronakis et al., 
2000), indicating that three TolC protomers assemble to form a 140 A long channel 
spanning the outer membrane and periplasmic space (Figure 1.23a). The TolC 
molecule is composed of three domains: a p-barrel domain, an a-helical domain, and a 
mixed ot/p-domain which forms a strap around the middle section of the helical barrel 
(Figure 1.23b). The a-helical barrel domain of trimeric TolC forms a cylinder of 100 A 
in length and 35 A internal diameter, which makes a mostly solvent-filled inner 
volume of roughly 43,000 A 3 , one of the largest known in a protein structure. The 
upper end of the TolC structure is open, providing wide solvent access, while the lower 
end of the structure is closed by dense packing of 12 tunnel-forming a helices (Figure 
1.23a). 
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Figure 1.23 The structure of outer membrane protein TolC. (a) The Side view of 
the TolC by a ribbon representation where three protomers are colored 
in red, yellow and blue, (b) TolC monomer by a ribbon representation 
where the P-barrel domain is in yellow, the a-helix domain is in green 
and the equatorial domain is in red (Koronakis et al., 2000). (c) A 
scheme of the mutations to stabilize channel opening of TolC. (d) The 
bottom view of the open and closed TolC structures (Bavro et al., 2008). 
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TolC must undergo a conformational change to open the entrance for 
translocation since it is too small for the substrates to enter the channel (Figure 1.23c). 
The disruption of the hydrogen bond between amino acid residue D 1 5 3 and Y 3 6 2 and the 
salt bridge between the D 1 5 3 and R 3 6 7 of TolC increase the conductance in lipid bi-
layers, enlarging the low end entrance (Figure 1.23c) (Andersen et al., 2002). The 
translocation of polypeptide substrate is prohibited by introducing disulphide bonds to 
constrain the entrance coiled coils in the close state (Eswaran et al., 2003), further 
supporting the proposal that the transition to the open state TolC is accomplished by 
the re-arrangements of the entrance helices. 
Bavro and co-workers determined two TolC structures in its partially open state 
(Bavro et al., 2008). Previous report indicated that the disruption of the hydrogen bond 
between amino acid residue D 1 5 3 and Y 3 6 2 and the salt bridge between the D 1 5 3 and 
R 3 6 7 of TolC can enlarge the TolC periplasmic entrance (Andersen et al., 2002). The 
structure of the double mutant (Y362F and R367E) of TolC was solved in two 
crystallin forms at 3.2 and 3.3 A resolution (Figure 1.23d). The crystal structures of the 
double mutant showed that three of the six pairs of colied coils move radially outward 
from the central in comparison of the closed state form, repacking the helices and 
partially opening the channel (Figure 1.23d). It was found that the greatest 
conformational changes occur in the H7/H8 helices; the H3/H4 helices are 
comparatively static and are like a stator around which the H7/H8 swings. Although 
the movements of the helices in the double mutant TolC strucutre enable the opening 
for passage of molecules pas the distal tip of TolC, the second aperature is still closed, 
suggesting that a further conformational change is required for greater channel opening. 
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AcrA structure 
The membrane fusion protein AcrA is a component of the tripartite multidrug 
efflux pump AcrA/AcrB/TolC in E.coli. AcrA has been shown to interact with both 
AcrB and TolC, which suggests that AcrA serves as a scaffold in the tripartite efflux 
pump (Touze et al., 2004; Tikhonova et al., 2004). In addition, AcrA may also 
function in the opening of the periplasmic end of TolC channel (Bavro et al., 2008). 
The crystal structure of a 28 kDa core of AcrA (residues 45-312) was shown to be 
comprised of an a-helical hairpin domain, a lipoyl domain and a P-barrel domain 
(Figure 1.24a). Indeed, it is closely related to the structure of the membrane fusion 
protein MexA from P. aeruginosa (Higgins et al., 2004; Mikolosko el al., 2006). 
Interestingly, in the lattice in the AcrA crystal, each a-helical hairpin of the four 
monomers has a different orientation (Figure 1.24b), which is not observed in the 
MexA structure. The difference in orientation of the a-helical hairpin of AcrA stems 
from an effective hinge, located between the a-helical hairpin and lipoyl domain, 
composed of residues 99-106 in a-helix 1 and residues 169-173 in a-helix 2. 
In contrast to AcrB and TolC, which form trimers, the oligomeric state of AcrA 
is uncertain. In the crystals, AcrA are seen to form a dimer through extensive contacts 
involving the a-helical hairpins as well as adjoining lipoyl and P-barrel domains. On 
the other hand, AcrA was monomeric in solution and was found to be trimeric when 
crosslinked in vivo by DSG, which has a short spacer arm (7.7 A) (Eswaran et al., 
2004; Zgurskaya and Nikaido, 2000). 
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Figure 1.24 Structure of AcrA. (a) Ribbon representation of the crystal structure of 
AcrA (residues 45-312) monomer, with the a-helical hairpin domain in 
red, lipoyl domain in green and P-barrel domain in cyan, (b) Four 
conformations of AcrA in the crystal show the conformational 
flexibility of the a-helical hairpin (Mikolosko et ah, 2006). 
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The AcrB/AcrA/TolC complex pumps 
TolC is a homotrimeric outer membrane protein that comprises an outer-
membrane P-barrel, prolonged by a 100 A a-helical transperiplasmic tunnel. The TolC 
extracellular exit channel is constitutively open, with a pore diameter of 35 A, but the 
periplasmic domain channel entrance was restrained by coiled-coil a-helices. Andersen 
and co-workers proposed an iris-like transition to the open state based on the 
realignment of the inner coils on the outer ones (Anderson et al., 2002). The inner 
membrane protein AcrB, known as being trimeric, consists of a transmembrane 
domain at its bottom and a huge periplasmic domain on top. The top docking domain 
forms a funnel, with about a 30 A internal diameter that is consistent with that of the 
TolC conduit. The sum of the periplasmic length of AcrB and TolC is about 170 A, 
which is enough to cross the periplasmic space (Koronakis et al., 2000; Murakami et 
al., 2002). Moreover, the length and topology of the periplasmic domains of both TolC 
and AcrB suggests that the two interact directly (Tamura et al., 2005). Substrates 
might access the AcrB central cavity from the periplasm through the AcrB lateral 
vestibules for transport to the cell exterior. 
AcrA and TolC in E. coli have been found to form a stable intermembrane 
multidrug efflux complex with or without the substrate (Eswaran et al., 2004; 
Tikhonova and Zgurskaya, 2004). The AcrA-AcrB complex was identified upon 
purification from cell membranes after stabilization by in vivo crosslinking in the 
absence of TolC (Zgurskaya and Nikaido, 2000). Moreover, AcrA was found to be 
crosslinked with AcrB and TolC individually in vivo, and microcalorimetry studies 
demonstrated energetically favourable interactions of AcrA with both purified AcrB 
and TolC (Touze et al., 2004). AcrB can also be isolated as a complex with TolC by in 
vivo crosslinking; however, isothermal titration calorimetry did not detect an 
interaction between the purified AcrB and TolC proteins, suggesting AcrA may serve a 
scaffold to stabilize the complex in vivo (Eswaran et al., 2004). 
The AcrB and TolC crystals structures indicated that the 70-A- and 100-A-long 
periplasmic domains of AcrB and TolC would come into close proximity (Murakami 
et al., 2002; Koronakis et al., 2000). The interaction between the apex of AcrB and the 
bottom of TolC was then revealed by in vivo disulfide crosslinking between AcrB and 
TolC without a crosslinking agent (Tamura et al., 2005). Domain swapping and 
crosslinking experiments suggest that the C-terminal region of AcrA is required for the 
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interaction with AcrB (Elkins and Nikaido, 2003; Touze et al., 2004). The crystal 
strucutures of AcrA and TolC (Mikolosko et al., 2006; Koronakis et al., 2000; Federici 
et al., 2004) suggested that the AcrA hairpin and the TolC lower a-helical domain 
could be involved in complex assembly; a proposal that has been proven by hairpin 
domain swapping (Stegmeier et al., 2006; Eda et al., 2006). 
Although AcrA, AcrB and TolC are proven to form a stable tripartite efflux 
pump in E. colli, some critical points about how the complex works are still uncertain. 
Touze (Touze et al., 2004) suggested the complex is assembled constantly since the 
assembly occurred independently of the presence of the substrate. Besides, it is 
estimated that around 500 toxic ethidium molecules are exported every second by each 
MexA/MexB/OprM pump in P. aeruginosa (Narita et al., 2003). On the other hand, 
Tamura suggested that there is not enough TolC, a multifunctional protein, to form 
permanent complexes with AcrB and AcrA, although the assembly is substrate 
independent (Tamura et al., 2005). Instead, he proposed two possibilities: (1) transient 
complex formation is simply substrate independent; or (2) an unknown intrinsic 
substrate which facilitates complex formation has not been discovered. As discussed in 
the previous section, we still do not know how TolC undergoes the conformational 
change from the close to open state during substrate transportation. Since there is no 
obvious conformational change in the TolC docking domain of AcrB during the 
translocation cycle, Murakami (Murakami et al., 2006) proposed the conformational 
change caused by proton translocation and drug binding may be transmitted, via AcrA, 
to TolC, thus causing opening of the TolC periplasmic channel. In this case, the AcrA 
a-helical hairpin may be involved in the opening TolC, via its conformational 
flexibility (Mikolosko et al., 2006). 
Unlike trimeric AcrB and TolC, our knowledge of how many AcrA fit into the 
tripartite pump remains uncertain. A complex model, based on homology modelling 
and molecular docking, was proposed (Fernandez-Recio et al., 2004). In this model the 
lipoyl domain of AcrA docks into the AcrB clefts, whilst three AcrA fit simultaneously 
into the interprotomer grooves of AcrB and the open state of TolC, so that the 
predicted protomer stoichiometry is 1:1:1 for the MFP: IMP: OMP components of the 
tripartite pump (Figure 1.25). In that case, the conformational change caused by proton 
translocation and drug binding may be transmitted through AcrA via a mutual pushing 
and pulling movement at the cleft (Murakami et al., 2006), consistent with a recent 
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report showing the cleft flexibility of AcrB is essential for the pump function 
(Takasuka and Nikaido, 2007). A recent study also suggested that there is only a single 
binding site on the TolC protomer (Lobedanz et al., 2007); however, by using in vivo 
crosslinking to map the extent of intermolecular contacts, it showed that AcrA 
contacted the intramolecular groove between the inner and outer entrance coils of TolC 
H7/H8/H3 which is different from the contacts with the groove by helices H3/H4/H7 
in the previous model. 
Figure 1.25 Two sides of view of the assembled tripartite efflux pump model 
consisted of AcrA (red), AcrB (green) and TolC (blue), (a) Side view of 
the complex, (b) Top view of the complex (Fernandez-Recio et al., 
2004). 
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Another model of the tripartite complex predicted a stoichiometry of 3:1:1 for 
the MFP: IMP: OMP components of the tripartite pump (Figure 1.26) (Higgins et al., 
2004). The modelled ring of nine MexA (AcrA homologue) is sufficiently large to 
form a sheath around the open state TolC and AcrB, stabilizing the complex and 
making a conduit that spans the entire periplasm. This sheath model may be crucial for 
MF transporters, without a periplasmic domain, as a scaffold to interact with outer 
membrane proteins. Isothermal titration calorimetry data indicated the AcrA-AcrB and 
AcrA-TolC bindings are concentration dependent (Touze et al., 2004); moreover, it 
suggested that there would be enough space on each protomer TolC to accommodate 
up to three membrane fusion proteins (Mikolosko et al., 2006; Higgins et al., 2004). 
(a) (b) 
periplasm 
• 3 - *> 
Figure 1.26 The model of the tripartite efflux pump, (a) Two perpendicular views 
of the nine MexA molecules forming like a ring structure where the ot-
helices hairpin are in green and the p-strands of the lipoyl domains are 
in blue, (b) The side view of the complex consisted of AcrA (blue), 
AcrB (white) and TolC (green) (Higgins et al., 2004). 
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1.5 What is known about the MacA/MacB/ToIC tripartite complex pump 
The ABC transporter MacB was first found to confer MacA and TolC 
dependent resistance to macrolides in E. coli cells (Kobayashi et al., 2001). By drug 
susceptibility test, Kobayashi and co-workers established that E. coli strain Kam3 cells 
{AAcrAE), harboring a plasmid encoding MacAB had an obvious enchancement in 
their resistance to macrolides, such as erythromycin, clarithromycin, oleandomycin 
and azithromycin. Furthermore, Kam3 cells transformed with a plasmid encoding 
MacAB were found to take up less [ l 4 C] erythromycin than ones without MacAB, 
suggesting active efflux of erythromycin out of the cells. A homologue of the MacA-
MacB ABC transporter of E. coli was identified in N. gonorrhoeae (Rouquette-
Loughlin et al., 2005); furthermore, Rouquette and co-workers indicated that E. coli 
cells JMZ120 (AAcrAB) harboring a plasmid encoding MacAB have higher resistance 
to erythromycin and azithromycin. 
It is predicated, by secondary structure analysis, that MacB putatively has four 
transmembrane helices, and there is a large periplasmic loop between the 
transmembrane helix 1 and 2; the NBD domain is located on the N terminal side of the 
polypeptide and the TMD domain is on the C terminal side. The MacB topology was 
determined by systematically replacing residues with cysteines and testing for the [ l 4 C] 
NEM binding (Figure 1.27) (Kobayashi et al., 2003). MacA share a sequence identity 
of 21.3%, and similarity of 38.7% to its homologous protein E. coli AcrA, which 
comprised of an a-helical hairpin domain, a lipoyl domain and a P-barrel domain in its 
truncated form. 
During the course of our study, another revealed that co-reconstitution of 
MacA and MacB into proteoliposomes increased the steady-state ATPase activity of 
MacB, suggesting that the MFP as not only serves a scaffold, for assembly of the 
tripartite complex, but also has a functional role (Tikhonova et al., 2007). We have 
established that the periplasmic (i-strand domain of MacA interacts with the 
periplasmic domain of MacB to modulate the ATPase activity of its cytoplasmic NBD. 
Our data suggests that this interaction promotes and stabilizes a conformation of MacB 
in which the substrate-binding site is outward-facing. This is concomitant with an 
increase in the resistance of cells to erythromycin that indicates that antibiotic 
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extrusion is stimulated. This suggests that MacA has a direct role in controlling the 
pump action to facilitate the transfer of substrates across the inner-membrane. 
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Figure 1.27 Topology of ABC transporter MacB from E . coli. Nucleotide binding 
motifs are boxed in pink squares and the putative transmembrane 
helices are boxed in yellow squares. Cys 5 6, replaced by Ala, and the 
other two intrinsic cysteins are shown in blod letters. NEM labelings 
which was completely or largely blocked, and not affected by AMS 
were shown in blue ovals and red ovals, respectively. [ 1 4 C] NEM which 
was not reacted regardless of pretreatment or not with AMS was shown 
in open circles (Kobayashi et al., 2003). 
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Chapter two: Material and methods 
2.1 Web and computer resources 
The nucleotide sequences of E. coli macB, macA and tolC were obtained from 
the National Center for Biotechnology Information (NCBI, www.ncbi.nlm.nih.gov). 
The Vector NT1 Advance 10 (Invitrogen) was used for the design and analysis of 
oligonucleotides, and for the alignments of DNA and protein sequences for 
comparison. Protein secondary structures were predicted by Jpred from the University 
of Dundee (www.compbio.dundee.ac.uk/~www-ipred/ ). The Dichroweb at Birbeck 
College (www.cryst.bbk.ac.uk/cdweb/html/home.htmn was used as an online Circular 
Dichroism (CD) data analysis program. The Research Collaboratory for Structural 
Bioinformatics protein data bank (RCSB, www.rcsb.org/pdb/home/home.do) was used 
as a source for protein structures. 
2.2 Media and antibiotics 
Luria-Bertani (LB) medium was used in molecular cloning. E. coli cells 
harboring plasmid(s) were grown in 2xYT medium at 37°C. The antibiotics 
carbenicillin (100 ug/ml), kanamycin (30 ug/ml) and inducing agent isopropyl-B-D-
thiogalactopyranoside (IPTG) were added as required. Reagents were of analytical 
molecular biology grade and sourced from Difco, Melford and Sigma unless otherwise 
stated. 
Luria-Bertani (LB) Medium 
NaCl 10g 
10g 
5g 
Trypton 
Yeast extract 
dH 2 0 up to 1L 
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Mueller-Hinton Medium 
Mueller-Hinton powder 23g 
dH 2 0 u p t o l L 
SOC Medium 
NaCl 0.585g 
KC1 0.1865g 
Trypton 20g 
Yeast extract 5g 
dH 2 0 up to 970ml 
The above were autoclaved and the following filter sterilised components were added. 
l M M g C l 2 10ml 
lMMgS04 10ml 
2M Glucose 10ml 
2x Yeast Tryptone (2x YT) Medium 
NaCl 5g 
Tryptone 16g 
Yeast extract 1 Og 
dH 2 0 u p t o l L 
2.3 Bacteria strains, media and vectors 
The bacterial strains and plasmids used in this study are listed in Table 2.1 and 
2.2. E. coli strain Novablue(DE3) was used for blue and white screening of constructs. 
E. coli strain C43(DE3) was used for protein expression, and Kam3(DE3) was used for 
drug resistance tests. 
Plasmid pGEM-T Easy vector (Promega) was used for blue and white 
screening of transformants in molecular cloning, and plasmids pET28a(+), pET21d(+) 
and pET21a (Novagen) were used as cloning and expression vectors for macA, macB 
and tolC individually. pETDuet™-l was used as cloning vector for mac A, macB and 
lolC for growth curve measurements. 
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Table 2.1 E. coli Strains. 
Strains Genotype Reference 
NovaBlue(DE3) 
endA1 hsdRM (r k i 2-m k 1 2 +) supEAA f/7/'-1 
recA1 gyrA96 re/A1 lac [F'proA+B+ 
/aclqZAM15::Tn?0(TetR)] 
Novagen 
C43(DE3) E. coli B F omp had S (rB~ mB~) dcm* Tef gal EndA The[argU ileY leuW Card] 
Miroux and 
Walker, 1996 
Kam3(DE3) AacrAB Morita et al., 1998 
Table 2.2 Plasmids. 
Plasmid Description Reference 
pGEM-T Easy Cloning vector compatible with complementation, Ap R Promega 
pET21a(+) 17 promoter expression vector, Ap R Novagen 
pET21d(+) T7 promoter expression vector, Ap R Novagen 
pET28a(+) T7 promoter expression vector, Km R Novagen 
pET45b(+) T7 promoter expression vector, Ap R Novagen 
pETDuet™-1 T7 promoter expression vector with two cloning site, Ap R Novagen 
pBAD/glll pBR322-derived expression vectors for secreted recombinant protein expression Invitrogen 
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2.4 Genetic manipulation 
2.4.1 Polymerase chain reaction 
Polymerase chain reaction (PCR) was achieved by a Qiagen hotstar taq DNA 
polymerase kit. Al l components were mixed gently in a PCR tube (Sarstedt) and then 
the mixture was divided equally into two tubes (each tube contains 50 ul), which were 
then transferred to a PCR machine. The reagent recipe used for PCR reactions is as 
follows. 
Reagents 
dH 2 0 
Volume (ul) 
84.5 
10X Buffer 10 
dNTPs 2 
Primer Forward 
Primer Reverse 
Hotstar taq 
DNA template 
0.5 
Total 100 
Primers were synthesised by Invitrogen Custom Primers, on a 50 nmol scale, 
and desalted. Stock solutions were prepared to a final concentration of 50 pmol/ul and 
stored at -20°C. Oligonucleotide primers used in this study are listed in Table 2.3. 
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Table 2.3 Oligonucleotide primers. Oligonucleotide names that end with 'F ' and 
'R' represent primer pairs. Bold sequences indicate restriction 
endonuclease sites. Italicised sequences indicate additional nucleotides 
inserted to keep target sequence in-frame with the start codon. 
Underlined sequences indicate stop codons incorporated to prevent 
addition of vector sequences into the transcription. Pitted.underlined 
indicate Shine-Dalgarno (SD) sequences (Shine and Dalgarno, 1974). 
Shaded sequences indicate part of the leading sequence on pBAD/glll 
which permits secretion of recombinant protein into the periplasmic 
space (Rapoza and Webster, 1993; Chen el at., 1994) 
Primers Nucleotide sequence (5' to 3') Application 
Ndel-macB Forward CAT ATG ACG C C T TTG C T C GAA TTA AAG GAT Chapter 3 
Sacl-stop-macB Reverse GAG C T C TCA C T C T C G T G C CAG AGC ATC TAC Chapter 3 
Ncol-macA Forward C C A T G G GA GCA TAT GGA GTA TTC AGA AAA TTT Chapter 4 
Ncol-FD20-macA F C C A T G G GA GGA CTG ATT ACG TTA TGG AGA ATT Chapter 4 
Xhol-macA Reverse C T C G A G TTG T G C AGC T C C TGG I I I G G C CTC Chapter 4 
Ndel-tolC Forward CAT ATG AAG AAA TTG C T C C C C ATT CTT ATC Chapter 4 
Xhol-RD43tolC Reverse C T C G A G TTC C G G ATT AGT GGA AAC C G G TTT Chapter 4 
Ncol-TolC Forward C C A T G G GA AAG AAA TTG CTC C C C ATT CTT ATC Chapter 5 
EcoRI-MacB Forward GAA TTC G ACG C C T TTG CTC GAA TTA AAG GAT Chapter 5 
Sal1-stop-MacB Reverse G T C G A C TCA C T C T C G T G C CAG AGC ATC TAC Chapter 5 
Sal1-SD-macA Forward GTC G A C GAG GAA TAA TAA ATG GCA TAT GGA GTA TTC AGA AAA Chapter 5 
Sall-SD-glll Seqence F GTC G A C GAG GAA TAA TAA ATG AAA AAA CTG C T G TTC G C G ATT Chapter 5 
Not1 -stop-T7tag-macA 
Reverse 
G C G G C C G C TCA ACC CAT TTG 
C T G T C C ACC AGT CAT GCT AGC 
CAT TTG TGC AGC T C C TGG TTT 
G G C CTC ACC AAT CAC CAC TTC 
ATC G C 
Chapter 5 
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2.4.2 DNA preparation and electrophoresis 
DNA purification was accomplished by a QIAGEN QIAquick gel extraction kit 
and a Promega Wizard® SV 96 Plasmid DNA Purification kit. DNA was then 
visualized on a 1% agarose gel containing adequate ethidium bromide (Sigma). A lkb 
DNA ladder (Invitrogen) allowed estimation of DNA fragment size. The Components 
of 6X DNA loading buffer and 10X TAE (Tris-acetate-EDTA) agarose gel running 
buffer are listed as below. 
6X DNA loading buffer 
Bromophenol Blue 0.25% 
Glycerol 30% 
I OX TAE buffer 
Tris Base 48.4g 
Glacial acetic acid 10.9g 
EDTA 2.92g 
dH 2 0 u p t o l L 
2.4.3 Cloning 
2.4.3.1 Cloning into pGEM-T easy vectors 
The pGEM-T easy vector system (Promega) was adopted for the cloning of 
PCR products. The pGEM-T Easy vector utilises single 3' thymidine overhangs on 
either side of the multiple cloning site to clone PCR products possessing 
complimentary 3' adenosine overhang generated by Taq DNA polymerase. The 
pGEM-T easy vector also contains T7 and SP6 RNA polymerase promoters flanking a 
multiple cloning region within the coding region for the a-peptide of (3-galactosidase. 
The successful insertion of a target gene inactivated P-galactosidase, which could then 
be identified as white colonies on LB plates containing 5-bromo-4-chloro-3-indolyl-P-
D-galactopyranoside (X-Gal) and IPTG. 
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After cleanup, the amplified DNA was mixed with pGEM-T easy vector and 
T4 DNA ligase, and then left overnight at 4°C for ligation. A detailed recipe for the 
ligation reaction is as follows. 
Reagents Volume (u.1) 
2x Ligase buffer 5 
PCR product 3 
pGEM-T easy vector 1 
T4 DNA ligase \ 
Total 10 
The plasmid was then transformed (see 2.4.4 for details) into E. coli 
Novablue(DE3) for the screening of transformants. Novablue cells harboring plasmids 
were stored with 20% glycerol at -80°C until used. 
2.4.3.2 Cohesive end DNA cloning 
Restriction digestion was performed using the relevant restriction enzymes 
(Promega) in order to generate insert sequences from pGEM-T easy plasmids and 
linear overexpression vectors. Al l reagents were added in order as below and incubated 
for 3 to 5 hours at 37°C as needed. 
Reagents Volume (ul) 
dH 2 0 35.2 
10X Buffer 8 
100XBSA 0.8 
Enzyme I 3 
Enzyme I I 3 
Plasmid 30 
Total 80 
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Ligations were carried out using the desired linear insert and vector. T4 DNA 
ligase HC (Invitrogen) catalyses the ligation of the complimentary ends of DNA 
fragment and linear vector, generated from digestion with the same restriction enzymes. 
The insert to vector molar ratio can have a significant effect on the outcome of a 
ligation and subsequent transformation step. Therefore, insert: vector molar ratios 
between 2 and 6 were utilized in this study. All components were added in the order 
listed as follows. 
Reagents Volume (ul) 
5x Ligase buffer 4 
Insert DNA variable 
Vector DNA variable 
T4 DNA ligase j_ 
Total 10 
The reaction mixture was incubated at 16°C for 90 min and then at 4°C 
overnight. 
2.4.4 Transformation into E. coli 
For transformation with DNA vectors, E. coli competent cells were prepared 
according to the procedure below. A chemical method for the induction of competence 
in E. coli strains is used for cloning. 
1 ml of an overnight culture of the desired bacterial strain was inoculated into 
100 ml of media and when the cells had reached an ODgoo of 0.5, they were cooled on 
ice for 5 min. The cells were then harvested by centrifuge at 5,000 xg for 5 min at 4°C 
and the supernatant was discarded. The cell pellet was resuspended in ice-cold TFB1 
buffer containing 100 mM rubidium chloride, 50 mM manganese chloride, 30 mM 
potassium acetate, 10 mM calcium chloride, 15% (v/v) glycerol, pH 5.8, and kept on 
ice for 90 min. The cells were harvested by centrifuge at 4°C and the supernatant was 
discarded. The cell pellet was resuspended in 4 ml of ice-cold TFB2 buffer containing 
10 mM MOPS, 10 mM rubidium chloride, 75 mM calcium chloride, 15% (v/v) 
glycerol, pH 6.8, and kept on ice for another 45 min. As described above, cells were 
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harvested, resuspended one more time in 4 ml ice-cold TFB2. Aliquots of 50 uL were 
flash frozen in a dry ice/ethanol bath and stored at -80°C. 
Another method was applied to make E. coli strains, for use in protein 
expression, competent by using MgC^ and CaCL;. The desired bacterial strain was 
grown in 5 ml LB media at 37°C for 5 hours and then placed on ice for 5 min before 
harvesting by centrifuge at 4°C- The cell pellet was resuspended in 1 ml ice-cold 0.1 M 
MgCh and harvested by centrifugation at 5,000 xg for 6 min. As described above, the 
cell pellet was resuspended in 1 ml ice-cold 0.1 M CaCh and harvested by 
centrifugation. Cells were then carefully resuspended in 200 ul ice-cold 0.1 M CaCb, 
and kept on ice for transformation. 
Transformation was performed as follows. Competent cells were kept on ice 
until thawed. After adding 5 ul of plasmid, the competent cells were then put back on 
ice for a further 30 min. The cells were treated with a 42°C heat shock for 30-90 sec 
and placed on ice for another 1~5 min. LB plates, with relevant antibiotics, were used 
for plating out of cells and incubated at 37°C overnight. Cells harboring the desired 
plasmids were stored at -80°C until used. 
2.4.5 XDE3 Lysogenisation of bacterial strains 
A X.DE3 Lysogenization Kit (Novagen) was applied for the integration of X.DE3 
prophage into an E. coli host cell chromosome, so that the lysogenized host could be 
used to express heterologous DNA from T7 expression vectors. Host cells were grown 
in LB media supplemented with 0.2% maltose and 10 mM MgSC^, at 37°C to an 
a Q 
ODeooof 0.5, and 1-10 ul host cells were taken to mix with 10 of pfu of X.DE3, 10 
pfu of helper phage and 108 pfu of selection phage. The mixture was incubated at 37°C 
for 20 min to allow the phage to adsorb to the host and spread on a LB plate. The plate 
was then incubated at 37°C overnight for cells to grow. 
The presence of the XDE3 prophage in host cells was verified with a T7 phage 
deletion mutant, T7 tester phage. The T7 tester phage can make large halo-like plaques 
on authentic X.DE3 lysogens in the presence of 1PTG, while smaller plaques appear in 
the absence of inducer. In duplicate tubes, 100 ul of infected host cells, at an ODeooof 
0.5, were added with 100 ul of T7 tester phage (1 * 103 pfu/ml). The mixtures were 
incubated at room temperature for 10 min to allow phage to adsorb to host and added 
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with 3 ml of molten agarose (no warmer than 47°C). The contents of one duplicate 
were poured out onto a LB plate and other one onto a LB plate with 0.4 mM IPTG. 
After 4 hours of incubation at 37°C the plates were ready to check. 
2.5 Protein overexpression and purification 
2L flasks of 2xYT media containing relevant antibiotics were inoculated with 8 
ml of pre-incubated cells harboring plasmids and incubated at 37°C. 0.2-0.5 mM IPTG 
was added when the cells density reached an ODeooof 0.5. The temperature was 
adjusted to 25°C and protein overexpression was allowed to proceed overnight. 
Cells were harvested by centrifugation at 4°C and resuspended in buffer 
containing 20 mM Tris-HCl pH 7.5, 500 mM, 10% (v/v) glycerol. Cell paste was 
added with a tablet of complete protease inhibitor (Roche) and 1000 units of DNAse I 
(Sigma) before going through a French press twice for cell lysis. Cell debris was 
removed by centrifugation at 24,000 xg (JA-20 rotor, Beckman), and cell membranes 
were isolated by ultracentrifugation at 168,000 xg (Type 50.2 Ti rotor, Beckman). 
Membranes pellets were resuspended in buffer containing 20 mM Tris-HCl pH 7.5, 
20% (v/v) glycerol and stored at -80°C until needed. 
2.5.1 Immobilized metal affinity chromatography 
Protein-His6 was solublized from cell membranes with Triton X-100 (5% [v/v]) 
(Promega) or n-dodecyl-P-maltopyranoside (DDM) ( 1 % [w/v]) (Melford) and loaded 
into a 1 ml N i 2 + or Cu 2 + charged HiTrap chelating column (GE Healthcare) by a 
peristaltic pump (Williamson) at 4°C . The column was then transferred onto an AKTA 
10 purifier (GE Healthcare) for further purification steps. The column was washed 
with, 15-30 times column volume, Tris-HCl buffer containing a suitable concentration 
of NaCl and imidazole to strip off contaminants and then eluted in buffer containing 
Tris-HCl pH 7.5, 500 mM NaCl, 500 mM imidazole or 50 mM L-histidine and 0.2% 
Triton X-100 or 0.05% DDM to isolate the target protein. PD-10 desalting columns 
(GE Healthcare) were used for desalting and protein was stored at -80°C for further use. 
Used columns were washed with distilled water to dispel salts, and 0.1 M 
EDTA was applied to strip off metal ions. After being washed thoroughly with 
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distilled water, the columns were recharged with 0.1 M NiSC>4 or CuSC>4 and kept at 
4°C until needed. 
2.5.2 Ion exchange chromatography 
Protein extraction was followed by ion-exchange purification using a Hitrap Q 
column (GE Healthcare). The sample was loaded on an AKTA 10 purifier and a salt 
gradient (10-100% 500 mM NaCl) was used to generate a separate isolated protein 
peak. Used columns were washed with Tris buffer containing 1 M NaCl and distilled 
water in order. Columns were stored with 20% ethanol at 4°C. 
2.5.3 Detergent exchange 
Purified MacB in Triton X-100 (0.2%) was mounted onto a HiTrap Q column 
and washed with 10 column volume of Tris Buffer 1 (20 mM Tris-HCl buffer, 10 mM 
NaCl, 10% glycerol, 0.2% DDM, pH 7.5) to remove the Triton X-100 detergent. The 
column was then washed with an additional 2 column volume of the Tris-HCl buffer 1 
containing 0.05% DDM. MacB-DDM was then eluted out with the Tris-HCl buffer 1 
containing 100 mM NaCl, and 0.05% DDM. 
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2.6 Protein Analysis 
2.6.1 Electrophoresis 
Recombinant proteins were resolved by SDS-PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis) to determine the efficiency of overexpression and 
purification. Proteins were visualized on NuPAGE pre-cast Bis-Tris polyacrylamide 
gels and gradient 4-12% or 12% gels which were adopted as appropriate. A NuPAGE 
LDS Sample Buffer (4X) (Invitrogen) was used in protein sample preparation and a 
Seeblue pre-stained protein marker (Invitrogen) allowed estimation of the protein 
molecular weight. The recipes for the MOPS running buffer, stain solution and destain 
solution were as follows: 
IPX MOPS running buffer 
MOPS 104g 
61g 
10g 
_3£ 
Tris base 
SDS 
EDTA 
dH 2Q Bring up to 1 Liter 
Stain solution 
Methanol 40% (v/v) 
Acetic acid 10% (v/v) 
Coomassie Brilliant Blue R250 0.1% (w/v) 
dH 2 0 50% (v/v) 
Destain solution 
Methanol 40% (v/v) 
Acetic acid 10% (v/v) 
50% (v/v) dH 2 0 
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2.6.2 Protein Assay 
Protein concentrations were determined using a Coomassie protein assay kit 
(Bio-Rad). The assay, based on the method of Bradford, is a Coomassie-binding assay 
where a differential color change of a dye occurs in response to various concentrations 
of protein. The absorbance maximum for Coomassie Brilliant Blue G-250 dye shifts 
from 465 nm to 595 nm when it binds to protein and primarily to basic and aromatic 
amino acid residues, especially arginine (Compton and Jones, 1985). 
Protein was diluted 200, 400 and 800 fold into 800uL dH 2 0 to ensure the 
protein concentration measured was within the working range of the assay (1.2-
lOug/ml). The samples were then added with 200 ul of dye reagent concentrate, mixed 
well, and left at room temperature for 5 min. The absorbance was measured at 595 nm 
against a d f^O blank. A calibration curve was generated using bovine serum albumin 
as a standard, and made by plotting the concentration (ug/jal) against the Abs595 and 
fitting the data by linear regression. Both standard and experimental reactions were 
performed in triplicate and the concentration of protein was then calculated. 
2.6.3 Western blot 
Protein samples were run using two SDS-PAGE gels by gel electrophoresis in 
duplicate, applied as experimental gel and control gel. The proteins on the 
experimental gel were transferred to a PVDF (Polyvinylidene difluoride) membrane 
(Millipore) where they were probed with the primary antibody. Mouse monoclonal 
anti-polyhistidine antibody (Sigma), S»Tag™ monoclonal antibody (Novagen) and 
T7«Tag® monoclonal antibody (Novagen) are used as primary antibodies as 
appropriate. The PVDF membrane was then incubated with a second antibody, goat 
anti-mouse immunoglobulin G AP (alkaline phosphatase) conjugate (Bio-Rad), and 
protein identified a colorimetric AP conjugate substrate kit (Bio-Rad) so that signal 
was viewable on a film. All buffers involved in the procedure are listed below: 
Transfer buffer 
Glycine 29g 
Tris base 5.8g 
SDS 0.37g 
Methanol 20% (v/v) 
(IH2O Bring up to 1 Liter 
ELISA Wash buffer 
Phosphate stock* 30ml 
NaCl 8.76g 
Tween 20 0.05% (v/v) 
(JH2O Bring up to 1 Liter 
* Phosphate stock 
KH2PO4 6.465g 
K2HPO4 35.3g 
Adjusted to pH 7.4 
dH 2 0 Bring up to 1 Liter 
Blocking buffer 
ELISA Wash buffer 
BSA (Bovine serum albumin) 
25ml 
0.75g 
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2.7 Biochemical assays 
2.7.1 ATPase activity 
The ATPase activity was determined using stopped flow spectrometer (PiStar-180 
spectrometer, Applied Photophysics). EnzChek phosphate assay, a Pi quantification 
assay (Molecular Probes) was adopted in the measurements of protein ATPase activity. 
When Pi is present, PNP (purine nucleoside phosphorylase) can enzymatically convert 
MESG substrate (2-amino-6-mercapto-7-methylpurine riboside) into ribose 1-
phosphate and 2-amino-6-mercapto-7-methylpurine, which results in a 
spectrophotometric shift in the maximum absorbance from 330 nm to 360 nm (Webb, 
1992). A standard curve was generated, using KH2PO4 as a standard, by plotting the 
phosphate concentration (nmoles) against the A360 and fitting the data by linear 
regression. The reaction components are as follows: 
Reagents Volume (ul) 
dH 2 0 740ul - x 
20X Reaction buffer 50 
MESG substrate 200 
KH 2 P0 4 x 
PNP 10 
Total 1000 
Measurements at A360 were recorded continuously when protein and ATP were 
mixed from two drive syringes. The reaction temperature was controlled at 25°C by a 
water bath (Jasco). The recipes for the two reservoirs are as follows: 
Protein sample syringe reservoir 
Reagents Volume (ul) 
dH 2 0 740ul - x 
20X Reaction buffer 50 
MESG substrate 200 
PNP 10 
Protein (s) x 
Total 1000 
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Substrate sample syringe reservoir 
Reagents Volume (uJ) 
740uJ - y dH 2 0 
20X Reaction buffer 50 
MESG substrate 200 
PNP 10 
ATP X 
Total 1000 
The data were analyzed by fitting a single exponential plus slope equation: 
/ (x) = a*exp (-kx) + bx + c 
Once the a, b, c, k values were determined, the Abs36o values were then 
collected and calculated into Pi concentration. The traces were plotted the phosphate 
concentration against time using Sigma Plot. 
2.7.2 Equilibrium binding of [ l 4 C] erythromycin 
50 ug of purified protein was incubated with 1, 5 and 10 uM of hot [N-methyl-
l 4 C] erythromycin (48.8 mCi/mmol, Perkin Elmer Life sciences, USA) and cold 
erythromycin for 30 min. The incubation was carried out in glass tubes in a final 
volume of 500 ul of buffer containing 10 mM Tris-HCl pH 7.4, 0.05% DDM. The 
samples were incubated at room temperature in the dark for 45 min, and rapidly 
filtered through 0.22 uM nitrocellulose filters (Whatmann), which were pre-
equilibrated overnight in ice-cold wash buffer containing 10 mM Tris-HCl pH 7.4, 150 
mM K G , 5 mM MgCl 2 . The filters were back-to-back washed once more with 3 ml of 
ice-cold wash buffer and soaked in scintillation fluid for at least 3 hours until totally 
dissolved. Subsequently, filter-retained radioactivity was measured by liquid 
scintillation counting using the scintillant Ultima Gold XR (Perkin Elmer Life 
Sciences, USA). Non-specific binding to MacB was determined as the amount of [ , 4 C] 
erythromycin bound to half molar quantities of 12 transmembrane helices-containing 
sugar transporter GalP (Velamakanni et ai, 2007), and was less than 30% of total 
binding. 
69 
2.7.3 Pull-down Assay 
Pull-down assays were used to determine i f there was a physical interaction 
between two proteins in vitro. In a pull-down assay, a tagged bait protein is captured 
on an immobilized affinity ligand ( N i 2 + in this study) specific for the tag. The 
immobilized bait protein can be incubated with putative prey proteins to capture the 
one that interacts with the bait protein. Membrane pellets containing preyed protein 
with an S-tag, a 15 residues tag sequence, were dissolved in detergent and mixed with 
purified bait protein with a polyHis tag. The mixture was loaded into a N i 2 + charged 
Hitrap chelating column (GE Healthcare), so that the bait protein could be immobilised 
on the column, along with the prey protein i f there was an interaction between them. 
The column was then washed with 15-20 column volumes o f 20 m M Tris-HCl buffer 
containing reasonably high imidazole (75-100 m M ) to eliminate any false positive 
results due to non-specific interactions. The bait-prey complex was eluted with 20 m M 
Tris-HCl buffer containing 500 m M imidazole; followed by the gel electrophoresis to 
visualize the bait and prey proteins. A Western blot was carried out using S«Tag 
monoclonal antibody (Novagen) to probe the prey protein, confirmating its identity. To 
eliminate false positive non-specific interactions between the prey protein and the 
column, a control experiment was done in a similar manner without the bait protein. 
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2.7.4 Protein cross-linking 
Crosslinker Dithiobis succinimidyl propionate (DSP) (Figure 2.1) was adopted 
for crosslinking o f MacB. It contains an amine-reactive iV-hydroxysuccinimide (NHS) 
ester at each end o f an 8-carbon spacer arm. NHS esters react with primary amines at 
pH 7-9 to form stable amide bonds, along with release o f the N-hydroxysuccinimide 
leaving group. D M A and DMS (Figure 2.1) belong to homobifunctional imidoester 
cross-linkers. The imidoester functional group is available for the modification o f 
primary amines and has minimal cross reactivity toward other nucleophilic groups in 
proteins. 
/ 0 I 
W—O—C—CHj,—CKy—S—S—CM ? —CH ? —C—O—N 
/ 
$> 
o DSP 
(Di{hiotHS(succinimkJylpfOp«35,iate)J 
also know as Lomanfs Reagenl 
MW 404.42 
Spaoef Arm Length 12A 
0 
H*CO 
NHo+C 
C H 2 - C H 2 - C H 2 - C H 2 C 
D M A 
O C H 3 
M.W. 245.15 
Space* Aim 8.6A 
H 3 C O 
DMS 
O C H g 
M.W. 273.20 
Spacer At no 1 lA 
Figure 2.1 Structures of crosslinkers. 
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2 mg/ml MacB in buffer containing 50 m M N a 2 H P 0 4 pH 7.5, 50 m M NaCl, 
10% glycerol was incubated with 1, 2, 10, 20, 50, 100-fold excess o f DSP 
concentration for 30 min at 30°C. To stop the reaction, 1 M Tris-HCl was added to the 
samples and boiled for 3 min before being analyzed by gel electrophoresis. Pre-stained 
marker Seeblue (Invitrogen) and bench marker (Invitrogen) were used for estimation 
o f protein molecular weight. 
2 mg/ml MacA, 1 mg/ml MacB or MacA-MacB was also crosslinked by 5 m M 
D M A or DMS individually for 60 min at room temperature, and analyzed in an 
analogous manner to that for DSP. 
2.7.5 Phenol-sulfuric acid colorimetric assay 
Detergents are essential for membrane protein isolation and purification. D D M , 
a glycosidic nonionic detergent, has been used for the membrane proteins manipulated 
in this study. A rapid, simple and sensitive procedure for the quantification o f 
glycosidic and bile salt-based detergents has been presented (Urbani and Warne, 2005). 
This method can quantify sugar or cholate moieties by colorimetric reactions with 
phenol and sulfuric acid, which can be used to quantify D D M . Furfural derivatives are 
generated when sugars are dehydrated in concentrated sulfuric acid; fol lowing a 
condensation reaction in the presence of phenol, an aromatic molecule, the p-
semiquinonoid chromogen is formed, which has as visible absorbance at 490 nm. The 
colorimetric assay was undertaken to quantify the D D M contribution in the MacB-
D D M complex via a similar approach to a previous report (Butler el al, 2004). 
The MacB-DDM complex and processing buffer, 20 m M Tirs HC1, 50 m M 
NaCl, 10% glycerol, with or without 0.2% D D M , pH 7.5, were collected after a 
detergent exchange and the buffer wi th D D M served as blank for correction for the 
background in absorbance measurements. The MacB concentration was determined as 
described in section 2.6.2 before assaying, which enable to estimate the total amount o f 
D D M , f rom MacB-DDM complex and D D M micelles in the buffer, and keep it in the 
effective range the standard curve (0-60ug in 60uL). The M a c B - D D M complex was 
diluted as necessary into the original purification buffer (Tris-HCl buffer) without 
D D M to make a final volume o f 60uL. The sample was fist mixed with 300 uL phenol 
(5%, w/v), then 720 uL concentrated sulphuric acid was carefully added and mixed 
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well by votexing with the tube cap closed. One thing needs to be paid attention to is 
the strong exothermic reaction that occurs on the addition o f concentrated sulfuric acid, 
during which the temperature can go up to 110-120°C. The mixture was allowed to 
cool down at room temperature for 20 min and transferred to a cuvette for the 
absorbance measurements at 490 run using buffer as a background blank. A standard 
curve was generated using D D M as a standard, and made by plotting the D D M 
concentration (ug/60uL) against the Abs49o, Fitting the data by linear regression. The 
molar ratio o f protein to detergent was then calculated. 
2.7.6 Growth curve measurements 
In order to test the ability o f the proteins to assemble into functional 
transporters that confer resistance in E. coli, drug susceptibility assays were 
undertaken by measuring cell growth curves in the presence o f erythromycin. Cells o f 
E. coli strain Kam3(DE3), harboring plasmids or blank vectors, were grown in 2xYT 
media at 37°C, wi th shaking at 200 rpm. 0.05-0.1 m M IPTG was added when the cells 
density reached an ODgooof 0.5-0.6. Cells were grown for overnight and diluted into 
media, incubated with the antibiotic erythromycin at the concentrations o f 100 ug/ml. 
Cells growth curves were recorded over the next 12 hours. For experiments to measure 
the loss in growth due to erythromycin, cells were grown for 3 hours in the absence 
and presence o f 50 ug/ml erythromycin and the relative growth is the ratio o f the 
OD600 values. 
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2.8 Structural approaches 
2.8.1 Dynamic light scattering ( D L S ) 
A Zetasizer Nano instrument (Malvern) was used for DLS analyses in order to 
determine particle distribution and molecule weight for the MacB protein. The protein 
was dialyzed against buffer containing 20 m M Tris-HCl pH 7.5, 100 m M NaCl, 1% 
glycerol, and 0.005% P D D M overnight at 4°C and diluted to a final concentration o f 1 
mg/ml. The sample was centrifuged at 14,000 xg for 10 min in order to check protein's 
stability before analysis. The data for the protein sample and buffer itself were 
recorded at 4°C and 16°C. 
2.8.2 Analytical size exclusion chromatography ( S E C ) 
A superdex 200 PC 3.2/30 column (GE Healthcare) was used in this 
experiment. The column was equilibrated with degassed and filtered buffer containing 
20 m M Tris-HCl pH 7.5, 300 m M NaCl, 10% glycerol and 0.05% D D M for 2 column 
volume. The sample was filtered through a 0.22 urn filter (Millipore) and centrifuged 
at 14,000 xg for 5 min before loading onto a column. The sample injection was 
accomplished by using a 100 ul loop and a 1 ml syringe. A high molecular weight gel 
filtration calibration kit containing aldolase (Mr 158 000), catalase (Mr 232 000), 
ferritin (Mr 440 000), thyroglobulin (Mr 669 000) and blue dextran 2000 served as 
standards for estimation of molecular weight of the protein. The used column was 
washed with distilled water and stored with 20% ethanol at 4°C. 
The M r o f protein was calculated from a calibration curve generated by plotting 
the log values o f the Mr o f the standards against their gel-phase distribution coefficient 
values ( K a v ) . The K a v values were calculated using their elution volumes ( V e ) , total bed 
volume o f 2.4 ml (V t ) and the void volume ( V 0 ) according to the equation Kav= ( V e -
V 0 ) / ( V C - V 0 ) , where V c represents total column volume. 
2.8.3 Analytical ultracentrifugation (AUC) 
A U C is one o f the most powerful and versatile techniques for the quantitative 
characterisation o f macromolecular associations in solution (Howlett et al., 2006). 
Sedimentation equilibrium measurements were performed using a Beckman Optima 
X L - A analytical ultracentrifuge equipped with both absorbance and interference optics, 
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allowing optical signals to be measured as a function o f radial distance. 100 uL o f 0.2 
mg/ml MacB in buffer 1 (20 m M Tris 8.0 150 m M NaCl, 1% glycerol and 0.006% 
p D D M ) supplemented with 10%, 25% or 50% D 2 0 was placed in the sample 
compartment of a epon double-sector centerpiece and 110 ul buffer 1 was placed in the 
reference compartment. The samples were centrifuged at 10°C and 10,000, 15,000 and 
25,000 rpm using an An60-Ti rotor. Scans were acquired using the absorbance optical 
system 15 hours after the start o f the experiment and in 1 hour intervals until 
equilibrium was attained. The buffer densities and partial specific volume of MacB 
were calculated using the program SEDNTERP (Laue et al., 1992) and the partial 
specific volume o f P D D M was taken as 0.809 cm 3 /g (Peterson et al., 1988). The 
equilibrium data was analyzed using SEDPHAT (Vistica et al., 2004). Sedimentation 
velocity measurements have been performed using the same hardware at 55,000 rpm at 
10°C. The measurements were performed in buffer 1. 
2.8.4 Circular dichroism (CD) spectroscopy 
Circular Dichroism (CD) is a valuable technique for examining the structure o f 
proteins in solution (Kelly et al., 2005). CD analysis was used to determine the 
secondary structure compositions o f proteins from the peptide bond region in this 
study. CD spectroscopy and data collection was achieved using a CD spectrometer, 
with a Xe arc light source (Jasco J-810). It is diff icul t to make measurements below 
180 nm by a conventional CD instrument since the intensity o f the radiation falls o f f in 
this region; besides, both the N2 used for purging the sample compartment and H2O 
solvent absorb significantly. Protein secondary structure observations by CD 
spectroscopy occur in the region o f 190-260 nm and the absorption is due to the 
peptide bond. There is a broad but weak signal centred around 220 nm based on n to n 
transition and a more intense n to n* transition centred around 190 nm. By determining 
the CD spectrum in this range, the secondary structure o f a protein can be determined. 
The priority for CD spectroscopy analysis is to keep the total absorbance o f the 
sample within reasonable bounds in order to avoid excessive noise. The signal/noise 
ratio for CD is theoretically a maximum when the absorbance is 0.869 (Fasman, 1996). 
The absorbance o f the sample is conveniently monitored by the trace o f the High 
Tension voltage (the voltage applied to the photomultiplier). For reliable data, this 
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should be less than 700 V, but this value w i l l depend on the particular instrument being 
used. 
The NaCl and imidazole in the protein samples were reduced as much as possible 
by dialysis to minimize the strong absorbance from the components o f the buffer. The 
spectrum o f proteins in 20 m M Tris buffer, 20 m M NaF, pH 7.5 was recorded f rom 
260 nm to 190 nm, six times and averaged; f rom this average spectrum the baseline 
spectrum for buffer itself was substracted to get the final spectrum. Data was then 
input into the online server Dichroweb at Birbeck College (Whitmore and Wallace, 
2004) and analyzed by a number o f algorithms, including SELCON3, CDSSTR and 
CONTIN-LL. 
2.8.5 Electrospray (ES) mass spectrometry 
MacB sample purification and preparation were accomplished as described in 
section 3.1. Analyses were performed using a nanoflow ES mass spectrometers Q-
ToF2 (Micromass) modified for transmission and isolation o f high mass ions (Sobott et 
al, 2002). The fol lowing experimental parameters were used to record the mass 
spectra o f 2 mg/ml MacB on the Q-ToF2 instrument: a needle voltage of 1.5 kV and an 
MCP of 2350 V. 
2.8.6 Atomic force microscope ( A F M ) 
MacB sample purification and preparation were accomplished as described in 
section 3.1. 1 mg/ml MacB in buffer containing 20 m M Tris pH 7.5, 50 m M NaCl, 
10% glycerol and 0.05% PDDM was diluted 1000 times to a final concentration o f 1 
ug/ml, and 45 ul o f the sample was allowed to adsorb to freshly cleaved mica. After 10 
min incubation, the sample was washed with M i l l i - Q water and dried under nitrogen. 
Imaging was performed with a Multimode atomic force microscope (Digital 
Instruments, Santa Barbara, CA) . Samples were imaged in air and experiments were 
carried out in tapping mode. The silicon cantilevers containing a diamond-like extra tip 
had a drive frequency o f a300 kHz and a specified spring constant o f 40 N/m 
(MikroMasch, Portland, OR). The applied imaging force was kept as low as possible 
(target amplitude sal.6-1.8 V and amplitude set-point fcl.3-1.5 V ) . 
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The molecular volumes of the protein particles were determined f rom particle 
dimensions based on A F M images. After adsorption o f the receptors onto the mica 
support, the particles adopt the shape o f a spherical cap. The heights and half-height 
radii were measured from multiple cross-sections o f the same particle, and the 
molecular volume was calculated by using the fol lowing equation: 
where h is the particle height and r is the radius (Barrera et al., 2005; Schneider 
etal, 1998). 
Molecular volume based on molecular mass was calculated by using the 
equation 
where Mo is the molecular mass, No is Avogadro's number, V\ and V2 are the 
partial specific volumes of particle and water, respectively, and d is the extent o f 
protein hydration (Barrera et al., 2005; Schneider et al., 1998). We used the value o f 
0.74 cm 3 /g for the partial specific volumes o f protein, and 0.4 g o f water per g o f 
protein for the extent o f protein hydration (Grant, 1957). Using automated recognition 
of proteins (Barrera et al., 2007; Barrera et al., 2008), it was calculated the molecular 
volume of isolated particles as described above. 
2.8.7 Transmission electron microscope ( T E M ) 
MacA and MacB sample purifications and preparations were accomplished as 
described in section 4.1 and 3.1 respectively. Protein samples in buffer containing 20 
m M Tris pH 7.5, 500 m M NaCl, 10% glycerol and 0.2% TX-100 were pipetted onto 
the carbon-coated side o f a grid. After 1 min, filter paper was used to take o f f 
excessive liquid without touching the grid. The grid was then negatively stained using 
1% uranyl acetate for 30 seconds. Filter paper was used to take o f f excess liquid 
without touching the grid. The gird was then examined using a transmission electron 
microscope instrument (Hitachi). 
V m = (71/7/6) ( 3 r + h2) (1) 
V c = (M(/No) (V, + dV2) (2) 
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2.8.8 Crystallization 
Crystallization is an important tool for the determination o f the structure o f 
biological macromolecules through the use o f X-ray diffraction for analyzing the 
atomic arrangement o f crystals. Proteins were initially screened with commercial 
sparse matrix screens that provided a broad range o f parameters to identify good 
crystallization conditions. Once an initial condition, good for protein crystals to grow, 
was found, modification o f the crystallization conditions was then carried on to obtain 
crystals that are o f X-ray diffraction quality. 
2.8.8.1 Sitting drops technique 
Crystallization trials were undertaken using the vapour diffusion sitting drop 
method on Greiner crystallization plates, which have 96 round wells; crystallization 
conditions were screened automatically using a Cartesian robot. The volume of each 
screen drop was around 50 nl. After setting up the drops the whole tray was sealed 
and spun at 1000 xg for 1 min in order to pull the drops into good shape at the bottom 
of the well . Crystals were grown at 18 °C and their development was monitored 
intermittent periods by light microscopy. 
2.8.8.2 Hanging drops technique 
Crystallization trials were carried out using 24-well crystallization plates 
(Nextal). A droplet o f protein solution was mixed with crystallization reagent on a 
platform inverted over the reservoir in vapor equilibration with the reagent. The initial 
reagent concentration in the droplet is less than that in the reservoir but w i l l eventually 
reach equilibrium and settle between the drop and the reservoir when the reservoir 
pulls water from the droplet in the vapor phase. During this equilibration process, the 
sample is also concentrated, increasing the relative supersaturation o f the sample in the 
drop. The plates were incubated at 18°C and the droplets were monitored by light 
microscopy to identify different stages o f crystallization. 
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Chapter three: Determination of the MacB oligomeric state 
The ABC transporter MacB has been shown to confer macrolides resistance in the 
presence of TolC via active drug efflux (Kobayashi et al., 2001). MacB has a topology 
that consists o f one N-terminal cytoplasmic nucleotide binding domain, four 
transmembrane helices and one large periplasmic loop between the helix 1 and 2. The 
MacB topology was determined by systematically replacing residues with cysteines 
and testing for the [ l 4 C ] N E M binding (Figure 1.27) (Kobayashi et al., 2003) 
Most ABC transporter, have been found to consist o f four domains: two 
nucleotide binding domains (NBD) that serve as engines for ATP hydrolysis, which is 
coupled to active transport, and two transmembrane domains ( T M D ) that are believed 
to constitute the transport pathway. The 3D structures o f such as Savl866, MsbA and 
ModB2C2A are in an agreement with a four domain organization in full-size ABC 
transporters (Dawson and Locher, 2006; Hollenstein et al., 2007). Well studied ABC 
exporters such as LmrA, Savl866 and MsbA are believed to form a fu l l transporter 
with twelve transmembrane helices; six helices being contributed by each subunit 
(Borges-Walmsley et al., 2003). After detergent solubilization the ABC transporter 
BmrA, f rom Bacillus subtilis, was found to be a dimer using analytical 
ultracentrifugation (Ravaud et al., 2006). Exceptionally, MacB has only "four" 
transmembrane helices rather than six, leading to the question o f MacB's functional 
oligomeric state. In the tripartite eff lux pump AcrA-AcrB-TolC, AcrB and TolC are 
proven to form trimers, whereas the AcrA oligomeric state is uncertain. MacB confers 
TolC-dependent macrolide resistance, which might indicate that MacB also forms 
trimers in order to coordinate TolC. 
In this chapter, I report on the development o f procedures that provide a good 
yield and purity o f MacB, which has enabled detailed characterisation o f its functional 
and structural states. Size exclusion chromatography (SEC), analytical 
ultracentrifugation (AUC) , electro-spray mass spectrometry and atomic force 
microscope (AFM) were applied to discover the oligomeric state o f MacB when in a 
detergent-solubilized state. 
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3.1 MacB-His6 construction and production 
Cells o f the E. coli strain Novablue, derived f rom E. coli K.12, served as the 
source o f chromosomal D N A for the macA and macB genes. The completed genome of 
E. coli is available f rom the N C B I database, as a source o f sequence information for 
the genetic manipulation o f these genes (section 2.1). A list o f primers, vector plasmids 
and E. coli strains used in the study can be found in section 2.3 and 2.4. The macB 
gene of E. coli was amplified by PCR, incorporating artificial restriction enzyme sites, 
suitable for cloning into a chemically inducible expression vector. The detailed 
methods for the construction can be found in section 2.4, genetic manipulation. 
The forward primer, Ndel-macB, and reverse primer, SacI-stop-macB, were 
designed to incorporate the restriction enzyme (RE) sites, Ndel and SacI, at the 5' and 
3' ends o f the amplified macB, respectively. Successful PCR amplification o f the 
macB sequence was shown to be consistent wi th the predicted size on an agarose gel 
(Figure 3.1a). The amplified macB gene was extracted and purified f rom the agarose 
gel and ligated into the A - T propagation pGEM-T Easy vector. The ligation mixture 
was then transformed into chemically competent E. coli NovaBlue. The pET28a(+) 
expression vectors and the recombinant pGEM-T Easy vectors were digested with 
Ndel and SacI simultaneously, and the digests were then separated by gel 
electrophoresis. The macB gene and linear pET28a were cut out and purified; followed 
by cohesive end ligation using T4 D N A ligase. The ligation mixture was transformed 
into chemically competent E. coli NovaBlue. Plasmid D N A purified from recombinant 
colonies was digested with Ndel and SacI to confirm the presence of inserted D N A 
(Figure 3.1b). 
The pET28a-/wacB expression construct was transformed into the E. coli strain 
C43(DE3) (Miroux and Walker, 1996) for protein production. The protocols for 
protein expression and for harvesting cell membranes were as described in section 2.5. 
The cell membranes were dissolved in 20 m M Tris buffer pH 7.5, 50 m M NaCl, 10 
m M imidazole, 1 m M THP, 10% glycerol and 5% Triton X-100 on a rotary shaker 
overnight. 
MacB-Hise was purified by metal affini ty chromatography using HiTrap C u 2 + 
column (section 2.5.1). MacB-His6 was eluted in buffer containing 20 m M Tris-HCl 
pH 7.5, 500 m M NaCl, 10% glycerol, 50 m M L-histidine and 0.2% Triton X-100. The 
buffer was exchanged into 20 m M Tris-HCl pH 7.5, 10 m M NaCl, 10% glycerol, and 
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0.2% Triton X-100 by using PD-10 columns prior to the second purification by ion 
exchange chromatography using HiTrap Q column (section 2.5.2). 
The efficiency o f expression and purification o f MacB-His6 was determined by 
gel electrophoresis (section 2.6.1) (Figure 3.2). The migration o f the major protein 
band (lanes 2 to 8) is between the 51 kDa and 64 kDa o f the SeeBlue protein marker 
(lane 1), which is marginally different f rom the MacB-His 6 calculated molecular 
weight o f 72.97 kDa. The identification o f MacB-His6 protein was confirmed by 
Western blot, as shown in figure 3.2. 
(a) 1 2 
2 Kb-> 
1.6 Kb ^ 
<- Amplified macB gene 
(1944bp) 
(b) 1 2 3 
5Kb 
2 K b ^ 
<r pET28a 
r 1 Inserted macB gene 
(1944bp) 
Figure 3.1 pET28a/macB construction (a) PCR amplification o f macB gene from 
E.coli K-12. Lane 1= D N A ladder. Lane 2= the amplified macB gene, 
(b) Restriction enzyme digestion analysis o f the pET28aJmacB plasmid. 
Lane 1= ladder. Lanes 2-3 indicate the presence of the macB gene. 
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1 2 3 4 5 6 7 8 
64 kDa 
51 kDa -> 
<- MacB-HiSR 
(72.97 kDa) 
Figure 3.2 S D S - P A G E of MacB-His 6 . Lane 1= protein molecular weight ( M r ) 
marker. Lanes 2-8 indicate the MacB proteins. The signals for MacB-
His6 were shown on the X-ray f i l m by using Western blot. 
3.2 Size exclusion chromatography of MacB 
Analytical SEC was used to determine the molecular weight o f MacB in order to 
investigate its oligomeric state. The analysis was performed on an A K T A using a 
Superdex200PC3.2/30 column as described previously (section 2.8.2). The elution 
profiles of MacB were monitored using a 280 nm U V detector. 
Blue dextran was applied to the column to determine the void volumn (Vo) o f the 
column. The protein molecular mass standards included aldolase, catalase, ferritin and 
thyroglobin, which were run individually in order to determinate the K a v for each 
stardard (Table 3.1), which was then used to generate a calibration curve (r 2 > 0.99) 
(Figure 3.3). 
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Standard Mr(kDa) Concentration (mg/ml) V e (ml) Kav=(Vc-V0)/(Vc-V0) 
Blue dextran — 2 1.01 — 
Aldolase 158 5 1.59 0.42 
Catalase 232 5 1.48 0.34 
Ferritin 440 2 1.32 0.22 
Thyroglobin 669 3 1.18 0.12 
Table 3.1 Generation of the gel-phase distribution coefficient values ( K s v ) 
( K a v ) = ( V e - V 0 ) / ( V C - V 0 ) , V e = elution volume for the protein, V 0 = 
column void volume and V c = geometric column volume (2.4 ml). 
0.45 
0.40 
0.35 
0.30 
0.25 
y= -0.46x + 2.83 0.20 
r= 0.99 
0.10 
1e+5 1e+6 
Log M 
Figure 3.3 A molecular weitht calibration curve generated for protein standards 
on an analytical Superdex 200 PC 3.2/30 gel filtration column. 
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Figure 3.4 Elution profile of MacB-His6 on the analytical gel filtration column 
Superdex 200 PC 3.2/30. Vo = column void volume obtained by blue 
dextran, T= thyroglobin (669 kDa), F= ferritin (440 kDa), C= catalase 
(232 kDa) and A - aldolase (158 kDa). 
MacB was first extracted and purified in Triton X-100; however, Triton X-100 
absorbed strongly at 280 nm, making it impossible to monitor the MacB elution profile. 
Thus, MacB-Hise was exchanged into buffer containing Tris-HCl pH 7.5, 300 m M 
NaCl, 10% glycerol and 0.2% D D M before being analyzed by SEC (section 2.5.3). 
Using an Enzchek Assay, MacB was confirmed to retain ATPase activity and retained 
activity after detergent exchange (data not shown). The MacB-His6 was applied to the 
column and it showed a sharp peak at an elution volume of approximate 1.32 ml ( V e ) , 
giving a K a v value o f 0.223, corresponding to a Mr for the MacB-His6/DDM complex 
o f 415 kDa (Figure 3.4). The average Mr for MacB-Hisg/DDM complex calculated 
f rom 2 runs in the solution is 410 kDa ± 10 kDa. 
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3.3 Quantification of D D M contribution in MacB/DDM complex 
Considering that MacB was in a detergent solubilized state, the detergent could 
make a significant contribution to the M r o f the protein-detergent complex (Ravaud et 
al., 2006). In order to determine the contribution o f D D M in the MacB/DDM complex, 
a phenol-sulfuric acid colorimetric assay was applied to quantify the D D M 
contribution (section 2.7.5). A standard curve containing six points between 0 ug to 20 
ug o f D D M was produced with a line o f best fit (r 2 > 0.99) (Figure 3.5). 
y= 0.04x + 7.5e-3 
r2 = 0.99 
1.5 
0 10 20 30 40 50 60 70 
ng DDM/ 60nL 
Figure 3.5 Standard curve of D D M quantity by using the colorimetric assay. 
A MacB protein sample and its elution buffer were obtained f rom the same batch 
used for the SEC analysis in the previous section, and used to determine the quantity o f 
bound D D M using a colorimetric assay. This MacB sample was determined to have 
concentration o f 0.85 mg/ml using coomassie protein assay kit (section 2.6.2). The 
colorimetric assays were performed in triplicate and two dilutions (1:10 and 1:20) to 
ensure that the amount o f D D M detected was within the range of the standard curve. 
Using the equation generated from the standard curve, the amount o f D D M bound by 
MacB was determined spectrometrically to be 1.2 g D D M / g MacB (Table 3.2), which 
is equivalent to a MacB: D D M molar ratio of 1: 171. Ravaud et al in 2006 concluded 
that the A B C transporter BmrA is a dimer in the detergent solubilized state and that the 
amount o f D D M bound by BmrA was about 1.5 g D D M / g BmrA. BmrA consists o f 
six transmembrane a-helices whereas MacB has only four transmembrane a-helices, 
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suggesting that the DDM: MacB ratio is reasonable. These results indicate that for 
every MacB molecule, bound DDM adds a further 88 kDa to the Mr of the complex, 
resulting in the Mr for a MacB monomer, with bound DDM, to be about 161 kDa. 
However, we should also consider that there would be a quantity of bound lipid, which 
would make a further contribution to the total Mr of the complex but this is probably 
less significant (Ravaud et al., 2006). The estimated Mr of 410 kDa for the complex 
from the SEC analysis suggested that there are at least two MacB protomers in the 
MacB/DDM/lipid complex, but the Mr of 410 kDa is slightly higher than expected for 
the dimer. The size estimate from the SEC analysis is on the basis of the radius of 
gyration. I f the particle is elongated, it tends to overestimate the size of the particle. 
Since MacB has a membrane domain that is sandwiched by cytoplasmic and 
periplasmic domain it is likely to have an elongated structure. 
1 to 10 Dilution (MacB 5.1 ng/60 pL sample volume) 
— 
Abs 4 9 0 
(blank off) 
Bound 
DDM (ug) 
Average of 
bound 
DDM (ug) 
MacB: DDM 
(g/g) 
Average 
MacB: DDM 
(g/g) 
1 0.2753 6.73 
2 0.2511 6.12 6.31 1: 1.24 1: 1.2 
3 0.2489 6.07 
1 to 20 Dilution (MacB 2.55 jig/60 pl_ sample volume) 
AbS4go 
(blank off) 
Bound 
DDM (ug) 
Average 
amount of DDM 
(ng) 
MacB: DDM 
(g/g) 
Average 
MacB: DDM 
(Molar/Molar) 
1 0.1277 3.02 
2 0.1201 2.83 3.01 1: 1.18 1: 171 
3 0.1411 3.36 
Table 3.2 The MacB/DDM ratio in the protein-detergent complex. Both the 
g/g and Molar/Molar ratio have been represented. 
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3.4 Crosslinking of MacB in vitro 
In order to stabilize the oligomeric state of the detergent solubilized complex, 
crosslinking experiments were undertaken in collaboration with Dr. Vassiliy N. Bavro 
at the University of Cambridge. 
Since Tris can quench the crosslinking reaction, purified MacB was exchanged 
into buffer containing 50 mM Na 2HP0 4 pH 7.5, 50 mM NaCl, 10% glycerol and 
0.05% DDM prior to crosslinking. The MacB crosslinking in vitro was performed 
using DSP, a crosslinker with 12 A spacer arms (section 2.7.4), and analyzed by gel 
electrophoresis. The Mr of the MacB-His6 monomer was predicated to be 72.97 kDa. 
On the gel, the MacB monomer was located between the 60 and 70 kDa protein 
makers and the most predominant band, predicated to be the MacB dimer, which was 
located between the 120 and 160 kDa markers (Figure 3.6a). However, the presence of 
some higher Mr bands may suggest MacB can also form higher order oligomers or 
erroneous crosslinking by the long spacer arm crosslinker DSP. In order to confirm the 
MacB oligomeric state and eliminate the possibility of erroneous crosslinking, the 
homobifunctional imidoester cross-linkers DMA (8.6 A spacer arm) and DMS (11 A 
spacer arm) were adopted in the MacB crosslinking. MacB dimers were clearly 
observed, whilst the higher order oligomers had vanished (Figure 3.6b), consistent 
with MacB forming dimers. 
(a) (b) 
1 2 3 4 5 6 7 8 1 2 
160 kDa 
120 kDa MacB dimers 
70 kDa hi wJ (145.94 kDa) 60 kDa 
50 kDa MacB monomer 
(72.97 kDa) 
fif 
mm 
Figure 3.6 SDS-PAGE of the crosslinked MacB-His6- (a) MacB was crosslinked 
with 1, 2, 10, 20, 50, 100 folds (Lane 2-8) of concentration of DSP. (b) 
MacB was incubated with 5 mM DMA or DMS (Lane 2 and 3) 
individually. 
87 
3.5 AUC analysis of MacB 
AUC analysis and data representation were carried out in collaboration with Dr. 
Martin Montcrieffe and Dr. Vassiliy N. Bavro at the University of Cambridge. 
In order to investigate more evidence that MacB is in a dimeric state, a 
combination of sedimentation equilibrium and sedimentation velocity analyses using 
analytical untracentrifugation was performed. The MacB was diluted into buffer 
containing low DDM (just below the CMC [critical micelle concentration]) (Section 
2.8.3) in order to minimize the intervention of DDM micelles. The protein was stable 
in this buffer condition for over a week, allowing several datasets to be collected from 
the same sample. To determine the detergent contribution in the buoyant mass of the 
protein-detergent complex, a series of different density buffers were used, which were 
prepared using different D2O concentrations (section 2.8.3). 
The apparent Mr for MacB was determined from sedimentation equilibrium 
measurements to be 162.6 kDa (Figure 3.7a), which corresponded to a MacB dimer 
(The Mr of a MacB monomer is estimated to be 72.97 kDa). Since the equilibrium is 
only dependent upon the mass as it is calculated by specific buoyancy, buffers with 
different D2O concentrations so as to provide different densities were prepared for the 
experiments in order to negate the detergent contribution in the complex. The idea is 
basically to create a buffer with the same background buoyancy as the detergent 
compound so that it is solely the mass of protein that is detected. For technical reasons 
we could not exactly match the buffer density to that of the DDM; fortunately, we used 
several different buffer compositions and for each of these we determined the 
equilibrium mass. Since the protein contribution is constant, it was possible to 
extrapolate the equilibrium mass to the theoretical point at which the buffer matches 
the specific density of DDM (Peterson et al., 1988). Sedimentation velocity is shape 
dependent and a sedimentation coefficient of 6.8 S was generated, which corresponded 
to a Mr of 160 kDa (Figure 3.7b). The sedimentation velocity, where detergent was 
taken into account, gave a very similar result to the sedimentation equilibrium, 
suggesting that few detergent molecules were bound. Our colorimetric data showed 
that there were 171 molecules of DDM bound to one MacB molecule in the buffer 
containing 0.2% DDM. However, the DDM in the sample for AUC analysis was much 
lower at 0.006%, just below the CMC, which may lead to the difference in the data. 
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Figure 3.7 AUC analysis of MacB. (a) Sedimentation equilibrium profiles of the 
MacB-DDM. It shows a representative sedimentation equilibrium 
profile from one of the runs (two different velocities of the same 
sample). Experimental data (dots) and fitted model (solid line) is shown 
for each. The bottom panel is the residuals (differences between data 
and model) after fitting, (b) Sedimentation velocity measurements of 
the MacB-DDM. Sedimentation velocity profiles of the MacB are 
consistent with a stable dimer formation. 
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3.6 Electrospray mass-spectrometry 
Electrospray mass-spectrometry experiments and data representation were 
carried out in collaboration with Dr. Nelson P. Barrera and Dr. Vassiliy N. Bavro at the 
University of Cambridge. 
Electrospray mass-spectrometry was used to determine accurately the Mr of the 
protein, under conditions that would dissociate the DDM, revealing a peak with a Mr 
of 145.96 ± 0.02 kDa, which is consistent with a MacB dimer (Figure 3.8). With 
known mass-to-charge ratio (m/z) and numbers of positive ion, the molecular weight 
of MacB can be calculated. 
The use of mass spectrometry to determine the Mr of membrane proteins is a 
novel and challenging field and our results are the first, to the best of our knowledge, 
to report on the determination of the oligomeric state of a native membrane protein 
from the ABC transporter family. 
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Figure 3.8 Mass spectrum of MacB. The charge states corresponding to the 
peaks are graphed. 
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3.7 AFM analysis of MacB 
AFM analysis and data representation were carried out in collaboration with Dr. 
Nelson P. Barrera and Vassiliy N. Bavro at the University of Cambridge^ 
Using AFM larger particles could clearly be seen at high-resolution to consist of 
two protein domains that are highly suggestive of a dimer (Figure 3.9). Not 
surprisingly, in the presence of AMP-PNP, a non-hydrolysable analogue of ATP, the 
ratio of dimers to monomers on the AFM grids increased, which would be consistent 
with the nucleotide stabilizing the interaction between monomers (Figure 3.10). 
Our findings are novel because detergent molecules tend to impair the resolution 
of AFM studies of detergent solubilized membrane proteins; so that in the case of 
MacB, we may be able to get information on the topology and stoichiometry of its 
assemblies with MacA and TolC. Indeed, when MacA, which was resolved as a single 
population of particles with a volume of 69 nm 3, was mixed with MacB, a number of 
particles with volumes far in excess of 238 nm 3 (e.g. MacB dimer volume) and 307 
nm 3 (e.g. MacB dimer volume + MacA volume) were resolved, indicative not only of 
the interaction of MacA and MacB but also the formation of multi-subunit complexes 
(data not shown). 
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t J * 
25 nm 
Figure 3.9 AFM imaging of MacB. (a) 3D picture of a low magnification 
image of MacB acquired in air in Tapping Mode with a diamond-like 
extratip of resonant frequency~300 kHz and spring constant of 40 
N/m. Letters 'm ' and 'd ' represent MacB monomer and dimer, 
respectively, (b) High resolution images of structures where two 
small particles ( 'm'+'m') are attached to one another, clearly 
indicative of dimer formation. 
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Figure 3.10 Frequency distribution of molecular volumes of MacB. (a) The 
curve indicates a fitted Gaussian function. The 'm' and 'd ' peaks 
correspond to volumes of 118 ± 1 nm 3 (n= 1642) and 238 ± 5 nm 3 
(n= 665). The data is consistent with the 'm ' and 'd ' peaks 
corresponding to the MacB monomer and dimer, respectively, (b) 
Frequency distribution of molecular volumes of MacB that had been 
incubated with the non-hydrolysable ATP analogue AMP-PNP. The 
peaks correspond to volumes of 112 ± 3 nm (n= 94) and 218 ± 14 
nm 3 (n= 116). This data indicates an increase in the dimer: monomer 
ratio in the presence of AMP-PNP. 
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3.8 Discussion 
Membrane proteins are notoriously difficult to overexpress and manipulate 
due to their high hydrophobicity; and the integral membrane protein MacB, a ABC 
transporter from E. coli, is no exception. The macB gene was first cloned into the 
plasmid pQE80 (Qiagen) for overexpression in the E. coli strain M15/PREP4 
(Qiagen), under the regulation of a T5 promoter. However, MacB tended to stop the 
cells from growing once induced and it degraded extensively using this expression 
system, resulting in an extremely low yield and stability (data not shown). The yield 
and stability of MacB protein was significantly improved using the T7 promoter 
regulated plasmid pET28a(+), along with the E. coli strain C43(DE3). Even so, 
using the latter expression system of the yield of pure MacB protein, after two 
purification steps, was only about 1 mg of protein from 2 L cells. MacB lost its 
ATPase activity when being extracted with 2% DDM, but retained activity when 
extracted with 5% Triton X-100 and subsequently switched into a buffer containing 
0.2% DDM. This observation indicates that the activity of MacB is detergent-
dependant, but the reason is unknown. 
Our colorimetric analysis indicated that there were 171 molecules of DDM 
bound to one MacB molecule, which is consistent with the values found for other 
membrane proteins (Butler et al., 2004; Ravaud et al., 2006). EmrE, the best studied 
SMR protein, was found to be a dimer in the detergent-solubilized state, with a 
molar ratio of DDM/EmrE of 104.5 ± 6 (Butler et al., 2004). BmrA was found to be 
dimeric in the detergent solubilized state and the molar ratio of DDM/BmrA was 
determined to be 194 (Ravaud et al., 2006). However, our sedimentation velocity 
AUC analyses, where the detergent was taken into account, gave a DDM/MacB of 
molar ratio of 24. This difference might be due to using a DDM concentration of 
0.006%, slightly below the CMC, in the buffer for AUC analysis. 
In this study, ES-MS has been used to successfully identify MacB oligomeric 
state. ES-MS is now widely accepted as a powerful method to determine accurately the 
stoichiometry of intact protein complexes (Hernandez and Robinson, 2001; Sharon and 
Robinson, 2007). However, it has remained extremely difficult to analyze membrane 
proteins, solubilized in detergent due to their hydrophobicity, under similar conditions. 
So far, only a few studies have reported the observation of membrane proteins or their 
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complexes in MS (Hanson et al., 2003; Hag et al., 2004; Lengqvist et al., 2004; Meier 
et al., 2007). In this study, using nanoflow ES (a miniaturized form of ES with reduced 
flow rates) and a high collision energy, which facilitates the desolvation process and 
induces dissociation of detergent-proteins clusters, we demonstrated for the first time 
the native dimeric state of MacB. Under our experimental conditions, it was possible 
to successfully maintain the non-covalent subunit interactions, determining the 
oligomeric state of the protein complex without ambiguity. The development of 
strategies to tackle this field is challenging, primarily since the large quantities of 
detergent suppress the protein signal while the highly hydrophobic membrane proteins 
in aqueous buffers often blocks electrospray needles. 
Also of interest is the association between structural results provided by MS 
and AFM. AFM imaging has been applied previously to determine the 
stoichiometry of purified membrane proteins (Barrera et al., 2005; Barrera et al., 
2008). Interestingly, using diamond-like extratips to scan the topography of isolated 
MacB, it was possible to identify both subunits forming the complex. Although 
AFM imaging cannot give very accurate measurements of molecular masses of 
particles, it provides a reasonable range for the MacB protein (approximately 130-
140 kDa). The structure of each component of the AcrA/AcrB/TolC complex pump 
has been determined, giving some insight into how the complex is assembled; 
however, the stoichiometry of the whole tripartite complex pump is still 
controversial (Fernandez-Recio et al., 2004; Higgins et al., 2004). In this study, 
using AFM, each subunit of the MacB dimer can be identified, suggesting the 
possibility to extend such analyses to determine how the tripartite complex is 
assembled. 
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Chapter four: Defining the role of the membrane fusion 
protein MacA in MacB's ATP hydrolysis 
Gram-negative bacteria such as E. coli employ membrane efflux systems to 
transport antibiotics, noxious chemicals and large protein toxins outside the cell 
(Koronakis et al., 2004). Multidrug efflux pumps consist of three components: an 
energy-providing integral inner membrane protein, either an ABC transporter or a 
proton antiporter of the RND family or MFS (Borges-Walmsley et al., 2003), 
cooperates with a protein of the TolC exit duct family. The third component of 
tripartite complex pumps is a membrane fusion protein, largely periplasmic and 
anchored to the inner membrane by a single transmembrane a-helix or an N-terminal 
lipid moiety. One of the best studied efflux pumps of E. coli is the AcrA/ArcB/TolC 
system, where the membrane fusion protein AcrA was proposed to provide a physical 
link between AcrB and TolC. 
Kobayashi et al in 2001 showed that the MacAB complex confers TolC-
dependent macrolide resistance via active drug efflux. In this chapter, the potential 
roles and domains of membrane fusion protein MacA to interact with MacB will be 
investigated. 
4.1 MacA-His6 construction and production 
A construct was made to overexpress the MacA protein in this study. The details 
of the construction are described in section 3.1. In short, the forward primer, Ncol-
macA, and reverse primer, XhoI-macA, were designed to incorporate the RE sites, 
Ncol and Xhol, at the 5' and 3' ends of the amplified macA, respectively. Successful 
PCR amplification of the mac A sequence was shown to be consistent with the 
predicted size on an agarose gel (Figure 4.1a). Plasmid DNA purified from 
recombinant colonies was digested with Ncol and Xhol to confirm the presence of the 
inserted DNA (Figure 4.1b). 
The pET2ld-macA expression construct was transformed into the E. coli strain 
C43(DE3) for protein production. The cell membranes were dissolved in 20 mM Tris 
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buffer pH 7.5, 300 mM NaCl, 15 mM imidazole, 1 mM THP, 10% glycerol and 5% 
Triton X-100 on a rotary shaker overnight. 
MacA-His6 was purified by metal affinity chromatography using a HiTrap N i 2 + 
column (section 2.5.1). MacA-His^ was eluted in buffer containing 20 mM Tris-HCl 
pH 7.5, 500 mM NaCl, 10% glycerol, 500 mM imidazole and 0.2% Triton X-100. The 
efficiency of expression and purification of MacA-His6 was determined by gel 
electrophoresis (section 2.6.1) (Figure 4.2). The migration of the major protein band 
(lanes 2 to 10) between the 39 kDa and 51 kDa bands of the SeeBlue protein marker 
(lane 1) is consistent with the calculated molecular weight of 41.8 kDa MacA-His6. 
Further identification of the MacA-His6 protein was achieved by Western Blot, as 
shown in figure 4.2. 
(a) 1 2 3 
1.6 Kb 
1 Kb <- Amplified macA gene 
(1113bp) 
(b) 1 2 3 4 
<- pET21d 
4- Inserted macA gene 
(1113bp) 
Figure 4.1 pET21d/macA construction, (a) PCR amplification of macA gene 
from E.coli K-12. Lane 2 = the DNA ladder. Lane 1 and 3 indicate the 
amplified macA gene, (b) Restriction enzyme digestion analysis of the 
pET2\d/macA plasmid. Lane 1= DNA ladder. Lanes 2-3 indicate the 
presence of the macA gene. 
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Figure 4.2 SDS-PAGE of MacA-His6. Lane 1= the protein M r marker. Lanes 2-10 
indicate the Mac A proteins. The signals of MacA-His6 were shown on 
the X-ray fi lm by using Western blot. 
4.2 MacA regulates the ATPase activity of MacB 
Although MacB belongs to the ABC superfamily it has an exceptional 
architecture. The presence of an NBD in MacB affords the opportunity to test for an 
interaction with, and modulation of its ATPase activity by, MacA, which can be 
carried out in solution. The MacB protein was purified as described in section 3.1. and 
shown to have its detergent-dependent ATPase activity, being active in Triton X-100 
but not in a high concentration of DDM. In order to investigate the potential role of the 
membrane fusion protein MacA in the ATP hydrolysis by MacB, the dye 2-amino-6-
mercapto-7-methylpurine riboside (MESG) was used to monitor the time course of 
ATP hydrolysis by detecting the production of inorganic phosphate (Pi) (section 2.7.1). 
A standard curve was generated, which illustrated the amount of Pi released in 
nanomoles (nmoles) plotted against the absorbance at 360 nm (Abs36o) and analyzed 
by linear regression. Points plotted were from an average of three independent 
experiments (Figure 4.3). 
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Figure 4.3 Standard curve of inorganic phosphate (Pi). Measurments were 
undertaken at absorbance 360 nm using the EnzChek phosphate assay. 
The MacB ATPase activity was determined in the presence of MgC^ and various 
concentration of ATP. The amount of Pi released in each sample was measured by the 
change in A 3 6 0 and was calculated by using the equation generated from the standard 
curve. The time course was characterized by a burst in Pi production, during the first 
20 seconds, followed by a slower steady-state rate (Figure 4.4). This kinetic behavior 
indicated that the ATP was hydrolyzed rapidly in the burst phase of the trace, and 
further turnovers were rate limited by the slow release of product. 
The amplitude of the burst phase, measured at eight different ATP concentrations, 
from 0.01 mM to 4 mM, ranged from 2.3-2.4 uM (Figure 4.4), which is equivalent to 
the MacB concentration (2.3 u.M). When the MacB concentration was increased to 3.5 
uM, the amplitude of the burst phase increased to 3.3 uM (Figure 4.5), indicating that 
the burst is approximately equivalent to the MacB concentration and that both NBDs 
within the MacB dimer are functional. The rate constant for the hydrolysis step was 
determined by fitting the burst phase to an exponential function, yielding a value of 
about 0.22 s"', which was independent of the ATP concentration. 
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Figure 4.4 A plot for Pi generation by MacB on concentration of ATP. MacB's 
ATPase activity was measured by the time course for the change in Pi 
concentration. 2.3 uM MacB was used and the ATPase activity was 
measured in the presence of various concentration of Mg-ATP, from 0.1 
mM to 4 mM. 
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Figure 4.5 A plot for Pi generation by MacB. MacB's ATPase activity was 
measured by the time course for the change in Pi concentration. 3.5 uM 
MacB was used, and the ATPase activity was measured at Mg-ATP 
concentration of 1 mM. 
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Figure 4.6 A plot for Pi generation by MacAB on concentration of ATP. 2.3 
uM MacA and MacB were used, and the ATPase activity was measured 
in the presence of Mg-ATP. 
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Figure 4.7 The steady-state rate of Pi production by MacB as a function of the 
ATP concentration in the absence (lower curve) and presence (upper-
curve) of an equivalent concentration of MacA. The data are 
characterized by V m a x and K m values of 8.9 nmoles ATP/mg MacB/min 
and 374 uM, respectively, for MacB alone; and of 12.3 nmoles ATP/mg 
MacB/min and 72 uM, respectively, for MacB in the presence of an 
equivalent concentration of MacA. 
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The steady-state phase was characterized by a rate of Pi production that increased 
in a hyperbolic manner with the ATP concentration (Figure 4.7). A maximal specific 
activity of 8.9 nmoles ATP/mg MacB/min and a K m of 374 uM were obtained by 
fitting the data to a hyperbolic function. The macrolides erythromycin and 
oleandomycin, substrates of MacB, were also added respectively in the reaction to 
investigate the possibility of a substrate-induced change in the ATPase activity; 
however, the presence of the macrolides did not affect ATP hydrolysis by MacB, 
which is consistent with a previous report on MacB (Tikhonova et al, 2007) but 
contrasts with the findings for Savl866 (Dawson and Locher, 2006). The ATPase 
activity of Savl866, reconstituted into liposomes, was stimulated by the anti-cancer 
drugs doxorubicin, vinblastine and the fluorescent dye Hoechst 33342. 
An equivalent concentration of MacA was added to 2.3 uM MacB, the ATPase 
activity was determined in the presence of MgCb and various concentration of ATP. 
Surprisingly, the Pi burst phase disappeared but the steady-state rate was enhanced 
(Figure 4.6). This behavior might suggest that MacA increased the rate of ADP 
dissociation from MacB, making this step is no longer rate-limiting. However, k c a t did 
not increase to a rate above that determined for the burst phase and so we must assume 
that the hydrolysis rate also decreases. 
Figure 4.7 illustrated the steady state ATPase activity of MacB on various ATP 
concentrations. The non-linear regression line was obtained by fitting in a hyperbolic 
trace. The equation of the regression line is as follows: 
y = a*x/(b+x) 
In the equation, "a" represents V m a x and "b" represents K m . The k c a t / K m ratio is 
often thought of as a measure of enzyme efficiency. Both a big value of K c a l (rapid 
turnover) or a small value of K m (high affinity to substrate) can makes k c a i / K m large. 
Although MacA increased the specific activity of MacB from 8.9 to 12.3 nmoles 
ATP/mg MacB/min, which would correspond to an increase in k c a ( from 0.011 to 0.015 
s"1, the steady-state rate did not exceed the rate for hydrolysis in the absence of MacA 
(e.g. 0.22 s"1). Accordingly, the increase in the steady-state rate, which was attributed 
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to product release, would not be rapid enough to prevent the phosphate burst. 
Consequently our results suggest that MacA hinders the rate of ATP hydrolysis, so that 
this process is no longer rate limited by the product release. This finding contrasts with 
a previous report on MacB, where the presence of MacA had no affect on the ATPase 
activity of MacB in solution. However, they did find that MacA, when co-reconstituted 
with MacB, had the effect of increasing both k^t (e.g. k c a t from 0.1 to 0.78 s'1) and the 
affinity of MacB for ATP (e.g. K m from 2.3 to 0.38 mM), which is similar to the effect 
of MacA on the steady-state kinetics of ATPase activity of MacB in a detergent 
solubilized state in our study. 
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4.3 The MacA periplasmic domain 
The previous section indicated that MacA regulates the ATPase activity of MacB. 
MacA is a membrane fusion protein with an anchored transmembrane domain. To 
investigate the possibility that the transmembrane domain is involved in the interaction 
with MacB, soluble truncated MacA, in which the first N-terminal 20 residues were 
deleted, was generated based on the predication of its secondary structure, using the 
program Jpred at University of Dundee (Section 2.1). Figure 4.8 illustrates the short 
transmembrane a-helix (pink) and large periplasmic domain (blue). 
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Figure 4.8 Secondary structure prediction of E . coli MacA. The predicted 
secondary structure elements of MacA are drawn above the amino acid 
sequence with the ct-helices and p-sheets depicted as H and E 
respectively. Horizontal arrows drawn above secondary structure 
describe predicted protein topology (Green arrow indicates cytoplasmic 
domain, pink arrow indicates membrane spanning domain and blue 
arrow indicates periplasmic domain). 
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4.3.1 Truncated MacA construction and production 
A construct was made for the expression of the N-terminal truncated MacA. The 
details of the construction are described in section 3.1, indicating the changes in DNA 
template and primers. In short, the forward primer, NcoI-FD20macA, and reverse 
primer, XhoI-macA, were designed to incorporate the RE sites, Ncol and Xhol, at the 
5' and 3' ends of the amplified mac A sequence, respectively. Plasmid DNA purified 
from recombinant colonies was digested with Ncol and Xhol to confirm the presence 
of the inserted DNA (Figure 4.9a). 
The pET2ld-A20macA expression construct was transformed into the E. coli 
strain C43(DE3) for protein production. A20MacA-Hisg was purified by metal affinity 
chromatography using a HiTrap N i 2 + column (section 2.5.1). MacA-His6 was eluted in 
buffer containing 20 mM Tris-HCl pH 7.5, 500 mM NaCl, 10% glycerol, and 500 mM 
imidazole. The efficiency of expression and purification of MacA-His6 was determined 
by gel electrophoresis (section 2.6.1) (Figure 4.9b). The migration of the major protein 
band (lanes 2 to 10) is just above the 39 kDa SeeBlue protein marker (lane 1), which is 
consistent with a calculated molecular weight of 39.3 kDa for MacA-His6. 
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Figure 4.9 pET21d/A20macA construction, (a) Restriction enzyme digestion 
analysis of the pETHdJAmacA plasmid. Lanes 1-2 indicate the presence 
of the truncated macA gene, (b) SDS-PAGE of truncated MacA-Hise. 
Lanes 1-9 indicate the truncated A20MacA protein. Lane 10= the 
protein M r marker. 
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4.3.2 N-terminal truncated MacA regulates the ATPase activity of MacB 
When N-terminal truncated MacA was added to MacB, at an equivalent 
concentration, a similar behavior was observed as in the presence of full length MacA, 
which is different as observed in the absence of MacB (Figure 4.4), indicating that 
truncated MacA was equally capable of regulating the ATPase activity of MacB 
(Figure 4.10). Thus, we concluded that the N-terminal transmembrane domain is not 
required in the regulation of the ATPase of MacB. This finding is consistent with a 
report on the membrane fusion protein AcrA, in which, a lipid-deficient derivative of 
AcrA was shown to retain its ability to cooperate with AcrB and TolC to confer 
resistance to drugs (Zgurskahya and Nikaido, 1999). 
MacB plus MacA 
o MacB plus deltaZOMacA 
1 
i i i i i i 
60 80 100 120 140 160 20 40 
Time (s) 
Figure 4.10 Pi generation by MacAB and A20MacA plus MacB. 2 uM MacB and 
A20 MacA were used, and the ATPase activity was measured at Mg-
ATP concentration of 1 mM. 
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4,4 The cc-helical hairpin of MacA is not required in the regulation of the ATPase 
activity of MacB 
The measurements of the ATPase activity of E. coli MacB in the presence of S. 
aureus MacA was undertaken in collaboration with Mrs. Helen Frankish from our 
group. 
Both gram-negative and gram-positive bacteria, such as E. coli and S. aureus, 
possess macAB genes encoding macrolide transporters; however, gram-positive 
bacteria would not be expected to require MacA to interact with an OMP due to the 
lack of an outer-membrane. We have noted that in some strains of S. aureus, MacA 
has a large deletion that corresponds to the coiled-coil hairpin which is the domain 
believed to interact with the outer membrane protein (Mikolosko el ai, 2006; Bavro 
et al, 2008). 
The genome sequence of S. epidermidis reveals three genes that putatively 
encode a macrolide efflux pump: SE2405, encoding a membrane translocase; 
SE2406, encoding an ATPase; and SE2407, encoding a membrane fusion protein. 
SE2405 and SE2406 have 46.5% and 55.4% sequence similarity, respectively, to the 
corresponding domains of E. coli MacB and SE2407 has 26% sequence similarity to 
E. coli MacA (Figure 4.11). Furthermore, secondary structure predications suggest 
that SE2407 and E. coli MacA are arranged into similar domains, consisting of an 
N-terminal transmembrane ot-helix and a pair of long helices between two P-strand 
containing domains. S. aureus possesses three homologous genes, with SAS0173 
and SAS0174 having 76.8% and 72.1% amino acid sequence similarity to SE2405 
and SE2406, respectively. Interestingly, the alignment of SAS0172 with SE2407 
indicates that the S. aureus MFP MacA encoded by SAS0172 has lost a large 
fragment, spanning residues 88-206 in the MFP encoded by SE2407 (Figure 4.11). 
This is the region that incorporates the hairpin that interacts with TolC, suggesting 
that S. aureus MacA has lost this domain because of absence of an outer membrane 
in gram-positive bacteria. However, S. aureus still retains the other domains of the 
MFP, strongly suggesting that this plays an important functional role, such as 
activating its cognate ABC transporter composed of SAS0173 and SAS0174. 
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Figure 4.11 MacA sequence alignment. A sequence alignment of the MacA 
membrane fusion proteins from the gram-negative bacterium E. coli and 
gram-positive bacteria S. epidermitis and S. aureus was represented. 
This analysis indicates that while the proteins from E. coli and S. 
epidermitis have similar secondary structures, the large a-helical 
domain predicted to harbor the TolC interaction site is missing in the S. 
aureus protein. The illustration of MacA sequence alignment was 
undertaken in collaboration with Dr. Vassiliy N. Bavro at the University 
of Cambridge. 
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In order to test the hypothesis, the ATPase activity of MacB was determined in 
the presence £ aureus MacA (SAS0172). The addition of an excess of S. aureus 
MacA to E. coli MacB was able to abolish the Pi burst and this kinetic behavior was 
consistent with the effect of E. coli MacA on MacB (Figure 4.12), suggesting that the 
the a-helical hairpin of MacA is not required for activation of MacB. This finding is 
consistent with a report on AcrA (Elkins and Nikaido, 2003). In this report, several 
chimeric mutants of AcrA were created by replacing with the corresponding sequences 
from YhiU, a homolog does not function with the AcrB. Drug susceptibility tests of 
these chimeras revealed that N-terminal region of AcrA could be replaced with the 
corresponding domain of YhiU up to residue 290 and these mutants still retained 
functional as native AcrA. However, AcrA lost its ability to function with AcrB when 
the region between residues 290 and 357 was replaced with corresponding sequence of 
YhiU, indicating a small region of AcrA close to its C terminus is involved in the 
interaction with its cognate pump protein, AcrB. 
7 
6 
a. 
^ 4 
to 
m 
•2 3 
0 •* 
No SaMacA 
o SaMacA 2.5nM 
SaMacA 3.5nM 
0 20 40 60 80 100 120 140 160 
Time (s) 
Figure 4.12 Pi generation by E. coli MacB in the presence of S. aureus MacA. 2 
uM MacB was used, and the ATPase activity was measured at Mg-ATP 
concentration of 1 mM. 
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4.5 CD analysis 
In the previous section, we predicted that S. aureus MacA encoded by SASOJ 72 
has lost the coiled coil hairpin structure found in E. coli MacA (Figure 4.11). In order 
to determine the secondary structure of the N-terminal truncated MacA from E. coli, 
CD spectrum analysis was applied. Protein samples were dialyzed against buffer 
containing NaF rather than NaCl, minimizing the strong absorbance from CI' in the far 
UV region. In order to estimate the best protein concentration for CD analysis, the 
absorbance of the sample was measured at in range of the wavelength (190 nm-260 
nm), on the priority of keeping the strongest absorbance value within 0.8-1, generating 
a concentration for CD at around 0.09 mg/ml (2.25 uM). The spectrum of proteins in 
Tris buffer containing 20 mM NaF, pH 7.5 was recorded from 260 nm to 190 nm, for 
an average of six and subtracted by baseline spectrum of buffer itself to get the final 
spectrum. A quench and a peak can be seen at around 210 nm and 195 nm respectively 
(Figure 4.13). The High Tension voltage, the voltage applied to the photomultiplier, 
reached 700 when the wavelength went down to 195 nm during the measurement of 
the protein sample; however, this situation can also be observed in the measurements 
of buffer and H 2 O respectively. Generally, for reliable data, the High Tension voltage 
should remain within 700 V, but this value will depend on the particular instrucment 
being used (Kelly et al., 2005). The reason could be due to the combination of using a 
weak Xe arc light source and the strong absorbance of H 2 O in the far UV region. 
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Figure 4.13 The CD Spectrum of A20MacA. Data was collected from 260 nm to 
190 nm for a 2 mm pathlength, with a 2 sec rate constant, 10 nm/min 
scanning speed and 1 nm bandwidth. 
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NRMSD:0.105 
Helix segments per 100 residues: 2.475 Strand segments per 100 residues: 5.512 
Ave helix length per segment: 7.168 Ave strand length per segment: 5.664 
Result Helixl Helix2 Strandl Strand2 Turns Unordered Total 
1 0.093 0.094 0.165 0.099 0 191 0.358 1 
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(b) 
NRMSD:0.027 
Helix segments per 100 residues: 1.332 Strand segments per 100 residues: 4.628 
Ave helix length per segment: 6.757 Ave strand length per segment: 6.726 
Helixl Helix2 Strandl Strand2 Turns Unordered Total 
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(c) 
NRMSD:0.086 Rvalue: 0.279 
All Matching Solutions 
Stage Helixl Helix2 Strandl Strand2 Turns Unordered Total 
3 0 031 0 085 0.255 0.126 0.208 0.277 0.982 
3 0.026 0.078 0.264 0 129 0.225 0.296 1.018 
3 0.034 0.076 0.245 0.120 0.213 0.281 0.970 
3 0029 0.075 0.254 0.120 0.219 0.284 0.981 
3 0 033 0.114 0.248 0.130 0.200 0.262 0.987 
4 0.031 0 085 0.255 0.126 0.208 0.277 0.982 
4 0.026 0.078 0.264 0 129 0.225 0.296 1.018 
4 0.034 0 076 0.245 0.120 0.213 0.281 0.970 
4 0.029 0.075 0.254 0 120 0.219 0.284 0.981 
4 0.033 0 114 0.248 0.130 0.200 0 262 0.987 
HELICES (Per 100 Residues) are: 2.103 STRANDS (Per 100 Residues) are: 6.135 
The AVERAGE LENGTH of HELICES : 5.608 The AVERAGE LENGTH of STRANDS : 6.075 
Figure 4.14 The secondary structure prediction of A20MacA. The data were 
analyzed by three algorithms (a) Contin-LL, (b) CDSSTR and (c) 
SELCON3. 
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Data was then input into the online server Dichroweb at Birbeck College, and 
analyzed by the algorithms SELCON3, CDSSTR and CONTIN-LL. The NRMSD 
(normalized root mean square deviation) values in the analyses generated from these 
three algorithms CONTIN-LL, CDSSTR, and SELCON3 are 0.105, 0.027 and 0.086 
respectively (Figure 4.14). Generally speaking, a low value for the NRMSD is a 
necessary but not sufficient condition for concluding that an analysis has produced a 
good result (Brahms S and Brahms J, 1980) That is, i f the NRMSD is high (> 0.1), the 
correspondence of the calculated secondary structure with the actual one is probably 
'incorrect', but a low NRMSD does not necessarily indicate an accurate analysis. 
Among the three algorithms, CDSSTR gave the lowest NRMSD value; however, this 
algorithm tends, but not always, to give the lowest NRMSD values for a given 
reference database, but this does not mean that those results are the most significant. 
Apart from the NRMSD, the total sum of the secondary structure compositions must 
be > 1. Based on these rules, the selected predicted compositions of a-helix were 
18.7%, 9%, and 10.4% from CONTIL-LL, CDSSTR, and SELCON3 respectively 
(Figure 4.14). The membrane fusion protein AcrA in E. coli in its truncated form 
(Mikolosko et al., 2006) has approximate 15% a-helix composition. Thus, our data is 
consistent with the prediction that the truncated MacA has the coiled coil hairpin 
structure. 
113 
4.6 Discussion 
Membrane fusion proteins have been found to be essential components of 
tripartite pumps utilizing RND, MFS, and ABC transporters (Putman et al., 2000). The 
ATPase domain of MacB supplies a good approach to study the interaction of MacA 
with MacB. At first, MacA was originally extracted from membranes using DDM, 
however, our EM analysis and gel filtration data (data now shown) indicated it 
aggregated immediately after purification. Oddly, both MacB and MacA lost stability 
when extracted with DDM, but they both retained activity when extracted with Triton 
X-100. 
Our kinetic data indicated that MacB had a maximal specific activity of 8.9 
nmoles ATP/min/mg MacB and a K m of 374 uM Mg-ATP. During the course of our 
studies another investigation reported on the ATPase activity of MacB (Tikhonova 
et al., 2007), in which it was found that MacB retained ATPase activity in Triton X-
100 but was inhibited by DDM. In this report, MacB, solubilized in 0.2% Triton X-
100, appeared to have a specific activity that was an order of magnitude higher than 
we had found; however, a discontinuous assay was used to determine the ATPase 
activity and this could have been exaggerated by the initial Pi burst in the reaction. 
Indeed, k c a l was marginally slower than the hydrolysis rate determined from the Pi 
burst phase in our experiments (e.g. 0.17 s"1 versus 0.22 s"1). In this report, they 
found that MacA could stimulate the ATPase activity of MacB when both of them 
were co-reconstituted into proteoliposomes; however, MacA had no substantial 
effect on the modulation of the ATPase activity of MacB in the detergent-
solubilized state, which contrasts with our findings in that MacA increases the rate 
of product release (k c a ( from 0.011 to 0.015 s~'), whilst decreasing the rate of 
hydrolysis to a similar rate to product release. The reason for this discrepancy could 
be because a discontinuous assay was used to determine the ATPase activity in the 
study undertaken by Tikhonova et al (Tikhonova et al., 2007), and the initial Pi 
burst in the reaction could have gone unnoticed. However, they did find that co-
reconstitution of MacB with MacA had the effect of increasing both k c a , (k c a, from 
0.1 to 0.78 s"1) and the affinity of MacB for ATP ( K m from 2.3 to 0.38 mM). This 
behaviour is similar to the effect of MacA on the steady-state kinetics of the ATPase 
activity of solubilized MacB in our study. To know i f the reconstituted protein 
behaves in an identical manner to the solubilized protein would require the 
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reconstitution of sufficient amounts of MacB to define any Pi burst, which is 
technically demanding. 
We found that the addition of a slightly sub-stoichiometric concentration of E. 
coli MacA to MacB was sufficient block the Pi burst catalysed by MacB, suggesting 
that the stoichiometry of binding of MacA:MacB is 1:2. This makes sense in the 
light of our finding that MacB forms dimers, which presumably bind a single MacA. 
Considering that TolC forms a trimer this would suggest that it binds at least three 
MacA molecules; implying that the minimal stoichiometry for the tripartite complex 
is a trimer of MacB dimers, each of which is connected to TolC via a single MacA 
(e.g. a MacA/MacB/TolC assembly of 3: 6: 3). Consistent with this proposal our 
AFM studies have identified particles larger than expected for a complex of a MacA 
monomer and MacB dimer (e.g. 307 nm3) and with volumes sufficient to 
accommodate a trimer of MacB dimers and MacA trimer (e.g. > 900 nm3). 
The CD data is consistent with our prediction that MacA possess a coiled-
coil hairpin structure. We predicted that S. aureus MacA has lost a large fragment, 
spanning residues 88-206 in the MFP encoded by SAS0172, and that this is the 
region that would incorporate the a-helical coiled-coil domain that interacts with 
the OMP (Lobedanz et al., 2007). The addition of either E. coli MacA or S. aureus 
MacA can regulate the ATPase activity of MacB, suggesting that it is the p-strand 
domain of MacA, which is involved in the MacA-MacB interaction. 
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Chapter five: Tripartite pump: MacA, MacB and open state 
TolC 
The membrane fusion protein AcrA, the RND transporter AcrB and the multi-
functional outer membrane protein TolC can form a functional complex, and the latter 
can also function with MF and ABC transporters (Saier and Paulsen, 2001). Although 
the structure of an assembled tripartite complex structure has not been determined, the 
structure of each component has revealed how those components may assemble. The 
MacA/MacB/TolC complex was shown to confer resistance to macrolides in E. coli 
(Kobayashi et al., 2001); in this study, our aim was to investigate how the complex is 
aeeembled and functions. 
5.1 A functional tripartite complex 
To evaluate the function of the tripartite complex, we adopted measurements of 
the growth of cells expressing various combinations of the macA, macB and tolC genes. 
The expression level of wild type TolC was not stable so the plasmid encoding the 
open-state TolC, which has a deletion of the last 43 amino acids and two mutation 
points, Y362F and R367E, was a courtesy from the lab of Dr. Ben Luisi at the 
University of Cambridge (Bavro et al., 2008), has been used in this experiment. This 
served as the template for PCR amplifications in all TolC constructs. 
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5.1.1 Constructions 
Constructs were made in a similar manner as described in section 3.1. In short, 
the chromosomal macB region of E. coli Novablue was amplified using PCR and 
cloned into EcoRI and Sail restriction sites in the first cloning site of pETDuet™-l to 
yield the pETDuet™-l/Wci? plasmid. The amplified tolC gene was then cloned into 
Nde\ and Xhol restriction sites in the second cloning site of the pETDuet™-l ImacB 
plasmid to yield the pETDue\iM-\/macB-tolC plasmid (Figure 5.1a). A Shine-
Dalgarno (SD) sequence was added upstream of the full length macA gene during PCR 
amplification. The amplified SD-macA gene was cloned into the Sail and Not! sites in 
the first cloning site of the pETDuet™-1 ImacB and the pETDuet™-l/wacB-/o/C 
plasmids to yield pETD\iet™-\/macB-macA and pETDuetJM-l/macB-macA-tolC 
plasmids, respectively (Figure 5.1b). In order to test whether the N-terminus of MacA 
is required for the functional assembly of the complex, the plasmid pETDuet™-
\lmacB-SS-A20macA-tolC plasmid was constructed in a similar manner but with a 
slight modification. The signal sequence g i l l from the vector pBAD/glll was fused to 
the 5' end of the SD-A20macA sequence in order to lead truncated MacA to the 
periplasm (Figure 5.1c). 
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Figure 5.1 Constructions for drug susceptibility tests, (a) Restriction enzyme 
digestion analysis of pETDuet™-1 ImacB-tolC plasmid. Lane 1= the DNA 
ladder. Lanes 2-3 indicate the presence of the tolC gene. Lanes 4-5 indicate 
the presence of the macB gene, (b) Restriction enzyme digestion analysis of 
pETDuet-l/macB-macA-tolC and pETDueV-\/macB-A20macA-tolC. Lane 
1= the DNA ladder. Lanes 2-3 indicate the presence of the macA gene. Lanes 
4-5 indicate the presence of the AlOmacA gene, (c) Restriction enzyme 
digestion analysis of pETDuet™-l/macB-gIII-A20macA-tolC. Lane 1= the 
DNA ladder. Lane 2 indicates the presence of the gIII-A20macA gene. 
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5.1.2 Drug susceptibility test 
Plasmids pETDuet™-l//Mac£, pETDue^-l/macB-macA, pETDuet™-l//w?c£-
tolC, pETDuet™-l/macB-macA-tolC and pETD\iet™-l/macB-A20macA-tolC were 
transformed into the E. coli /SacrAB strain Kam3(DE3), which is highly susceptible to 
a range of antibiotics (Morita et al., 1998). The X.DE3 lysogenisation of Kam3 was 
described in section 2.4.5. 
The macA, macB and tolC genes were simultaneously expressed from 
pETDuet™-l in the Kam3(DE3) strain, conferring elevated resistance to the macrolide 
erythromycin compared to the control Kam(DE3), harboring only the pETDuet™-l 
vector, indicative of the formation of a functional complex (Figure 5.2). 
Our previous data in section 4.3 suggested that the N-terminal transmembrane 
domain of MacA is not required in the regulation of the ATPase activity of MacB. In 
order to test whether the N-terminus of MacA is required for the functional assembly 
of the complex. A construct in which the g i l l signal sequence was fused to truncated 
MacA, targetting it to the periplasm, was capable of conferring resistance to 
erythromycin (Figure 5.2), indicating that the N-terminal transmembrane domain is not 
essential for the assembly of the functional complex. This finding is consistent with 
two reports on membrane fusion proteins. Yoneyama et al (Yoneyama et al., 2000) 
substituted cysteine 24 with phenylalanine or tyrosine and showed this mutant soluble 
MexA, without the lipid moiety, retained its function in the MexA/MexB/OprM 
complex pumps, retaining the antibiotic susceptibility. Membrane fusion protein AcrA, 
when being truncated the first 25 residues, still functional active in the 
AcrA/AcrB/TolC complex pumps, conferring erythromycin and novobiocin resistance 
in the AacrA deletion E. coli strain N43 (Zgurskaya and Nikaido, 1999). 
Cells expressing macB with tolC conferred modest resistance to erythromycin in 
comparison to cells expressing macB, tolC and macA, indicating that MacA is required 
to couple MacB to TolC (Figure 5.2). 
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Figure 5.2 Growth curve measurements. The cell growth of Kam3 cells 
harboring plasmids were measured at absorbance 600 nm up to 12 
hours in the presence of erythromycin at the concentration of 100 ug/ml. 
MacB alone conferred elevated resistance to erythromycin, probably due to its 
ability to pump the antibiotic into the periplasm, but we consistently found that 
expressing macB with either tolC or macA conferred greater resistance. Consequently, 
we sought to test i f MacA could enhance this ability. However, it is difficult to 
distinguish the slight difference in resistance since cells harboring different plasmids 
tend to grow at different rates. Consequently, we adopted an alternative procedure of 
monitoring the growth of cells in the presence and absence of erythromycin and 
determining the loss in growth due to the antibiotic. This procedure enable us to 
determine the susceptibility of the MacB and MacAB expressing cells to erythromycin, 
revealing a more significant loss in growth of the MacB expressing cells compared to 
the MacAB expressing cells and indicating that the simultaneous expression of MacA 
and MacB increases the resistance of the cells to erythromycin (Figure 5.3). This data 
suggests that MacA enhances the ability of MacB to confer antibiotic resistance. 
Similarly, a previous study reported that MacAB, but not MacB alone, conferred 
resistance to macrolides (Kobayashi et al., 2001). 
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Figure 5.3 Drug susceptibility histogram. The cell growth of Kam3 cells 
harboring plasmids were measured at absorbance 600 nm up to 3 hours. 
Relative growth (%) was obtained by dividing the growth of cells in the 
presence of 50 ug/ml erythromycin by the growth of cells in the 
absence of erythromycin. MacAB represents the cells expressing 
MacAB proteins; MacB represents the cells expressing MacB protein; 
Control represents the cells harboring empty vector; and Wild 
represents the wild Kam3(DE3) E. coli strain. 
5.2 MacA enhanced the erythromycin binding to MacB 
The equilibrium binding of erythromhycin experiments were undertaken in 
collaboration with Dr. Saroj K. Velamakanni at the University of Cambridge. 
From the previous section, we concluded that MacA, MacB and TolC can form a 
functional tripartite pump, conferring E. coli resistance to erythromycin. Furthermore, 
the cells harboring the plasmid encoding MacAB showed greater resistance than the 
plasmid encoding MacB itself. Our kinetics data has indicated that MacA regulates 
MacB ATPase activity; in this section, we detected the binding of [N-methyl- l 4C]-
erythromycin to purified MacB in the presence and absence of MacA (section 2.7.2). 
The experiments were divided into three groups containing 50 ug MacA, 50 ug MacB, 
and 25 ug MacB with 25 (.ig MacA respectively, where equal amount of protein was in 
each group. Interestingly, our data indicated that MacB bound more erythromycin in 
the presence of MacA, in a concentration dependent manner (Figure 5.4). However, it 
was not possible to increase the erythromycin to a concentration that saturated MacB 
to determine affinity due to erythromycin high hydrophobicity, leading erythromycin 
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to precipitate with proteins at higher concentration. The data indicate that MacA not 
only modulates the ATPase activity of MacB but also enhances its capacity to bind 
erythromycin. 
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Figure 5.4 Histogram of erythromycin equilibrium binding to MacA, MacB 
and MacAB proteins. The bars represent the erythromycin bound by 
MacA (left, black), MacB (middle, light grey) and MacAB (right, dark 
grey)-
5.3 in vitro crosslinking of MacA-MacB 
The protein crosslinking experiments and data representation were undertaken 
in collaboration with Dr. Vassiliy N . Bavro at the University of Cambridge. 
Our drug susceptibility tests indicated that MacA, MacB and TolC can form a 
functional complex pump in vivo; whilst our kinetics data indicate that purified MacA 
can regulate the ATPase activity of purified MacB in a detergent solubilized state. In 
this section, protein-protein crosslinking was adopted to gain more evidence that MacB 
can interact with MacA in vitro. Purified MacB and MacA were incubated with the 
crosslinker DMA and DMS for 1 hr at room temperature. Interestingly, additional 
bands (Lane 5, 6, 9 and 10) appeared with an Mr greater than the MacB monomer, and 
the one in the lane 5 was cut out along with the control bands in lane 3 for MALDI 
(Matrix-Assisted Laser Desorption/Ionization) analysis. MALDI in gel-digestion 
indicated that both MacA and MacB proteins were present in the cross-linked band 
(Figure 5.6); a miniscule amount of MacA could only be detected in the control band. 
This data suggested that MacB can interact directly with MacA. 
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Figure 5.5 SDS-PAGE of the crosslinked MacA-MacB complexes by using 
DMA and DMS. MacB-MacA complexes are framed in red boxes. Lane 
1= MacA, Lane 2= MacB, Lane 3= MacA + 5 mM DMA, Lane 4= 
MacB + 5mM DMA, Lane 5= MacA + MacB + 5 mM DMA incubated 
for 1 h, Lane 6= MacB+ 5 mM DMA to be incubated for 30 min + 
MacA for another 30 min, Lane 7= MacA + 5 mM DMS, Lane 8= 
MacB + 5 mM DMS, Lane 9= MacA + MacB +5 mM DMS incubated 
for 1 h, Lane 10= MacB+ 5 mM DMS incubated for 30 min + MacA for 
another 30 min. 
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Figure 5.6 M A L D I analyses of the MacA-MacB complex fragment. Fragments 
positively identified by MALDI are colored in red. (a) MacB protein 
has 42% sequence coverage of the peptide map. (b) MacA protein has 
37% sequence coverage of the peptide map. 
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5.4 in vitro interaction between components in the complex 
Interactions between E. coli MacA, MacB and TolC were tested for using 
detergent solubilized proteins for pull down assays. The strategy for the pull-down 
assay involved using a bait protein and a prey protein (section 2.7.3). MacB-His6 
served as the bait protein in the detection of MacA-MacB and MacB-TolC interaction, 
and TolC-His6 served as the bait protein in the detection of TolC-MacA interaction. 
5.4.1 Construction and overexpression of the bait proteins 
Purifed MacB-His6 protein was overexpressed and purified as previously 
described (section 3.1). 
pET21a//o/C plasmid was constructed in a similar manner, to that described in 
section 3.1; and relevant primers, vector plasmids and E. coli strains can be found in 
section 2.3 and 2.4. In short, the amplified tolC gene was cloned into the Ndel and 
Xhol restriction sites of the pET21a(+) plasmid to yield the pET21a/7o/C plasmid 
(Figure 5.7a). The pET21a//o/C expression construct was then transformed into the E. 
coli strain C43(DE3) for protein production. The protein expression and cell 
membranes harvest were manipulated as described in section 2.5. The cell membranes 
were dissolved in 20 mM Tris buffer pH 7.5, 300 mM NaCl, 10 mM imidazole, I mM 
THP, 10% glycerol and 5% Triton X-100 on a rotary shaker overnight. 
TolC-His6 was purified by metal affinity chromatography using a HiTrap N i 2 + 
column (section 2.5.1), and eluted in buffer containing 20 mM Tris-HCl pH 7.5, 500 
mM NaCl, 10% glycerol, 500 mM imidazole and 0.2% Triton X-100. The yield and 
purify of the TolC-Hise was determined by gel electrophoresis (section 2.6.1) (Figure 
5.7b). The migration of the major protein band (lanes 2 to 6) is just above the 51 kDa 
protein marker band (lane 1), which is consistent with the Mr of the TolC-Hise, with a 
calculated molecular weight of 49.2 kDa. 
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Figure 5.7 pET21a/toIC construction and overexpression (a) Restriction enzyme 
digestion analysis of pET21a/to/C plasmids. Lane 1= the DNA ladder. 
Lanes 2-3 indicate the presence of the tolC gene, (b) SDS-PAGE of 
TolC-His6. Lane 1= the protein M r marker. Lanes 2-6 indicate the TolC-
His6 proteins. 
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5.4.2 Construction of the prey proteins 
Constructs were made in a similar manner to those described in the previous 
section. In short, the amplified A20macA, macA and tolC genes was cloned 
individually into the Ncol and Xhol restriction sites of the pET45b(+) plasmid to yield 
the pET45b/zJ20macA, pET45b/macA and pET45b//o/C plasmids (Figure 5.8a). Each 
of those expression constructs was transformed into the E. coli strain C43(DE3) for 
membrane slurry production. 
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Figure 5.8 S-tagged protein construction for pull-down assay, (a) Restriction 
enzyme digestion analysis of pET45b/mac4 and pET45b/A20mctcA 
plasmid. Lane 1= the DNA ladder. Lanes 2-3 indicate the presence of 
the A20macA gene. Lanes 4-5 indicate the presence of the macA gene, 
(b) Restriction enzyme digestion analysis of the pET45b//o/C plasmid. 
Lane 3= the DNA ladder. Lanes 1-2 indicate the presence of the tolC 
gene. 
126 
5.4.3 Pull down Assay 
In the AcrA/AcrB/TolC tripartite complex pump, calorimetry demonstrated 
energetically favourable interactions of AcrA with both purified AcrB and TolC 
proteins (Touze el al., 2004). We previously concluded that MacA, MacB and TolC 
form a functional complex on the basis of our drug susceptibility test data and our 
findings indicate that MacB directly interacts with MacA in crosslinking studies. 
Using pull-down assay (section 2.7.3), in which MacB-His6, served as the bait 
protein, we were able to capture the prey protein MacA-Stag (Figure 5.9). Membrane 
pellets containing MacA-Stag was dissolved in Triton X-100 and added to purified 
MacB-His6. The mixture was loaded into a Ni charged chelating column to 
immobilize the MacB-His6, along with MacA-Stag. Unbound MacA-Stag can be seen 
in the flow-through (Figure 5.9 lane 6); the column was then given highly stringent 
wash to eliminate unbound MacA-Stag. A fraction was collected before the elution of 
the MacB-His6-MacA-Stag complex and only a very tiny amount of MacA-Stag could 
be detected, indicating little or no unbound MacA-Stag suspending in the column 
(Figure 5.9 lane 5). The MacB-His6 and MacA-Stag can be clearly observed in the 
elution (Figure 5.9 lane 4), revealing MacA could interact with MacB. No MacA-Stag 
was seen in the elution of the control group (Figure 5.9 lane 1), suggesting that there 
was no non-specific interaction between MacA and the column. 
Using MacB-His6and N-terminal truncated MacA-Stag for the pull-down assay, 
A20MacA can be observed in the elution (Figure 5.10), indicating that there is 
interaction between the periplasmic domain of MacA and MacB. This behaviour is 
consistent with our previous data that indicated that truncated MacA can regulate the 
ATPase activity of MacB. Similarly, using TolC-His6 and MacA-Stag, a strong 
interaction can be detected (Figure 5.11). Using MacB-His6 and TolC-Stag, an 
interaction can be observed (Figure 5.12), but this interaction is apparently a lot 
weaker than those between MacA and MacB/TolC. 
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Figure 5.9 MacA-Stag pulled down by MacB-His6. Lanel= elution, Lane 2= 
wash, Lane 3= flow-through (Lanes 1-3 were collected in the absence 
of the MacB-His6 protein). Lane 4= elution, Lane 5= wash, Lane 6= FT 
(Lanes 4-6 were collected in the presence of the MacB-His6 protein. 
Lane 7= the MacB-His6 protein and Lane 8= the protein M r marker. The 
identity of the MacA-Stag protein was confirmed by Western blot using 
S-Tag monoclonal antibody. 
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Figure 5.10 A20MacA-Stag pulled down by MacB-His6. FT represents flow-
through, W l represents early stage of wash, W2 represents later stage 
of wash, and E represents elution. "+" indicates the presence of the 
protein, whereas "-" indicates the absence of the protein. In the film, the 
prey protein was detected by Western blot using S-Tag monoclonal 
antibody. 
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FT W1 TolC-His 6 MacA-Stag 
+ 
Figure 5.11 MacA-Stag pulled down by TolC-Hise. FT represents flow-through, 
W l represents early stage of wash, and E represents elution. "+" 
indicates the presence of the protein, whereas "-" indicates the absence 
of the protein. In the film, the prey protein was detected by Western 
blot using S-Tag monoclonal antibody. 
49.2 kDa 
49.2 kDa 
FT W2 MacB-His 6 TolC-Stag 
Figure 5.12 TolC-Stag pulled down by MacB-His6. FT represents flow-through, 
W2 represents later stage of wash, and E represents elution. "+" 
indicates the presence of the protein, whereas "-" indicates the absence 
of the protein. In the film, the prey protein was detected by Western 
blot using S-Tag monoclonal antibody. 
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5.5 Discussion 
Gram-negative bacteria possess tripartite pumps composed of an inner 
membrane protein, a periplasmic protein and an outer membrane protein, which work 
together to confer multidrug resistance. In order to determine the function of the 
MacA/MacB/TolC tripartite-complex pump, we undertook growth curve measurement 
to determine the drug susceptibility of the strains expressing different combinations of 
the MacA, MacB and TolC proteins. 
Originally, minimum inhibitory concentration tests (MIC) were adopted to 
determine whether the MacA/MacB/TolC complex pump confers resistance to the 
macrolide erythromycin in bacteria. However, E. coli strain Kam3(DE3) harboring 
plasmids encoding MacA, MacB and TolC didn't have a substantial effect on the 
resistance of the cells to erythromycin (data not shown). It could be that although the 
proteins assembled together to translocate drugs successfully, the high toxicity of the 
three proteins had a detrimental effect on the host cells, leading to the insignificance of 
drug resistance. As an alternative, growth curve measurements were undertaken to 
determine the function of the tripartite complex pump. During the grow curve 
measurements, the tubes were put in an incubator with shaking to enable more O2 to be 
dissolved into the media, allowing the host cells to grow more vigorously. The effect 
was that in the growth curve measurements, the minimum concentration that inhibited 
growth of erythromycin is a lot greater than the one in the MIC tests (e.g. 300 uM vs 
16 uM erythromycin). 
Our drug susceptibility tests revealed that MacB can confer elevated resistance 
in bacteria to erythromycin in the presence of MacA (Figure 5.3) and our equilibrium 
erythromycin binding experiments indicated that MacA increases the binding ability of 
MacB to erythromycin (Figure 5.4); besides, our kinetics data suggested that MacA 
increased the rate of product release from MacB, speeding up the turn over rate. We 
speculated that MacA increases the binding ability of MacB for erythromycin to catch 
up the faster conformation switch between the outward-facing and inward-facing 
conformation, speeding up the transportation of drugs. 
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In the AcrA/AcrB/TolC complex pump, AcrA can be crosslinked with AcrB 
and TolC individually in vivo, and microcalorimetry studies demonstrated 
energetically favourable interactions of AcrA with both purified AcrB and TolC in 
vitro (Touze et al., 2004). Our pull-down data indicated that any two components of 
the MacA/MacB/TolC complex pump can interact directly in the absence of the third 
component. However, the intensity of the band in Figures 5.10, 5.11 and 5.12 suggests 
that the interaction between MacB and TolC is weak compared to those between 
MacA and MacB/TolC. This may suggest that the dimerization of MacB can recruit 
TolC, via MacA, and simultaneous open TolC for translocation. 
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Chapter six: Crystallization trials 
Integral membrane proteins such as transporters and receptors are critical 
components of many fundamental biological processes. Furthermore, integral 
membrane proteins are important in biomedical and biotechnological applications; 
whilst the majority of drug targets are integral membrane proteins. The macrolide 
ABC transporter MacB putatively has an exceptional structure comprising of four 
transmembrane helices, which is drastically different to the topology of the structure 
determined for ABC exporters Savl866 and MsbA, which has six transmembrane 
helices, in bacteria. In this chapter, I report on how the MacB protein was to 
crystallization screens in order to acquire crystal for structure determination. 
6.1 Dynamic light scattering of MacB 
Purified MacB in buffer containing 20 mM Tris-HCl pH 7.5, 50 mM NaCl, 
0.05% DDM and 10% glycerol was analyzed by dynamic light scattering to determine 
the size distribution profile of MacB. The DLS profiles of 1 mg/ml MacB and the 
buffer itself were measured at 16°C and 4°C. A good correlation between the traces 
suggested that measurements and data are reliable, and MacB showed its high 
homogeneity (> 97%) at both 16°C and 4°C (Figure 6.lab), indicating that it is 
monodispersed in solution. The analysis of the buffer itself served as the control, 
compared to MacB, eliminating the chance of a false signal from the buffer (Figure 
6.1c). 
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re 6.1 Size distribution analysis of MacB. The DLS profile of MacB was 
measured at 16°C (a) and at 4°C (b), and the DLS profile of the buffer 
was measured at 4HC (c). 
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6.2 Preliminary sparse matrix screen of MacB 
The protein crystallization and data collection were undertaken in collaboration 
with Dr. Vassiliy N. Bavro and Mr. Zbigniew Pietras at the University of Cambridge. 
The macB gene sequence was cloned on to the pET28a(+) plasmid vector, which 
introduces a thrombin digestion site between the N-terminal His tag and the cloning 
site, making it possible to make tag-free MacB proteins for crystallization trials. 
However, after being treated with thrombin enzyme (Novagen), a small proportion of 
MacB still retained the tags, detected by Western blot (section 2.6.3), causing 
heterogeneity in the protein prep (data not shown). To avoid heterogeneity, the tag and 
the cleavage sequence were left on the N-teminal on MacB when it was crystallized 
Purified MacB in Triton X-100 (0.2%) (section 3.1) was exchanged and dialyzed 
against buffer containing 20 mM Tris-HCl pH 7.5, 50 mM NaCl, 0.05% DDM and 
with or without 10% glycerol before being used in crystallization trials. Preliminary 
crystallization trials of MacB were accomplished using sparse matrix screens to 
discover a suitable starting condition. 
The commercial sparse matrix screens used were SMI, MbClass, MbClassII, 
Classics, Classics light, pHClear I I (Qiagen), MembFac (Hampton Research), and 
MemSys (Molecular Dimensions). Crystallization trials were undertaken using 10 
mg/ml MacB in the vapour diffusion sitting drop method on 96 well plates with round 
bottoms and automated screening by a Cartesian robot. The development was 
monitored intermittent by light microscopy. 
As shown in Figure 6.2, a few putative micro-crystals could be observed in five 
conditions, but only one of them was from non-glycerol MacB samples (#57 Classics 
light), suggesting that MacB is more stable in the presence of glycerol. Among the five 
conditions, 28-30% PEG400 is found in three conditions (Classics 74 and 75, and 
MbClassII 39), suggesting that precipitant PEG 400 is suitable for MacB crystalization; 
however, no specific salt or pH value is preferable for the formation of MacB crystals 
(Table 6.1). 
Having identified a promising starting condition, the condition can be further 
optimised to improve crystal quality through adjustments in precipitant and salt 
concentration, and pH ranges (Delucas el al., 2005). 
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ure 6.2 Photographs of putative MacB micro-crystals taken under light 
microscopy. Micro-crystals indicative of initial microcrystal 
development identified from (a) #74 Classics (b) #75 Classic (c) #57 
Classics light (d) #39 MbClassII (e) #62 SMI screen kits. 
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Kit Salt Buffer Precipitant 
Classics 74 0.2 M Calcium chloride 0.1 M HEPES sodium salt pH 7.5 
28 %(v/v) 
PEG 400 
Classics 75 0.1 M Cadmium chloride 
0.1 M Sodium 
acetate pH 4.6 
30 %(v/v) 
PEG 400 
Classics 
Light 57 
0.5 M Ammonium 
sulfate 
0.1 M tri-Sodium 
citrate pH 5.6 
0.5 M Lithium 
sulfate 
MbClassll 39 
0.1 M Magnesium 
chloride 
0.1 M Sodium 
acetate pH 4.6 
30 %(v/v) 
PEG 400 
SM1 62 — 0,1 M sodium acetate anhydrous pH 4.5 
20% (w/v) 
PEG3000 
Table 6.1 Compositions of conditions yielding putative micro-crystals. 
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6.3 Preliminary sparse matrix screen of MacA/MacB/TolC complex 
The protein crystallization and data collection were undertaken in collaboration 
with Dr. Vassiliy N . Bavro and Mr. Zbigniew Pietras at the University of Cambridge. 
Purified MacA in Triton X-100 (0.2%) (section 4.1) and MacB (section 3.1) in 
Triton X-100 (0.2%) , and open state TolC (supplied by Dr. Bavro) were exchanged 
and dialyzed against buffer containing 20mM Tris-HCl pH 7.5, 150 tnM NaCl, 0.05% 
DDM and with 10% glycerol. 40 uL of MacA (3 mg/ml), 60 uL of MacB (8 mg/ml) 
and 20 uL of TolC (10 mg/ml) were mixed together to make a final concentration of 
around 6.5 mg/ml, allowing the Molar ratio of MacA: MacB: TolC = 1: 2: 2. 
Preliminary crystallization trials of the MaA/MacB/TolC complex were accomplished 
using sparse matrix screens to discover a suitable starting condition. 
The commercial sparse matrix screens used were SMI , MbClass, and MbClassII, 
Classics (Qiagen). Crystallization trials were undertaken using the mixture of the 
proteins in the vapour diffusion sitting drop method on 96 well plates with round 
bottoms and automated screening by a Cartesian robot. The development was 
monitored intermittent by light microscopy. 
As shown in Figure 6.3a, a micro-crystal could be observed in the SMI 66 
condition, 0.2 M MgCl 2 , 0.1 M Tris pH 7.0, and 10% (w/v) PEG 8000. The crystal 
was frozen using cryo-agent 30% PEG 400 and taken to the European Synchrotron 
Radiation Facility (ESRF) to test for X-ray diffraction. The crystal generated a low 
diffraction of 20 A in the lattice (Figure 6.3). Unfortunately, there was a technical 
problem to get a definitive result indicating either single protein or the protein complex 
within the crystal since the crystal was too small to tell. 
The optimizations of the crystal condition of the complex proteins were 
undertaken by a gradient of PEG 8000 (5.5-13%, with an interval of 1.5%) versus pH 
(6.5-8, with an interval of 0.5) and of PEG 8000 (5-15%, with an interval of 2%) 
versus MgSC<4 (50-200 mM, with an interval of 50 mM). However, no crystal was 
observed in this optimization. The possible reason could be that we used proteins for 
crystallization from batch to batch, causing the crystal not reproducible. 
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Figure 6.3 Images of the crystal of the MacA/MacB/TolC complex, (a) The 
image of the MacA/MacB/TolC crystal in the well of SMI 66. (b) The 
image of the loop and the crystal during scanning, (c) The complex 
diffraction image, with a diffraction of 20 A limit. 
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6.4 Discussion 
Membrane protein crystallography is a challenge. It is reasonable to state that 
from expression, purification to crystallization and structure determination of integral 
membrane proteins still remain non-trivial endeavors that require substantial time and 
resources (Caffrey, 2003; Wiener et al., 2004). Even more, diffraction-quality crystals 
are particularly difficult to get when a membrane protein source is used. The reason 
could be current limited ability to manipulate proteins bearing 
hydrophobic/amphiphilic surfaces that are usually enveloped with membrane lipid. 
For this reason there are only around 160 structures for unique membrane proteins 
(White, 2008). 
MacB retained ATPase activity when detergent solubilized but this was 
detergent dependent, being active in Triton X-100 but not in high DDM. MacB was 
first extracted using 2% DDM but didn't retain its ATPase activity under these 
conditions. However, interestingly, MacB remained functional when extracted with 
5% Triton X-100 and then exchanged into low DDM concentrations (e.g. 0.05%). The 
reason why MacB does not remain functional when extracted by DDM is unknown. 
MacB went through two steps of purification before the crystallization trials; after 
which a DLS analysis showed that the MacB samples had reached 97% homogeneity. 
Figure 6.2 shows some putative micro-crystals of MacB but the majority of them do 
not have angles, indicating 10 mg/ml of MacB may be too high, resulting in shortage 
of time for crystal formation. Besides, MacB was extracted by 5% Triton X-100 to 
obtain the best yield, but excess detergent may result in excess delipidation, causing 
protein instability. (Boulter and Wang, 2001). 
Another hindrance in MacB crystallization is that the tag and the cleavage 
sequence were left on the N-teminal on MacB when it was crystallized. This could be 
surmounted by taking a further step purification for affinity chromatography to isolate 
the tagged and tag-free MacB proteins. However, too many purification steps may lead 
to protein delipidation. Another suggestion is to put the His tag onto the C-terminal of 
139 
MacB; since the NBD is on the N-terminal of MacB, we speculated that a C-terminal 
tag on MacB may avoid a disordered hydrophilic contact. 
Structure determination of ABC transporters has been challenging due to their 
dynamic nature in a detergent solubilized state, which often hinders formation of well-
ordered, three-dimensional crystals. The addition of AMP-PNP may be helpful to fix 
the protein flexibility. Since MacB ATPase activity is detergent dependent, another 
approach to think about is to exchange into polyoxyethylene glycol detergents such as 
C^Es, which has a similar structure to Triton X-100 but without a benzene ring. 
Savl866 and ModB2C2A were both crystallized successfully in the presence of the 
detergent C12E8. 
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Chapter seven: Final discussion 
Tripartite pumps in gram-negative bacteria can facilitate the extrusion of a 
wide variety of substrates from the cell. There three components assembled in the 
tripartite pumps are as follows: an inner membrane protein (IMP), an outer membrane 
protein (OMP) and a membrane fusion protein (MFP), making it possible to 
translocate substrates across both the inner and outer membranes. Interestingly, gram-
positive bacteria that lack an outer membrane are also found to possess MFPs, 
suggesting an additional function on top of serving as a scaffold to stabilize the pump 
assembly. Murakami proposed that conformational changes in AcrB can be transmitted 
via AcrA to TolC, suggesting AcrA may play a role in addition to stabilize the 
interaction between AcrB and TolC (Mikolosko et al., 2006). In order to verify this 
assumption, we chose the MacA/MacB/TolC tripartite complex pump in E. col\ 
(Kobayashi et al., 2001) since there are clearly homologous systems in gram-positive 
bacteria. The MFP MacA not only stabilizes the tripartite-assembly by interacting with 
both the IMP MacB and the OMP TolC but also has a role in regulating the function of 
MacB, apparently increasing its affinity for both erythromycin and ATP. Moreover, a 
better understanding of this complex will give us a better insight into type I secretion 
systems in bacteria, such as HlyB/HlyD/TolC, where HlyB is an ABC transporter 
(Thanabalu et al., 1998). 
Generally, the MFP is anchored to the inner membrane by either an a-helix or a 
lipid moiety, attached to a cysteine residue, located towards the N-terminus of the 
protein (Tikhonova et al., 2004). This might suggest that there is only a requirement to 
anchor the MFP to the inner membrane, rather than a need for specific interactions 
between the IMP and MFP. Using pull-down assay, we showed that the anchor, N -
terminal a-helix, of E. coli MacA was not required for complex formation with either 
MacB or TolC. This is consistent with a previous report that N-terminal truncated 
MacA could interact with MacB (Tikhonova et al., 2007). However, using drug 
susceptibility tests, we showed that the transmembrane helix of MacA was required to 
target MacA to the periplasm, where the periplasmic domain of MacA could interact 
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with the periplasmic domains of MacB and TolC to form a functional tripartite 
complex. This is consistent with a report about the MFP AcrA in E. coli, which 
concluded that the truncated lipid-deficient AcrA derivative was as functional as full 
length AcrA, as judged by the resistance of the cells to erythromycin and novobiocin 
(Zgurskaya et al., 1999). However, this behaviour is different from another report that 
the deletion of the N-terminal a-helix of MacA, whilst not blocking its interaction with 
MacB, yielded a derivative that when expressed with MacB didn't confer elevated 
resistance to erythromycin (Tikhonova et al., 2007). The exact reason for the failure of 
this study to detect the elevated resistance of cells expressing N-terminal truncated 
MacA is unknown. One possibility is that we used different truncations; in our study 
we used A20MacA whilst Tikhonova et al used a A31MacA; alternatively maybe the 
A31MacA fused to the OmpA signal sequence failed to reach the periplasm? 
The MFP component of the tripartite efflux systems of gram-negative bacteria 
is believed to act as a bridge between the outer and the inner membranes proteins. The 
MFP AcrA incorporates a pair of a-helices that form a coiled-coil, sandwiched 
between two p-strand domains, which have been shown to interact with the a-helical 
barrel of the OMP TolC (Lobedanz et al., 2007; Bavro et al., 2008). Furthermore by 
domain swapping experiments showed the p-strand domains are crucial for the 
interaction with AcrB, but the exact role of these domains remains obscure (Elkins and 
Nikaido, 2003). Here, we provided evidence that the P-strand domain activates the 
MacB ATPase. When excess S. aureus MacA was added to E. coli MacB, no 
phosphate burst was observed but the steady-state rate was enhanced (Figure 4.12), in 
direct analogy with the effect of E. coli MacA on E. coli MacB, indicating that this 
interaction is via the P-strand domains of the MFP MacA. We established that cells 
expressing only MacB were less resilient, in terms of their growth, than those 
expressing both MacA and B, when exposed to erythromycin, suggesting that the latter 
are more efficient in extruding the antibiotic (Figure 5.3). This may have acted as a 
selective pressure for gram-positive bacteria to retain the MFP. In the case of S. aureus, 
we speculate that there has been a selective pressure to retain MacA, but because there 
is no OMP with which it would interact, there has been no pressure to retain the 
coiled-coil domain that has been deleted from MacA. Recently, the role of the MFP 
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BesA in the fuction of the BesABC complex pump has been reported (Bunikis et al., 
2008). BesC, a TolC homologue, interacts with the putative inner membrane 
transporter BesB, an AcrB homologue, and the AcrA homologue BesA, a periplasmic 
adaptor protein. Interestly, in this system BesA lacks the ct-helical hairpin. It could be 
that the interaction between IMP BesB and OMP BesC is suffient to trigger and 
stabilize the opening of BesC. The reason for the retention of BesA in the BesABC 
system is most likely associated with its function in the activation of the inner-
membrane component, BesB, which could explain the preservation of the hairpin-
lacking MFPs in gram-positive bacteria, such as S1. aureus. 
MacB has a nucleotide-binding domain that incorporates Walker A and B motifs 
and an ABC signature sequence, which are characteristic features of members of the 
ABC superfamily. Biochemical and structural data suggested the conserved motifs are 
involved in the binding and hydrolysis of ATP, which are believed to be the key steps 
in the transport mechanism of ABC transporters. The binding of ATP to both soluble 
ATPase subunits (Chen et al., 2003) and to the NBDs within a complete ABC 
transporter (Dawson and Locher, 2007) have been shown to promote dimerisation as 
the ATP is bound at the interface of these nucleotide binding-sites, sandwiched 
between the Walker A motif of one NBD and the ABC signature motif of the other 
NBD. The ATP occlusion model in human p-gp, different from the ATP switch model 
as described previously, indicated that ATP-driven NBD dimerization was followed by 
a rapid, temperature-dependent occlusion of ATP at one of the ATP sites, which 
showed an asymmetry. The latter step is actually energetically driven, involves 
relatively large conformation changes, and may drive the conformational change in the 
TMDs (Sauna and Ambudkar, 2007). 
In this chapter, using SEC, crosslinking, AUC, ES-Mass spectrometry, and AFM, 
MacB was proven to be dimeric in a DDM solubilized state. Although MacB has an 
exceptional four transmembrane helices, different from the six helices characteristics 
of ABC exporters such as Savl866 and MsbA, its ability to form dimer suggests that 
MacB operates by a similar mechanism to ABC transporters. 
Our AFM studies indicated that there are a higher proportion of MacB dimers in 
the presence of the non-hydrolysable nucleotide AMP-PNP. A proposed mechanism of 
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complete ABC transporters suggested that the binding of ATP triggers the transporter 
to adopt a conformation in which the substrate binding site is outward-facing, because 
ATP bridges the two NBDs, closing off the inward-facing substrate binding site 
(Hollenstein et al., 2007). Conversely, the release of the hydrolysis products ADP and 
phosphate promotes an inward-facing conformation, as the structural constraint 
imposed by binding of the nucleotide is released. Consistent with this proposal, several 
studies indicate that NBD dimerisation cannot be induced by ADP (Zaitseva et al., 
2006), because interactions between the y-phosphate of ATP and the signature 
sequence catalyse these events (Lu et al., 2005; Oloo et al., 2006). Our kinetic data 
indicated that Mac A can increase the affinity of MacB for ATP and decrease the rate 
of ATP hydrolysis in the initial stage, so that MacA actually helps to stimulate and 
stabilize the ATP binding conformation of MacB, presumeably the outward-facing 
conformation. In this manner, MacA could play a direct role in driving antibiotic 
translocation between MacB and TolC. Our equilibrium erythromycin binding data 
pointed out that MacB bound more erythromycin in the presence of MacA and that the 
amount bound increased in a concentration dependent manner, suggesting that MacA 
not only modulate the ATPase activity of MacB but also its capacity to bind drugs. 
Our studies established that the conformational changes of MacB can be 
propagated from the periplasmic domain of MacA to the cytoplasmic NBD of MacB, 
so it is possible that TolC, by interacting with MacA, can detect the nucleotide state 
of MacB. The binding of ATP to MacB could stimulate MacA to interact with TolC, 
possibly via the coiled coil hairpin of MacA, trigger the formation of the tripartite 
complex pump. Murakami (Murakami et al., 2006) proposed the conformational 
change caused by proton translocation and drug binding may be transmitted, via 
AcrA, to TolC, thus causing opening of the TolC periplasmic channel. In this case, 
the AcrA a-helical hairpin may be involved in the opening TolC, via its 
conformational flexibility (Mikolosko et al., 2006). 
There is an anology in the mechanism of operation of ABC importer that works 
in conjunction with a periplasmic binding-protein (Daus et al., 2007). In the E. coli 
maltose transporter, the binding of ATP to the ATPase subunit MalK induces 
conformational changes in the periplasmic loops of the membrane subunits MalF 
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and MalG (Daus et al., 2006); whilst EPR studies revealed that ATP-binding, but 
not ADP-binding, caused an increase in affinity between the transporter and the 
maltose binding-protein (MBP), and opening of the MBP (Chen et al., 2001). The 
binding of ATP to MacB could induce reorientation of the substrate binding-site of 
MacB and recruit TolC, via MacA, and simultaneous open the TolC to receive the 
translocated antiobiotic. The interaction between TolC and MacA would uncouple 
them from MacB, promoting reorientation of the substrate binding-site that would 
be assisted by the rapid hydrolysis of ATP to ADP. 
• ATP r IM 
OM OM 
I f IM IM 
i OM IM • 
ATP ADP ATP ADP 
+ + 
Pi PI 
Figure 7.1 Proposed mechanism of action for the MacA/MacB/TolC pump. 
MacAs are represented by orange squares; MacBs are colored in red, in 
which NBDs are represented by circles and TMDs are represented by 
ovals; TolCs are represented by blue cylinders; substrates are 
represented by black stars; ATP molecules are represented by green 
spheres. 
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Based on our studies of MacB and knowledge of the structure and function of 
other ABC transporters we proposed the following mechanism of action for the 
MacA/MacB/TolC pump. MacB recruits the substrate from the inner leaflet of the 
membrane or the cytoplasm, triggering a conformational change of MacB, from the 
inward-facing conformation to the outward-facing conformation, and relocates the 
NBDs of MacB, allowing the formation of the ATP sandwich in the presence of 
nucleotide (Figure 7.1). Meanwhile, the MacA can interact with the MacB dimer, 
increasing the affinity of MacB for ATP, helping the formation of ATP sandwich and 
decreasing the initial ATPase activity of MacB to stabilize dimer formation. The 
recruitment of the TolC to the MacAB complex allows translocation of the substrate 
across the periplasm and leads to the ATP hydrolysis; at this stage, MacA helps to seal 
the channel across the periplasm and aids ATP hydrolysis by increasing the steady 
state ATPase activity of MacB due to an increase in the release rate of the products of 
ATP hydrolysis, allowing a faster conformational change of MacB, from the outward-
facing to the inward-facing conformation, resetting the transporter in its original 
conformation. 
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Gram-negative bacteria utilize specialized machinery to translo-
cate drugs and protein toxins across the inner and outer mem-
branes, consisting of a tripartite complex composed of an inner 
membrane secondary or primary active transporter (IMP), a 
periplasmic membrane fusion protein, and an outer membrane 
channel. We have investigated the assembly and function of the 
MacAB/TolC system that confers resistance to macrolides in Esch-
erichia coli. The membrane fusion protein MacA not only stabi-
lizes the tripartite assembly by interacting with both the inner 
membrane protein MacB and the outer membrane protein TolC, 
but also has a role in regulating the function of MacB, apparently 
increasing its affinity for both erythromycin and ATP. Analysis of 
the kinetic behavior of ATP hydrolysis indicated that MacA pro-
motes and stabilizes the ATP-binding form of the MacB trans-
porter. For the first time, we have established unambiguously the 
dimeric nature of a noncanonic A B C transporter, MacB that has an 
N - terminal nucleotide binding domain, by means of nondisSoriat-
ing mass spectrometry, analytical ultracentrifugation, and atomic 
force microscopy. Structural studies of ABC transporters indicate 
that ATP is bound between a pair of nucleotide binding domains to 
stabilize a conformation in which the substrate-binding site is out-
ward-facing. Consequently, our data suggest that in the presence of 
ATP the same conformation of MacB is promoted and stabilized by 
MacA. Thus, MacA would facilitate the delivery of drugs by MacB 
to TolC by enhancing the binding of drugs to it and inducing a 
conformation of MacB that is primed and competent for binding 
TolC. Our structural studies are an important first step in under-
standing how the tripartite complex is assembled. 
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Gram-negative bacteria utilize transport systems composed 
of a tripartite assembly of proteins that span both the inner and 
outer membranes to pump cytotoxic compounds, such as 
antibiotics (1), and protein toxins (2), such as a-hemolysin, 
from the cell. These assemblies are composed of inner 
(IMP) 7 and outer (OMP) membrane proteins that are con-
nected by a periplasmic membrane fusion protein (MFP), 
which is anchored to the inner membrane. The systems respon-
sible for toxin extrusion invariably utilize an A B C transporter 
as the IMP (2), whereas those involved in antibiotic extrusion 
largely utilize proton antiporters (1), but there are some that 
utilize A B C transporters (3). The same OMP can be utilized for 
both drug and toxin extrusion; for example, TolC functions 
with antibiotic H + antiporters, such as AcrB that belongs to the 
regulation nodulation cell division family of transporters (4,5), 
with ABC transporters, such as the macrolide transporter 
MacB (3), and with HlyB that extrudes the protein toxin a-he-
molysin(2). ,|F :trmmmff!r • 
Although the structure of an assembled tripartite complex 
has not yet been determined, the structures of a few individual 
components have been elucidated. Most significantly, the 
structure of the RND transporter AcrB (6,7) and of its cognate 
MFP, AcrA (8), and OMP, TolC (9), have been determined. 
Both AcrB and TolC are organized as homotrimers. The AcrB 
trimer has a periplasmic headpiece formed by the loops 
between helices 1 and 2 and helices 7 and 8. The headpiece has 
a funnel-shaped internal cavity that is connected by a pore to a 
large central cavity formed between the periplasmic and mem-
brane domains. The trimeric TolC forms a cylindrical channel 
with a structure that is arranged into two major domains as 
follows: a /3-barrel in the outer membrane and a periplasmic 
a-helical barrel. It has been proposed, and is supported by 
cross-linking studies (10), that the six hairpins from the upper 
headpiece of the AcrB trimer contact the tips of the six helical 
pairs of the TolC trimer (11) to form a continuous path across 
7 The abbreviations used are: IMP, inner membrane protein; /3DDM, /3-dode-
cyl maltoside; MFP, membrane fusion protein; OMP, outer membrane pro-
tein; AUC, analytical ultracentrifugation; ES-MS, electrospray-mass spec-
trometry; AMP-PNP, adenosine 5'-(/3,y-imino)triphosphate; S-tag, for 
proteins fused to the 15-amino acid polypeptide {e.g. Lys-Glu-Thr-Ala-Ala-
Ala-Lys-Phe-Glu-Arg-Gln-His-Met-Asp-Ser) derived from RNase A; NBD, 
nucleotide binding domain; MBP, maltose binding-protein; AFM, atomic 
force microscopy. 
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the periplasmic space. The structure of AcrA revealed an elon-
gated monomer that is composed of three subdomains as fol-
lows: a 0-barrel, a lipoyl domain, and a 58-A-long a-helical 
hairpin (8). AcrA has been reported to interact with both TolC, 
via the a-helical hairpin (12), and AcrB, via the /3-domains (13), 
to stabilize the tripartite complex (4, 5). 
Several lines of evidence suggest that assembly of the tripar-
tite complex is a dynamic process that induces conformational 
changes in the protein components. The structures of a number 
of OMPs indicate that the channel is closed at one or both sides, 
requiring conformational changes to allow passage of the sub-
strate (11-14). Several studies support the hypothesis that a 
small number of key interactions between adjacent coiled-coils 
of the OMP are broken to allow the inner coils to untwist and 
realign with the outer coils, thereby opening the OMP entrance 
aperture (11, 15-17). The conformational flexibility of AcrA 
may enable realignment of the coiled-coil to stabilize the open 
state of TolC (8,11,15). Recently, the structures of a number of 
different conformations of AcrB have been determined that 
support a mechanistic model in which there is a functional rota-
tion in the periplasmic domains driving transfer of drugs into 
the OMP (18-21). The conformational asymmetry in the IMP 
is also reflected in the asymmetry in the open state of the OMP 
TolC (11). Such conformational changes in AcrB could be 
transmitted to TolC via AcrA. Furthermore, studies of the RND 
transporter AcrD from Escherichia coli, whose typical sub-
strates, aminoglycosides, are not expected to diffuse spontane-
ously across the lipid bilayer, revealed that only when AcrD was 
reconstituted with AcrA was it able to take up aminoglycosides, 
implying that AcrA is needed to "activate" AcrD (22). Collec-
tively, these findings suggest that the MFP supports conforma-
tional changes in both the IMP and OMP. 
We have sought to further investigate the assembly of the 
tripartite complex using the MacABTolC system responsible 
for the extrusion of macrolides from R coli (3). To date this is 
the only tripartite pump for antibiotics that has been shown to 
utilize an A B C transporter, MacB, which has a novel architec-
ture, consisting of a four-helix transmembrane domain, an 
N-terminal cytoplasmic nucleotide binding domain (NBD), 
and a large periplasmic domain formed by the loops connecting 
helices 1 and 2 (3, 23). The fact that the ATPase activity of the 
transporter can be monitored, using purified proteins, provides 
an additional tool for elucidating how its activity is modulated 
by assembly and disassembly of the tripartite complex. Indeed, 
recent studies, reported while this work was in progress, estab-
lished that the MFP MacA modulates the steady-state ATPase 
activity of the IMP MacB (24). Our studies have confirmed 
these findings and, by undertaking pre-steady-state analysis of 
the kinetics, extended them by identifying how MacA modu-
lates the ATPase mechanism of MacB. In addition, we have 
established that MacA also increases the capacity of MacB for 
binding erythromycin. This behavior provides a rationale for 
the retention of MacA by related systems from Gram-positive 
bacteria, such as Staphylococcus aureus, which lack an outer 
membrane and OMP (supplemental Fig. 1). Such analyses will 
not only have a bearing on understanding the function of tri-
partite drug-pumps but also of related toxin transporters. 
Strains and Plasmids—The E. coli strains and plasmids used 
are described in supplemental Table 1, and the primers used for 2 5 1 
construction of plasmid vectors are described in supplemental zsi 
Table 2. 
Protein Overexpression and Purification—All the proteins 
used in this study were purified as fusion proteins with a six-
histidine tag from E. coli overexpressing strains according to 
the protocols given in the supplemental material. zsi 
Pulldown Assays—For pulldown assays, proteins were over-
expressed with a C-terminal S-tag for use with the cognate pro-
tein that was His-tagged. Membrane pellets, dissolved in deter-
gent, or cell supernatant containing the S-tagged prey protein 
were mixed with 2 mg of purified His-tagged bait-protein. The 
mixture was loaded onto a Ni 2 + -charged Hitrap chelating col-
umn (GE Healthcare), so that the bait-protein could be immo-
bilized on the column along with the prey-protein if they inter-
act. The column was then washed with 15-20 column volumes 
of Tris buffer containing 75-100 mM imidazole and Triton 
X-100 (0.2% (v/v)) to eliminate any false-positive results 
because of nonspecific interactions. The bait-prey protein com-
plex was eluted with 500 mM imidazole Tris buffer, containing 
Triton X-100 (0.2% (v/v)), and SDS-PAGE was used to visualize 
the bait- and prey-proteins. A Western blot was performed 
with anti-S-tag antibodies to confirm the presence of the 
S-tagged prey-protein. 
Growth Curve Analyses—E. coli cells, of strain Kam3(DE3), 
harboring plasmids were grown at 37 °C, with shaking at 200 
rpm, until the cell density gave an A600 of 0.5, when 0.05-0.1 
mM isopropyl l-thio-j3-Drgalactopyranoside was added to the 
cells. The cells were grown for a further 3 h, when the cells were 
diluted with 2X Y T media containing 50 or 100 ju.g/ml erythro-
mycin, and the growth curve was recorded over the next 3 h. For 
experiments to measure the loss in growth because of erythro-
mycin, cells were grown for 3 h in the absence and presence of 
50 or 100 u.g/ml erythromycin, and the growth loss is the ratio 
of the iAeo,, values. 
Analytical Ultracentrifugation—Sedimentation equilibrium 
measurements were performed using a Beckman Optima X L - A 
analytical ultracentrifuge equipped with both absorbance and 
interference optics. 100 fjd of MacB in buffer 1 (20 mM Tris, pH 
8.0,150 mM NaCl, 1% w/v glycerol, and 0.006% (w/v) /3DDM) 
supplemented with 10,25, or 50% D 2 0 was placed in the sample 
compartment of a Epon double-sector centerpiece, and 110 /u.1 
of buffer 1 was placed in the reference compartment. The final 
protein concentrations used in the runs were between 0.5 and 
1.0 mg/ml. The D 2 0 was used to match the density of the sol-
vent to the density of the detergent as described previously (25) 
The samples were centrifuged at 283 K (10 °C) and 10,000,15,000, 
and 25,000 rpm using an An60-Ti rotor. Scans were acquired using 
the absorbance optical system 15 h after the start of the experiment 
and in 1-h intervals until equilibrium was attained. Sedimentation 
velocity measurements were performed using the same hardware 
at 55,000 rpm at 10 °C in buffer 1. The details of the data analysis 
are given as supplemental material. zsi 
Mass Spectrometry—Analyses were performed in a nanoflow 
ES mass spectrometer Q-ToF2 (Micromass). The following 
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FIGURE 1. MacA interacts with both MacB a n d To lC . A, overexpression and 
purification of MacA, MacB, and TolC. An SDS-polyacrylamide gel of purified 
MacB (tone 1), MacA {lane 2), and TolC [lane 3) is shown. The purified His-
tagged MacB and TolC proteins were used as bait, immobilized on a N i 2 + -
agarose column, over which a slurry of either detergent-solubilized mem-
branes (e.g. from strains overexpressing S-tagged MacA or TolC) or soluble 
proteins (e.g. from strains overexpressing S-tagged A20MacA) was passed to 
test whether the cognate proteins from the tripartite pump could be pulled 
out of this complex mixture of proteins. B, pulldown of MacA by MacB. 1st and 
2nd lanes, SDS-polyacrylamide gel of immobilized His-tagged MacB (isf fane) 
and the detergent-solubilized membranes from cells overexpressing the 
S-tagged MacA (2nd lane). 3rdto 11th lanes. Western blot using antibodies to 
the S-tag (1:5000 dilution) on MacA. The pulldown assay was performed with 
His-tagged MacB immobilized on a N i a + -agarose column, over Which a slurry 
of detergent-solubilized membranes from cells overexpressing S-tagged 
MacA was passed (7th to 9fh lanes). The flow-through (9th lane), 100 mM imid-
azole wash (8th lane), and the 500 mM imidazole elution (7th lane) were tested 
for the presence of MacA, which was now also detected in the elution fraction, 
indicating that it was bound to MacB. A negative control experiment was 
performed in the absence of immobilized MacB in which MacA was passed 
through a Ni 2 + -agarose column (3rd to Sth lanes), and the flow-through (Sth 
lane), 100 mM imidazole wash (4th lane), and the 500 mM imidazole elution 
(3rd lane) were tested for the presence of MacA, which was only found in the 
flow-through (5th lane), establishing that S-tagged MacA does not bind to the 
column. These results indicate that MacB can pull MacA from a complex mix-
ture of membrane proteins. Purified His-tagged MacB did not cross-react with 
the antibodies to the S-tag (10th lane). C pulldown of MacA by TolC. An SDS-
polyacrylamide gel (lanes 1-8) for the pulldown of S-tagged MacA by His-
tagged TolC and the corresponding Western blot (lanes V-8') probed with 
antibodies (1:5000 dilution) to the S-tag on MacA. Purified His-tagged TolC 
was immobilized on a Ni 2 + -agarose column (lanes 1 and / ' ) ; a slurry of deter-
gent-solubilized membranes from cells overexpressing S-tagged MacA was 
passed through the column and the proteins in the flow-through (lane 2 and 
2'), released by washing the column with 100 mM imidazole (lanes 3 and 3') 
and eluted with 500 mM imidazole (lanes 4 and 4'), were detected. As a neg-
ative control, S-tagged MacA was passed through the column (lanes 6 and 6'), 
in the absence of immobilized TolC, and the column was washed with 100 mM 
(lanes 7 and 7') and 500 mM (lanes 8 and 8'). Comparing lane 4' and 8' dem-
onstrates that MacA is only bound to the column in the presence of TolC, 
indicative of its interaction with TolC. D, pulldown of TolC by MacB. An SDS-
polyacrylamide gel (lanes 1-4) for the pulldown of S-tagged TolC by His-
tagged MacB and the corresponding Western blot (lanes V-4') probed with 
antibodies (1:5000 dilution) to the S-tag on TolC. Purified His-tagged MacB 
was immobilized on a Ni 2 + -agarose column (lanes 1 and I'), and a slurry of 
detergent-solubilized membranes from cells overexpressing S-tagged TolC 
was passed through the column (lane 3 and 3'), which was then washed with 
75 mM imidazole (lanes 4 and 4'), and bound proteins were eluted with 500 
mM imidazole (lanes 5 and 5'). A weak band, which was not present in the 
absence of immobilized MacB, was apparent in lane 5', indicative of a weak 
interaction between MacB and TolC. A control experiment was performed in 
the absence of immobilized MacB in which TolC was passed through a N i 2 + -
agarose column and the flow-through (lane 6), the 100 mM imidazole wash (lane 
7), and the 500 mM imidazole elution (lane 8) were tested for the presence 
experimental parameters were used to record mass spectra of 2 
mg/ml MacB in the Q-ToF2 instrument: needle voltage of 1.5 
kV and MCP 2350 V. 
Atomic Force Microscopy—MacB was diluted to a final con-
centration of 1 /xg/ml, and 45 /AI of the sample was allowed to 
adsorb to freshly cleaved mica. Imaging in air was performed 
with a Multimode atomic force microscope (Digital Instru-
ments, Santa Barbara, C A ) in tapping mode. The silicon canti-
levers containing a diamond-like extratip had a drive frequency 
of =300 kHz and a specified spring constant of 40 newtons/m 
(MikroMasch, Portland, OR), and the applied imaging force 
was kept as low as possible (target amplitude = 1 . 6 - 1 . 8 V and 
amplitude set-point = 1 . 3 - 1 . 5 V). The molecular volumes of 
the protein particles were determined from particle dimensions 
based on A F M images (see supplemental material). 
ATPase Assays—An EnzChek phosphate assay kit (Invitro-
gen) was used to determine the ATPase activity of MacB hydro-
lyzing MgATP to release phosphate, when the reactants were 
mixed in a stopped-flow device (see supplemental material). 
Generally, 2.3 LIM protein was mixed with varying concentra-
tions of ATP, up to 4 mM, in the presence of 6 mM MgCl 2 , to 
ensure that all the A T P was complexed with M g 2 + . In control 
experiments, no ATPase activity was apparent in the absence of 
M g 2 + . Generally, for MacB alone, the hydrolysis of ATP was 
characterized by a P s burst, which was of near equivalence to the 
MacB concentration, consistent with the ATPase activity being 
attributable to MacB, rather than any contaminant proteins. 
Quantification of Erythromycin Binding to Affinity-purified 
Mac Proteins—The equilibrium binding of [N-methyl-^Cjeryth-
romycin to purified Mac proteins was determined by rapid filtra-
tion and quantification of the radioactivity remaining on 0.2-/xm 
filters as outlined in the supplemental material. 
RESULTS -M 
MacA Interacts with Both MacB and TolC via Its Periplasmic 
Domain—Interactions between E. coli MacA, MacB, and TolC 
were tested using detergent-solubilized proteins for pulldown 
assays (Fig. 1) . MacA interacted with MacB (Fig. 15 ) , which we 
confirmed by cross-linking the proteins (supplemental Fig. 2A), 
of TolC, which was only found in the flow-through (lane 6'), establishing that 
S-tagged TolC does not bind to the column. A protein M, marker was run in 
lane 2. E, pulldown of N-terminal truncated MacA by MacB. An SDS-polyacryl-
amide gel shows the His-tagged MacB (lane 1) that was immobilized on a 
Ni 2 + -agarose column (lane 1), a slurry of cytoplasmic proteins released by 
disruption of cells overexpressing S-tagged A20-MacA (lane 2), which was 
passed through the column, over immobilized MacB, and the proteins in the 
flow-through detected (lane 3); the proteins were released by washing the 
column with 100 mM imidazole (lane 4); and the proteins were eluted with 500 
mM imidazole (lane 5). A Western blot was performed on each of the corre-
sponding protein fractions (indicated with 1'-5') using antibodies to the 
S-tag (1:5000 dilution) to detect S-tagged MacA. The elution of MacB yields an 
extra, low M„ band on the SDS-polyacrylamide gel that corresponds to that 
expected for MacA (lane 5) and was identified as such by Western blotting 
(lane 5'). A control experiment was performed in the absence of immobilized 
MacB in which A20MacA was passed through a Ni 2 + -agarose column and the 
flow-through (lane 7), the first and second washes with 100 mM imidazole 
(lanes 8 and 9, respectively), and the 500 mM imidazole elution (lane 10) were 
tested for the presence of MacA, which was only found in the flow-through 
and first wash (lane 7' and 8', respectively), establishing that S-tagged MacA 
does not bind to the column. These results indicate that MacA does not 
require the N-terminal a-helix, which anchors it to the inner membrane, to 
interact with MacB. A protein M, marker was run in lane 6. 
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FIGURE 2. MacAB-TolC form a tripartite complex that confers resistance 
to erythromycin. A, growth curves for £ coli cells, of strain Kam(DE3), harbor-
ing the plasmids pETDuet ( • ) , pETDuet-MacB (O), pETDuet-MacB/MacA (T) , 
pETDuet-MacB/TolC (A), pETDuet-MacB/MacA/TolC ( • ) and pETDuet-MacB/ 
glll-SS-A20MdcA/TolC ( • ) grown in the presence of 100 p.g/ml erythromycin. 
B, bar chart showing the extent of inhibition of the growth of £ coli cells in 
response to 50 /xg/ml erythromycin, of strain Kam3(DE3), harboring the plas-
mids pETDuet (blank), pETDuet-MacB {MacB), pETDuet-MacB/MacA (MacAB) 
or no plasmid [Wild). For each strain the A ^ , was determined aftergrowth for 
3 h in the absence and presence of erythromycin, and the growth inhibition 
was determined as the ratio of these measurements. Cells expressing both 
MacA and MacB suffered less from erythromycin growth inhibition than 
those expressing only MacB, suggesting that MacA confers elevated resist-
ance to erythromycin on the MacB strain. 
and TolC (Fig. 1C). Although we detected an interaction between 
TolC and MacB (Fig. ID), the intensity of the band suggested a 
weak interaction. N-terminal truncated MacA (A20-MacA) inter-
acted with MacB (Fig. IE) , indicating that it is the periplasmic 
domains of these proteins that interact. The fact that in each case 
the cognate pump protein could be pulled out of a complex mix-
ture of detergent-solubilized proteins from membranes or cells 
indicated that the interactions are specific. 
E. coli MacA and MacB Form a Functional Complex with 
TolC— The simultaneous expression of macA, macB, and tolC 
in the E. coli AacrB strain Kam3 (26) conferred resistance to 
erythromycin, indicative of the formation of a functional com-
plex (Fig. 2A). Cells expressing macB with tolC conferred mod-
est resistance to erythromycin in comparison with cells 
expressing macB, tolC, and macA, indicating that MacA is 
required to couple MacB to TolC (Fig. 2A). We sought to test 
whether the N terminus of MacA, which incorporates an a-he-
lix that could interact with MacB, is required for the functional 
assembly of the complex. A construct in which the gill-signal 
sequence was fused to truncated MacA, targeting it to the 
periplasm, was capable of conferring resistance to erythromy-
cin (Fig. 2A), indicating that the N-terminal domain is not 
essential for the assembly of the functional complex. This is 
consistent with a report that a truncated lipid-deficient AcrA 
derivative was functional as judged by resistance of the cells to 
erythromycin (27). MacB alone conferred elevated resistance to 
erythromycin, probably because of its ability to pump the anti-
biotic into the periplasm, but we consistently found that 
expressing macB with either tolC or macA conferred greater 
resistance. Consequently, we sought to test if MacA could 
enhance this ability. To overcome the difficulty in comparing 
the growth of cells overexpressing multiple proteins that tend 
to grow at different rates, we monitored the growth of cells in 
the presence and absence of erythromycin and determined the 
growth loss (for cells growing in the presence of erythromycin 
in comparison with cells growing in the absence of erythromy-
cin) (Fig. 2B). This revealed a significant loss in growth of the 
cells expressing MacB compared with those expressing MacAB, 
indicating that the simultaneous expression of MacA and MacB 
increases the resistance of the cells to erythromycin (Fig. 2B), 
suggesting that MacA enhances the ability of MacB to confer 
antibiotic resistance. Similarly, a previous study reported that 
MacAB, but not MacB alone, conferred resistance to macroli-
des (3). 
MacB Forms Dimers—MacB has an atypical structure for an 
A B C transporter as it is predicted to have an N-terminal cyto-
plasmic NBD, which is connected to a four-helix transmem-
brane domain, with a large periplasmic domain formed by the 
loops connecting helices 1 and 2 (3, 23). If MacB resembles 
other A B C transporters that use a pair of NBDs to bind ATP, 
then it should function as a dimer. However, many transport-
ers, including A B C transporters, have 12 membrane-spanning 
helices; MacB could adopt a similar topology by forming trim-
ers. Furthermore, AcrB (4,5) and TolC (9), which assemble into 
a tripartite complex with AcrA, clearly form trimers. If the tri-
meric arrangement of the periplasmic domains in AcrB forms a 
necessary scaffold for binding of AcrA, so that it can effectively 
interact with TolC, then by analogy the periplasmic domain of 
MacB might also be forced into forming trimers when interact-
ing with MacA and TolC. 
Therefore, we sought to determine the oligomeric state of 
MacB. Size-exclusion chromatography indicated that it forms 
higher order oligomers consistent with a dimer (data not 
shown), but such measurements are not only dependent upon 
the molecular weight but also the shape of the protein. Further-
more, there is a need to determine the number of detergent 
molecules complexed by the protein. Consequently, to deter-
mine whether the detergent-solubilized MacB was dimeric, we 
added a cross-linker to trap the oligomers; when we ran the 
cross-linked protein on an SDS-polyacrylamide gel, the most 
predominant band ran between the 120- and 160-kDa markers, 
indicative of a dimer, which has a calculated molecular mass of 
145.8 kDa (supplemental Fig. 2B). 
To further confirm the basic oligomeric unit as a dimer, we 
used two other techniques, analytical ultracentrifugation 
(AUC) and electrospray mass spectrometry (ES-MS). For the 
A U C experiments, we reduced the /3DDM concentration to 
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FIGURE 3. Biophysical evidence for MacB dimer format ion. A, AUG sedi-
mentation equilibrium profiles of MacB. A representative sedimentation 
equilibrium profile from one of the runs (two different velocities of the same 
sample) is shown. Experimental data [dots) and fitted model for a 162.6-kDa 
particle (solid line) is shown for each. The bottom panel represents the residu-
als after fitting. 6, AUC sedimentation velocity profiles of MacB are consistent 
with the formation of a stable dimer. The upper panel shows sedimentation 
profile curves at different time points, and the lower panel presents a c(s) size 
distribution analysis with solutions of the Lamm equation.The sedimentation 
coefficient is 6.8 S corresponding to an apparent molecular mass of 160 kDa, 
consistent with a dimer with about 16 detergent molecules bound. C mass 
spectrum of MacB. The charge states corresponding to the peaks are 
graphed. The mass spectrum indicated a molecular mass for MacB of145.96 
kDa, which is consistent with a dimer. 
just below the critical micelle concentration to avoid the forma-
tion of micelles. To determine the detergent contribution in the 
buoyant mass of the protein-detergent complex, we used a 
series of different density buffers prepared using a range of D 2 0 
concentrations. The apparent molecular mass for MacB was 
determined from sedimentation equilibrium measurements to 
be 162.6 kDa (Fig. 3A) and from sedimentation velocity meas-
urements to have a sedimentation coefficient of 6.8 S, corre-
sponding to a molecular mass of 160.0 kDa (Fig. 3B). This 
molecular mass is greater than expected for monomeric and 
less than expected for trimeric MacB, complexed with bound 
detergent, but it is highly consistent with a MacB dimer to 
which about 16 /3DDM molecules are bound. Although the 
amount of detergent bound to the MacB dimer appears to be 
lower than reported for RND (28) and MF (29) transporters, 
this reflects the fact that in our experimental set-up the deter-
gent contribution was actively suppressed using a solvent den-
sity matching technique (25). Our independent measurement 
of bound detergent using a calorimetric assay (30) indicated 
that, when the detergent concentration was close to the critical 
micelle concentration, the amount of bound detergent was sim-
ilar to that of other membrane proteins (e.g. MacB solubilized in 
0.05% w/v /3DDM bound 1.2 g of /3DDM/g of MacB, which is 
equivalent to a /3DDM:MacB molar ratio of 164:1). Electros-
pray-mass spectrometry (ES-MS) was used in nontandem con-
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figuration to determine accurately the molecular mass of the 
protein, under conditions that would dissociate the /3DDM, 
revealing a peak with a molecular mass of 145,961.25 ± 20.57 
Da that is consistent with a MacB dimer (Fig. 3C). 
We also sought to visualize single particles of MacB by A F M 
(Fig. 4, A and D). Two populations were revealed with average F 4 
molecular volumes of 118 and 238 nm 3 (Fig. 4B). These would 
accommodate proteins of about 60-70 and 130-140 kDa, 
respectively. Furthermore, the larger particles could clearly be 
seen at higher resolution to consist of two protein domains that 
are highly suggestive of a dimer. We found that in the presence 
of AMP-PNP, a nonhydrolysable analogue of ATP, the ratio of 
dimers to monomers on the A F M grids increased (Fig. 4C), 
which would be consistent with the nucleotide stabilizing the 
interaction between monomers. Our findings are novel because 
detergent molecules tend to impair the resolution of A F M stud-
ies of detergent-solubilized membrane proteins; this implies 
that for MacB, we may be able to get information on the topol-
ogy and stoichiometry of its assemblies with MacA and TolC. 
Indeed, under coincubation of MacA and MacB, we could 
clearly distinguish a significant distribution of particles with 
molecular volumes larger than those corresponding to MacB 
dimers, which is consistent with multiprotein complexes 
formed between both proteins (data not shown). Such promis-
ing data paves the way toward further characterization of mem-
brane multiprotein complexes and could prove a powerful 
instrument for determining the stoichiometry of the tripartite 
assembly. S 
MacA Regulates the ATPase Activity of MacB—MacB 
retained ATPase activity when detergent-solubilized, but this 
was detergent-dependent, being active in Triton X-100 but not 
inj/3DDM (data not shown). The time course for hydrolysis of 
MgATP by MacB was determined in, a stopped-flow spectro-
photometer, using the dye 2-aminO'6-mercapto-7-methylpu-
rine riboside to monitor the production of inorganic phosphate 
(Pi). The time course was characterized by a burst in P, produc-
tion, during the first 20 s, followed by a slower steady-state rate 
(Fig. 5A). This kinetic behavior is consistent with the ATP being FS 
rapidly hydrolyzed, to produce P, and ADP, but further turn-
overs are rate-limited either by a subsequent conformational 
change or the slow release of products. Because previous stud-
ies have established that the ATPase activity of MacB is inhib-
ited by vanadate (24), which stabilizes bound ADP, this indi-
cates that P, is released before ADP, suggesting that ADP 
release is rate-limiting. The rate constant for the hydrolysis step 
was determined by fitting the burst phase to an exponential 
function, yielding a kC3t value of 0.24 s~ \ whereas the amplitude 
of the burst phase was 2.2 /AM for 1 mM ATP (Fig. 5A). When the 
MacA and MacB concentrations were increased to 3.5 JAM, the 
amplitude of the burst phase increased to 3.3 JAM (data not 
shown), indicating that the burst is approximately equivalent to 
the MacB concentration and that both NBDs within the MacB 
dimer are functional. We did not notice any deviation from a 
single exponential that would indicate that these NBDs turn 
over ATP differentially. The steady-state phase was character-
ized by a rate of Pt production that increased in a hyperbolic 
manner with the A T P concentration (Fig. SB); fitting the 
steady-state rate data to a hyperbolic function yielded a maxi-
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FIGURE 4. A F M analyses , A F M imaging of MacB. A three-dimensional picture of a low magnification image of 
MacB acquired in air in Tapping Mode with a diamond-like extra tip of resonant frequency —300 kHz and spring 
constant of 40 newtons/m. m and d show particles that belong to the first and second peak in B, respectively. 
S, frequency distribution of molecular volumes of MacB. The curve indicates a fitted Gaussian function. The m 
and d peaks correspond to volumes of 118 ± 1 n m 3 (n = 1642) and 238 ± 5 n m 3 (n = 665), consistent with the 
monomer and dimer, respectively. C, frequency distribution of molecular volumes of MacB that had been 
incubated with the nonhydrolysable ATP analogue AMP-PNP. The peaks correspond to volumes of 112 ± 3 
n m 3 (r> = 94) and 218 ± 14 n m 3 (n = 116). These data indicate an increase in the dimenmonomer ratio in the 
presence of AMP-PNP. D, high resolution images of structures where two small particles (m+m) are attached to 
one another, clearly indicative of dimer formation. 
mal specific activity of 8.9 nmol of ATP/min/mg MacB and a 
Km of 374 JAM. A progressive reduction in the amplitude of the 
burst phase for ATP concentrations below the steady-state Km 
value hindered analyses because the pre-steady-state phase 
tended to merge with the steady-state phase; consequently, we 
only used the steady-state rates determined at ATP concentra-
tions of 0.1 mM and above. For comparison, the lipid A trans-
porter MsbA, an half-ABC transporter, was characterized by a 
V m a x of 37 nmol of ATP/min/mg and a Km of 878 U M (31). 
When MacA was added to MacB, at an equivalent or higher 
concentration, with both proteins in detergent, no phosphate 
burst was observed (Fig. 5A). Considering that the detergent 
was present for both the ATPase assays with MacB and MacAB 
suggests that the burst phase is mechanistically important and 
cannot be attributed to the deter-
gent modifying the behavior of 
MacB. Interestingly, although there 
was no P ( burst by MacB in the pres-
ence of MacA, there was a lag in Pj 
production; this could signify that a 
conformational change that pre-
cedes the hydrolysis step becomes 
rate-limiting for the first turnover. 
The steady-state rate of ATP hy-
drolysis by MacB, in the presence of 
MacA, was enhanced (Fig. 55). At 
first glance, this behavior might 
appear consistent with MacA in-
creasing the rate of ADP dissocia-
tion from MacB, so that this step 
was no longer rate-limiting. How-
ever, although MacA increased the 
specific activity of MacB from 8.9 to 
12.3 nmol of ATP/mg MacB/min, 
which would correspond to an in-
crease in kcat from 0.011 to 0.015 
s"1, the steady-state rate did not 
exceed the rate for hydrolysis in the 
absence of MacA (e.g. 0.24 s~') (Fig. 
55). Accordingly, the increase in the 
steady-state rate, which we attribute 
to product release, or a conforma-
tional change preceding this, would 
not be rapid enough to prevent the 
phosphate burst. It seems more 
likely that MacA also retards the 
rate of ATP hydrolysis, so that this 
process becomes slower than the 
rate of product release. Indeed, we 
found that the affinity of MacB for 
A T P was increased by more than 
5-fold, from 374 to 72 AIM, in the 
presence of MacA (Fig. 55). If the 
effect of MacA was simply to 
enhance product release to a rate 
faster than that for nucleotide 
hydrolysis, then we would have 
expected a decrease in affinity for 
ATP. On the other hand, if MacA simply retarded nucleotide 
hydrolysis to a rate slower than product release, then the max-
imal steady-state rate would have decreased. Our data are con-
sistent with MacA increasing the rate of product release, while 
decreasing the rate of hydrolysis to a similar rate to product 
release. 
In contrast to a previous study, which indicated that the 
ATPase activity of reconstituted MacB was not activated by 
N-terminal truncated MacA (24), we found that when MacB 
was mixed with A20-MacA no Pj burst was apparent (data not 
shown). In the same study, and consistent with our findings, 
N-terminal truncated MacA was shown to interact with MacB; 
however, in contrast to our findings, when MacB was expressed 
with N-terminal truncated MacA in erythromycin-susceptible 
9 
6 JOURNAL OF BIOLOGICAL CHEMISTRY ^ § i M $ i § ^ V O L U M E 2 8 4 - N U M B E R ? ? • ? ? ? ? ? ? , 2 0 0 9 
balt3/zbc-bc/zbc-bc/zbc00409/zbc6134-09z xppwsS=1 19/11/08 6:43 4/Color Figure(s) F4 ARTNO: M80696420O 
MacB 6 
o MacAB 
!8 
0) 
0) 
o 1 
0 
80 100 120 20 40 60 140 160 
Time (s) 
B 16 
14 
E 12 
" 10 n 
oi 8 
6 
* MacB 
o M a c A B 
2.5 3.0 3.5 4.0 4.5 
[ATP] (mM) 
FIGURE 5. MacA regulates the ATPase activity of MacB. A, time course for 
the change in P, concentration, corresponding to the absorbance change of 
the 2-amino-6-mercapto-7-methytpurine riboside in A, where 2.3 CIM MacB 
was mixed with 1 mM ATP in the absence {upper trace) and presence (tower 
trace) of an equivalent concentration of MacA. In the absence of MacA, MacB 
produced a phosphate (P,) burst, with a rate and amplitude of 0.235 (±0.001) 
s"1 and 2.20 (±0.01) /AM, respectively. MacB did not produce a P, burst in the 
presence of MacA. B, steady-state rate of P, production by MacB as a function 
of the ATP concentration in the absence (lower curve) and presence {upper 
curve) of an equivalent concentration of MacA. The data are characterized by 
V m m and Km values of 8.9 (±0 .7) nmol of ATP/mg MacB/min and 374 (±126) 
ju M, respectively, for MacB alone; and of 12.3 (±0.5) nmol of ATP/mg MacB/ 
min and 72 (±22) I I M , respectively, for MacB in the presence of an equivalent 
concentration of MacA. 
cells, there was no increase in erythromycin resistance (24). The 
reason for the difference with our own findings is unclear; how-
ever, in the previous study the signal sequence of OmpA was 
used to target MacA, truncated at position 32, to the periplasm 
(24), raising the possibility that the shorter MacA sequence 
and/or the OmpA signal sequence interfered with the ability of 
MacA to affect the ATPase activity of MacB. 
In accord with previous studies (24), we could not detect an 
effect of erythromycin on the kinetics of MacB ATPase either in 
the absence or presence of MacA (data not shown). Recent 
studies have established that the ATPase activity of Pdr5 is 
uncoupled from substrate binding; this basal ATPase activity 
might be required to constantly cycle the transporter between 
conformations, so as to maintain the accessibility of the cyto-
solic substrate-binding site (32). In the case of MacB, its ATPase 
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FIGURE 6. MacA increases the capaci ty of MacB to bind erythromycin. 
Purified proteins (50 tig of MacA or MacB, or 25 yuq of MacA plus 25 tig of 
MacB) were incubated in the presence of [N-methyl- Qerythromycin at con-
centrations as indicated (1,5, or 10 /xM), after which drug binding was meas-
ured by rapid filtration. The bars represent the erythromycin bound by MacA 
{left, black), MacB {middle, light gray), and MacAB {right, dark gray). The data 
indicate that MacA enhances the binding of erythromycin to MacB. 
activity might instead be stimulated by TplC, to reset its con-
formation following drug transfer to TolC. 
MacA Increases the Capacity of MacB to Bind Erythromycin— 
Although we could not detect any effect of erythromycin on the 
ATPase activity of MacB, we could detect the binding of 
[14C]erythromycin to detergent-solubilized MacB (Fig. 6). F 6 
Importantly, we found that the MacAB complex bound more 
erythromycin than MacB alone (which binds considerably 
more than MacA alone) and that the amount bound increased 
in a concentration-dependent manner, as would be expected if 
MacA increased the affinity of MacB for erythromycin. How-
ever, because of the insolubility of the antibiotic in aqueous 
solutions, it was not possible to test a full range of erythromycin 
concentrations that might saturate MacAB. Consequently, we 
cannot exclude the possibility of the formation of additional 
sites within the MacAB complex that are not apparent in either 
MacB or MacA alone. Our data indicate that MacA not only 
modulates the ATPase activity of MacB but also enhances its 
capacity to bind erythromycin (be this due to an increase in 
affinity of MacB for drugs or the formation of additional drug-
binding sites within the MacAB complex). 
DISCUSSION 
Gram-negative bacteria possess tripartite pumps that facili-
tate the extrusion of protein toxins and cytotoxic compounds, 
such as antibiotics, from the cell. In these tripartite assemblies 
the IMP is coupled to an OMP by a periplasmic MFP, forming a 
pump that can translocate molecules across both the inner and 
outer membranes. Intriguingly, Gram-positive bacteria that 
lack an outer membrane also possess MFPs, suggesting that 
they play a role in addition to stabilizing the interaction of the 
IMP with the OMP. Indeed, we have noted in some of these 
MFPs a large deletion corresponding to the coiled-coil hairpin 
that would interact with the OMP (supplemental Fig. 1). To zsi 
investigate this possibility, we sought to determine the role of 
MacA, the MFP that couples the IMP MacB, an ATP-driven 
transporter, with the OMP TolC in E. coli to extrude macrolide 
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antibiotics (3). We established that Mac A interacts with both 
MacB and TolC (Fig. 1) to form a functional tripartite complex 
(Fig. 2). However, we also found that MacA enhanced the resist-
ance to erythromycin conferred by MacB alone (Fig. 25), sug-
gesting that it modulated the transport activity of MacB, which 
is consistent with our data demonstrating that MacA regulates 
the drug binding and ATPase activity of MacB (Figs. 5 and 6). 
The role of the MFP BesA in the activity of the BesABC pump in 
Borrelia burgdorferi, the causative agent of Lyme disease, has 
recently been highlighted (33). It is quite remarkable that in this 
system BesA also lacks the a-helical hairpin. As such this 
periplasmic protein is unable to unlock the periplasmic entry 
site of the OMP, a function that is attributed to the hairpin (11). 
To compensate, the OMP has evolved to be constitutively leaky. 
The reason for the retention of BesA in the Borrelia system is 
most likely associated with its function in the activation of the 
inner membrane component, in that case an RND transporter. 
It is conceivable then, that a similar role is also present in the 
ABC transporters and their associated MFPs, and it could 
explain the preservation of the hairpin-lacking MFPs in Gram-
positive bacteria, such as S. aureus (supplemental Fig. 1). 
Although E. coli MacB has an NBD, which incorporates 
Walker A and B motifs and an ABC signature sequence that are 
characteristic features of members of the ABC superfamily, it is 
not a classic ABC transporter. It has a large periplasmic domain, 
reminiscent of that found in RND transporters, which form 
trimers in which these domains form substantive sites of con-
tact between the protomers. Consequently, we sought to deter-
mine the oligomeric state of MacB and in doing so have devel-
oped a novel ES-MS approach to unambiguously establish that 
MacB forms dimers (Fig. 3C). ES-MS is now widely accepted as 
a powerful method to determine accurately the stoichiornetry 
of intact protein complexes (34). However membrane proteins, 
solubilized by detergent or adsorbed in micelles, have remained 
difficult to analyze under similar MS conditions. The develop-
ment of strategies to tackle this field is challenging, primarily 
because the large quantities of detergent suppress the protein 
signal, whereas the poor solubility of membrane proteins in 
aqueous buffers often causes the electrospray needle to block. 
To date only a few MS studies have reported the observation of 
membrane proteins or their complexes by MS (35-39). Here we 
report on the use of a miniaturized form of ES with reduced 
flow rates (nano-ES), and a high collision energy that facilitates 
the desolvittion process and induces dissociation of detergent-
proteins clusters, to determine the oligomeric state of an inte-
gral homomeric membrane protein. In our protocol we used 
lower quantities of /3DDM, than have been reported previously, 
without apparent detrimental effects on the stability of the pro-
tein. Under our experimental conditions, we have successfully 
maintained the noncovalent subunit interactions, such that the 
oligomeric state of the protein complex could be determined 
without ambiguity. As would be expected for an ABC trans-
porter in which the NBDs interact, our biophysical studies of 
MacB indicate that it forms dimers (Figs. 3 and 4 and supple-
mental Fig. 3). This is an interesting observation because it 
raises the following question. How does dimeric MacB interact 
with trimeric TolC and the number of MacA molecules needed 
to stabilize the tripartite complex? Extension of our AFM stud-
ies will be vital for determining the stoichiometry of the inter-
actions to provide an understanding of the assembly of the tri-
partite complex, which may be difficult to address by other 
methods, such as crystallization of the complex. 
Our findings and previous studies, which have shown that 
disruption of the Walker A and B motifs not only inhibits the 
ATPase activity but also blocks the capacity of MacB to confer 
macrolide resistance (24), suggest that MacB operates by a sim-
ilar mechanism to typical ABC transporters. Our understand-
ing of how ABC transporters couple ATP hydrolysis to trans-
port is still rudimentary, but the determination of the crystal 
structures of several ATPase subunits and complete ABC trans-
porters has suggested conservation of key steps in the molecu-
lar mechanism. The binding of ATP to both soluble ATPase 
subunits (40), solubilized NBDs from ABC transporters (41, 
42), and to the NBDs within a complete ABC transporter (43, 
44) has been shown to promote dimerization as the ATP is 
bound at the interface of these nucleotide-binding sites, sand-
wiched between the Walker A motif of one NBD and the ABC 
signature motif of the other NBD. Our AFM studies indicated 
that there is a higher proportion of MacB dimers in the pres-
ence of the nonhydrolysable nucleotide AMP-PNP (Fig. 4). In 
complete ABC transporters, the binding of ATP causes the 
transporter to adopt a conformation in which the substrate-
binding site is outward-facing, because ATP bridges the two 
NBDs, closing off the inward-facing substrate-binding site (45). 
Conversely, the release of the hydrolysis products ADP and 
phosphate is thought to promote an inward-facing conforma-
tion, as the structural constraint imposed by binding of the 
nucleotide is released* Consistent with this proposal, several 
studies indicate that NBD dimerization cannot be induced by 
ADP (46), because interactions between the y-phosphate of 
ATP and the signature sequence catalyze these events (47). We 
found that MacA modulates these processes in MacB (Fig. 5), 
and so our kinetic data have clear implications in terms of such 
a mechanism. Most significantly, MacA increases the apparent 
affinity of MacB for ATP, while decreasing the rate of ATP 
hydrolysis, so as to promote and stabilize the ATP binding con-
formation, which we presume to be the conformation in which 
the antibiotic-binding site is outward-facing. In this manner, 
MacA would play a direct role in driving antibiotic transloca-
tion between MacB and TolC. 
During the course of our studies another investigation 
reported on the effect of MacA on the steady-state ATPase 
activity of MacB (24). In this study, MacB, solubilized in Triton 
X-100, appeared to have a specific activity that was an order of 
magnitude higher than we had found; however, a discontinuous 
assay was used to determine the ATPase activity, and this could 
well have been influenced by pooling the time points from both 
the burst and steady-state phases. Indeed, kcM was marginally 
slower than the hydrolysis rate determined from the P( burst 
phase in our experiments (e.g. 0.17 versus 0.24 s - ' ) . Possibly for 
similar reasons, this assay did not detect the effect of MacA on 
MacB solubilized in Triton X-100. However, they did find that 
MacB reconstituted into liposomes was characterized by a 
reduced fccat {e.g. k c a t = 0.10 s~') and decreased affinity of MacB 
for ATP {e.g. Km = 2.30 mid). Co-reconstitution of MacB with 
MacA had the effect of increasing both kcat (e.g. kcat = 0.78 s~l) 
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and the affinity of MacB for ATP (e.g. Km = 0.38 IDM). This 
behavior is similar to the effect of MacA on the steady-state 
kinetics of the ATPase activity of solubilized MacB in our study. 
To know if the reconstituted protein behaves in an identical 
manner to the solubilized protein would require the reconsti-
tution of sufficient amounts of MacB to define any P, burst, 
which is technically demanding. Consequently, although these 
earlier studies support our conclusion that MacA affects the 
ATPase activity of MacB, they do not give the detailed insight 
into the ATPase mechanism provided by our pre-steady-state 
analyses. 
Our studies established that conformational changes can be 
propagated from the periplasmic domain of MacA to the cyto-
plasmic NBD of MacB (Figs. 1 and 2), and consequently, it is 
plausible that TolC, by interacting with MacA, can detect the 
nucleotide state of MacB. The binding of ATP to MacB would 
stimulate MacA to interact with TolC, inducing the latter to 
adopt the open state. Because ATP and MacA stabilize in the 
outward-facing conformation of MacB, drug transfer from 
MacB to TolC would be facilitated. TolC would then commu-
nicate with the NBD of MacB (again, such communication is 
probably conveyed Via MacA) to stimulate ATP hydrolysis, 
which would be required to reset MacB in the inward-facing 
conformation. If ATP hydrolysis is controlled by TolC, so that 
the MacB conformation is only reset after the interaction with 
TolC and productive transfer of drugs, this would provide an 
explanation of the apparent insensitivity of the ATPase activity 
of MacB to drugs. Indeed, without such a feedback control 
mechanism of drug export, it would appear that drug stimula-
tion of the ATPase activity of MacB would be counter-produc-
tive because the MacB conformation could be reset before drug 
transfer to TolC. There is an analogy in the mechanism of oper-
ation of ABC transporters that work in conjunction with a 
periplasmic binding protein (47). In the E. coli maltose trans-
porter, the binding of ATP to the ATPase subunit MalK induces 
conformational changes, detected by tryptic digestion, in the 
periplasmic loops of the membrane subunits MalF and MalG 
(48), although EPR studies revealed that ATP binding, but not 
ADP binding, caused an increase in affinity between the trans-
porter and the maltose-binding protein (MBP), and "forcing 
open" the bound MBP to release its substrate (49). The trans-
porter is reset in its original inward-facing conformation by 
ATP hydrolysis, which is stimulated by the MBP (50). In our 
model TolC replaces the MBP and, because the open state 
requires disruption of the second selectivity filter and subse-
quent twisting of the helices of the TolC channel to keep it fully 
open, there is a need for the MacA hairpins to stabilize this 
conformation, which could not be achieved by interaction with 
MacB alone. Although we have interpreted our findings in 
terms of an alternating conformation model for MacB, in which 
the drug-binding sites are inwardly and outwardly exposed, 
such a model could easily be refined to account for drug binding 
to a fixed periplasmic site, in analogy to AcrB, with ATP binding 
and hydrolysis coupled to conformational changes that induce 
TolC association and dissociation. Clearly the work presented 
here provides an important framework for further studies that 
will enable the elucidation of the mechanism underlying the 
MacB Dimer Is Regulated by MacA 
dynamics of assembly of the MacABTolC tripartite pump in the 
future. 
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